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ABSTRACT 
 
MATTHEW J. PETERSON: Epidemiologic Evidence for Physical Activity as a Preventative 
Factor for Metabolic Syndrome and Frailty: the Health ABC Study 
(Under the direction of Carol Giuliani and Miriam C. Morey) 
 
The presence of metabolic syndrome (MS) or frailty aligns an older adult with increased 
risk for health decline. Physical activity is an important part of health maintenance in older 
adults, but optimal doses of physical activity are unclear with these two health conditions. 
This study examined the longitudinal associations between different doses and types of 
physical activity and incidence of MS and frailty. Participants from the Health, Aging and 
Body Composition Study were followed for six years to ascertain long-term MS and frailty 
status. Physical activity doses at baseline included weekly time (low, recommended, high), 
intensity (sedentary, light, moderate, vigorous) and type (sedentary, lifestyle active, exercise 
active). In MS as the outcome, in men, dose-response curves generally were linear, with 
increasingly lower doses of time, intensity and activity type resulting in a higher incidence of 
MS. In women, intermediate doses of time and intensity were associated with the lowest 
incidence of MS, indicating a U-shaped dose-response curve. Results also indicated that the 
time and intensity physical activity doses were not associated with frailty; however, being 
exercise active was associated with reduced risk for frailty. In those who had progressed to 
frailty within six years, we found that the sedentary and lifestyle active participants were at 
increased risk for severe frailty compared to the exercise active in a dose-response manner. 
The optimal dose of physical activity for reducing the risk of MS in older men is spending, 
iv
on average, more than thirty minutes per day in vigorous activities. The optimal dose of 
physical activity for reducing the risk of MS in older women is meeting the current 
recommendations for time spent in weekly physical activity in activities of light intensity 
such as light housework, shopping, or volunteering. Expending 1000 kcals/week in physical 
activities that are done with the intent of exercising, such as walking for exercise, strength 
training or aerobic dance, can reduce the risk of frailty onset and severity in older adults.  
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Chapter I. BACKGROUND 
 
The US is in the midst of an unprecedented aging boom. By the middle of this 
century the eighty-five and older age group is expected to rise four-fold (U.S. Census Bureau 
Population Division National Projections Program 2004). However, the expansion of older 
age group brackets also brings the issues of their healthcare needs. Medical advancements 
have allowed the possibility of surviving longer, but this is associated with higher rates of 
chronic illnesses, disability, and substantial healthcare burdens (Guralnik and Simonsick 
1993). Two health conditions particularly prevalent in older adults that have received 
increasing attention in the medical and research communities over the last two decades are 
frailty and metabolic syndrome. Because of their associations with poor health outcomes, 
preventing and treating frailty and metabolic syndrome remain priorities for gerontology 
researchers (Hogan, MacKnight et al. 2003; Scuteri, Morrell et al. 2005). 
Physical activity has been proposed and tested as an intervention in older adults to 
positively impact their health and quality of life (Singh 2002). Physical activity also has 
shown to be a strong preventative factor for many age-related health conditions (American 
College of Sports Medicine 1998). The mechanisms underlying the physical activity-disease 
prevention relationship are very clear in some cases. For instance, lifetime joggers have a 
lower probability of heart disease compared to age-matched lifetime sedentary groups 
(Pollock, Mengelkoch et al. 1997). The cause-effect link between chronic aerobic exercise 
and reduced risk for heart disease is clear in the literature.  
2The physical activity-disease prevention link is less clear in multi-dimensional health 
conditions, such as frailty and metabolic syndrome, both of which consist of clusters of 
conditions that can have multiple and differing pathogeneses. The lack of a cause-effect link 
is especially true in older adults with frailty and metabolic syndrome, thus studies to 
determine appropriate modalities and doses of physical activity are important for determining 
how to treat and positively affect frailty and metabolic syndrome in older adults. 
Aging and the Metabolic Syndrome  
The metabolic syndrome is a constellation of risk factors for diabetes, coronary heart 
disease, and coronary heart disease related deaths (Ford, Kohl et al. 2005; Scuteri, Morrell et 
al. 2005). The prevalence of metabolic syndrome increases substantially with aging, from 
approximately 20% in the middle-aged to approximately 40% in the elderly in some studies 
(Ford, Giles et al. 2002; Goodpastor, Krishnaswami et al. 2005). According to the Adult 
Treatment Panel III consensus statement, three or more of the following factors indicate the 
presence of metabolic syndrome: increased waist circumference (>102 cm. in men and >88 
cm. in women), high triglycerides (> 1.7 mmol/l), low HDL cholesterol (<1.04 mmol/l in 
men and <1.29 mmol/l in women), high blood pressure (>130/85 mmHg or pharmacological 
treatment of hypertension), and fasting glucose (>6.1 mmol/l). The aggregate effect of these 
risk factors are greater than any one factor alone (Ford, Kohl et al. 2005), and the startling 
increased risk of insulin resistance with the presence of metabolic syndrome has been 
identified as a major public health concern (Panagiotakos, Pitsavos et al. 2004).  
 Epidemiologic studies have shown consistent associations between low levels of 
physical activity and increased risk for metabolic syndrome (Farrell, Cheng et al. 2004; 
Katzmarzyk, Church et al. 2004; Ford, Kohl et al. 2005; Katzmarzyk, Church et al. 2005). 
3However, to date there are no published reports on the associations between physical activity 
levels and metabolic syndrome in older adults. This is important because with lower levels of 
activity and higher prevalence of metabolic syndrome and chronic illnesses in older adults, 
these associations and their interactions are important to understand for the design of 
effectively tailored health interventions. 
 
Aging and Frailty 
Frailty in older adults is a concerning state for the individual, his/her family and 
healthcare providers. Frail older adults are more likely than the non-frail to experience rapid 
functional decline and disability (Gill, Williams et al. 1995). Ferrucci defines frailty as, “a 
pathologic condition that results in a constellation of signs and symptoms and is 
characterized by high susceptibility, impending decline in physical function and high risk of 
death” (Fried, Ferrucci et al. 2004). By definition frailty is a pre-disability state, and can be 
considered a primary pathway to disability. Approximately 4-7% of the U.S. population over 
sixty-five years old is frail (Fried, Tangen et al. 2001). Compared to the non-frail, frail 
individuals are more likely to fall, have worsening mobility and ADL disability, require 
hospitalization or institutionalization, and die over three and seven year follow-up periods 
(Fried, Tangen et al. 2001). An equally troubling statistic is the estimated prevalence of pre-
frail older adults (those transitioning to frailty), with estimates ranging from 28% to almost 
50% of adults over age sixty-five. The risks for adverse health outcomes for the pre-frail and 
frail groups are very similar, and in some instances pre-frail risks are slightly higher, such as 
risk for future mobility limitations (Fried, Tangen et al. 2001). 
 The impact of physical activity on frailty is not well known. Several studies have 
explored the effectiveness of a physical activity intervention on frailty risk factors, such as 
4mobility limitations, strength and endurance (Keysor and Jette 2001), or studies have 
examined functional outcomes in a cohort identified at baseline as frail (Gill, Baker et al. 
2002).  To appropriately design physical activity intervention studies it is first necessary to 
look in the epidemiologic evidence to determine which, if any, targeted interventions have 
the greatest probability of affecting frailty status.  
 
Physical Activity Types and Doses 
 
Determining the optimal dose of physical activity that has the greatest impact on 
subsequent health is a difficult endeavor. In 2000, the Canadian and US governments co-
sponsored a symposium entitled, “Dose-response issues concerning physical activity and 
health: an evidence-based symposium.” This symposium provided an opportunity to review 
and synthesize the evidence regarding optimal doses of physical activity to generate health 
benefits. Only one paper presented evidence on the dose-response associations between 
physical activity and health outcomes (quality of life and independent living) specifically in 
older adults (>65 y.o.) (Spirduso and Cronin 2001).  These authors concluded that, “Whether 
a PA group defined “dose-response” exists, or whether an activity level threshold is 
operative, is unclear.” The lack of evidence can be partly attributed to lack of studies 
exploring specific doses of physical activity a priori. In fact, the authors state that most dose-
responses are observed in post-hoc analyses of clinical trials, where the participants are 
grouped using attendance or physiological monitoring (i.e. exercise heart rates).  Optimally, 
trials using older adults as participants would be designed to test the effect of differing doses 
of physical activity on health outcomes. Use of large population-based data sources to 
5examine potentially effective dose-response associations could assist in designing these 
trials. 
Since the landmark 1996 Surgeon General’s Report on Physical Activity and Health, 
there has been much debate surrounding the issue of whether health professionals should 
recommend increased physical activity or exercise for health benefits. Physical activity is 
defined as any bodily movement produced by skeletal muscles that results in increased 
energy expenditure. Exercise is defined as planned, structured, and repetitive bodily 
movement for the purpose of improving or maintaining one or more components of fitness. 
By definition exercise is a form of physical activity; however, not all types of physical 
activity can be classified as exercise. For instance, housework and gardening, while fitting 
the definition of physical activity, can be repetitive in nature, but not likely performed to 
improve fitness levels---thus difficult to classify as exercise. Research has shown physical 
activity and fitness (a product of regular exercise) to have differing dose-response 
associations with health outcomes such as major chronic diseases (CHD, CVD, cancer, 
stroke) and mortality. In fact, when physical activity and cardiorespiratory fitness were 
included in the same hazards model, physical activity was not associated with mortality, 
while the highest fitness levels group showed a 70% reduction in risk of death compared to 
the lowest fit group (Blair, Cheng et al. 2001). The motivation, purpose, and context of 
physical activity and exercise are often times quite divergent, thus it seems plausible that 
their pathways of health benefit also differ. It may be advantageous to consider physical 
activity and exercise as differing entities. This will assist in determining their differing 
impact on the health outcomes of older adults with and without metabolic syndrome and 
frailty, and determining if such differences do exist. 
6Public Health Implications 
The potential public health implications of this work are extensive. First, the costs of 
physical inactivity are well documented. It is estimated that one in three cases of heart 
disease, a substantial health risk in those with metabolic syndrome, is attributable to physical 
inactivity (NA Garrett AJPM, 2004). Further, the medical expenditures of those with 
diabetes, also a major risk of metabolic syndrome, is almost 2.5 times that of a non-diabetic 
(ADA, Diabetes Care, 2003). The potential to decrease the risk of heart disease and diabetes 
with focused physical activity interventions aimed at preventing or attenuating metabolic 
syndrome is a potential public health benefit of this research. The public health results for 
this work in affecting frailty are also substantial. For instance, sarcopenia, a direct cause of 
one frailty factor (poor strength), cost an increase in healthcare expenditures of 
approximately $900 per person in 2000 (I Janssen, JAGS, 2004). And it is estimated that, in 
hospitalized elders, for each 0.1 meter/second/year increase in gait speed (a second frailty 
factor) an associated reduction of $1100 in yearly health care costs is observed. The 
prevention of strength and mobility loss can directly impact frailty status and the subsequent 
public health impact of disability; therefore, determining those doses and types of physical 
activity that are most closely associated with the prevention of frailty is of great importance.  
 
7Statement of the Problem    
Frailty and metabolic syndrome are two conditions that affect a growing number of 
older adults. Unlike other well-studied aging-related health conditions, physical activity 
interventions aimed at frailty and metabolic syndrome have been designed and conducted 
without sufficient epidemiologic evidence for targeted interventions. Specifically, questions 
such as the strength of the associations between regular physical activity and frailty and 
metabolic syndrome, physical activity exposure and subsequent severity of disease status, 
dose-response associations, and differing effects in sub-populations (minorities, healthcare 
disparate, military veterans, oldest-old) are largely unexplored with these conditions. Using 
data from the Health, Aging and Body Composition Study, the analyses in this dissertation 
will explore the prospective relationships between physical activity and the outcomes of 
frailty and metabolic syndrome. This proposed body of work will assist in beginning to 
understand which specific behavioral interventions have the greatest potential to combat the 
deleterious effects of metabolic syndrome and frailty in older adults.  
 
8Objectives and Hypotheses 
 
Objective 1: 
To determine if there are longitudinal associations between physical activity and metabolic 
syndrome in older adults.  
Hypothesis 1 (Focused on Intensity of Physical Activity): Older adults who engage in 
vigorous (6+ Mets) physical activity on a regular weekly basis have a lower incidence 
of metabolic syndrome as compared to those who engage regularly in physical 
activities of moderate (3-6 Mets) or light (<3 Mets) intensity, or to those who are 
sedentary.
Hypothesis 2 (Focused on Time Spent in Physical Activity): Older adults who engage 
in greater than the recommended amount of weekly time (200+ minutes/week) in 
physical activity have a lower incidence of metabolic syndrome as compared to those 
who engage in the recommended amount (150-200 minutes/week), or less than the 
recommended weekly amount of time (<150 minutes/week).
Hypothesis 3 (Focused on Type of Physical Activity): Older adults who expend 
weekly energy primarily from exercise activities have a lower incidence of metabolic 
syndrome as compared to those whose expenditure is primarily lifestyle activities, or
to those who are sedentary.
Objective 2: 
To examine how different doses and types of physical activity affect the development and 
severity of frailty status in older adults. 
9Hypothesis 1 (Focused on Intensity of Physical Activity): Older adults who engage in 
vigorous (6+ Mets) physical activity on a regular weekly basis have a lower incidence 
of frailty as compared to those who engage regularly in physical activities of 
moderate (3-6 Mets) or light (<3 Mets) intensity, or to those who are sedentary 
Hypothesis 2 (Focused on Time Spent in Physical Activity): Older adults who engage 
in greater than the recommended amount of weekly time (200+ minutes/week) in 
physical activity have a lower incidence of frailty as compared to those who engage 
in the recommended amount (150-200 minutes/week), or less than the recommended 
weekly amount of time (<150 minutes/week) 
Hypothesis 3 (Focused on Type of Physical Activity): Older adults who expend 
weekly energy primarily from exercise activities have a lower incidence of frailty as 
compared to those whose expenditure is primarily lifestyle activities, or to those who 
are sedentary.
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LIST OF ABBREVIATIONS 
Blood pressure (BP) 
 
Centimeters (cm) 
 
High density lipoprotein (HDL) 
 
Kilocalories per week (kcals/week) 
 
Metabolic equivalents (Mets) 
Meters per second (m/sec) 
 
Milligrams per deciliter (Mg/dl) 
 
Millimeters of mercury (Mm/Hg) 
 
Ninety-fifth percentile confidence interval (95%CI) 
 
Odds ratio (OR) 
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Definition of Terms 
 
Metabolic Syndrome- defined as having three or more of the following metabolic risk 
factors: (The Expert Panel on Detection 2001)  
1) Waist circumference of 102 cm. for men and 88 cm. for women, 
2) serum triglyceride 150 mg/dl,  
3) HDL < 40 mg/dl for men and 50 mg/dl for women, 
4) BP > 130/85 mm/Hg or taking anti-hypertensive medications, 
5) serum glucose > 110 mg/dl or taking oral/injectible diabetes medications. 
 
Frailty- a pathologic condition that results in a constellation of signs and symptoms and is 
characterized by high susceptibility, impending decline in physical function and high risk of 
death.  
 
Frailty Model- adapted from Gill et al (Gill, Baker et al. 2002), and includes the following 
criteria: 
1) Inability to rise from a chair five times with arms folded  
2) A usual pace gait speed less than 0.60 m/sec. 
 
Not Frail- defined as fitting neither of the frailty criteria. 
Moderate frailty- defined as fitting one of the two frailty criteria. 
Severe frailty- defined as fitting both criteria. 
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Physical Activity Groups- based on current recommendations for weekly energy expenditure 
via physical activity (U.S. Department of Health and Human Services 1996) (American 
College of Sports Medicine 1998).  
 
Intensity Group- these intensity doses were based American College of Sports Medicine 
guidelines for determination of activity intensities based on Met level cut-offs (Ainsworth, 
Haskell et al. 2000) and on recommended accumulated weekly energy expenditure for health 
benefits (minimum of 1000 kcals/week) (U.S. Department of Health and Human Services 
1996). 
Vigorous Intensity Dose- individuals accumulating a minimum of 1000 kcals/week in 
physical activities of an intensity of 6 Mets or greater. 
Moderate Intensity Dose- individuals accumulating a minimum of 1000 kcals/week in 
physical activities of an intensity of 3-6 Mets, and less than 1000 kcals/week in vigorous 
intensity activities. 
Light Intensity Dose- individuals accumulating a minimum of 1000 kcals/week in physical 
activities of an intensity of less than 3 Mets, and less than 1000 kcals/week in vigorous and 
moderate intensity activities. 
Sedentary Dose- individuals accumulating less than 1000 kcals/week in any physical 
activities. 
 
Time Group- these doses were based on current recommendations for weekly accumulated 
time spent in physical activity (U.S. Department of Health and Human Services 1996) (Pate, 
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Pratt et al. 1995). Due to availability of data, these groups were constructed using only the 
sum of minutes per week spent walking of any intensity  
High Time Dose- individuals accumulating a minimum of 200 minutes/week in physical 
activities of any intensity. 
Recommended Time Dose- individuals accumulating between 150-200 minutes/week in 
physical activities of any intensity. 
Low Time Dose- individuals accumulating less than 150 minutes/week in physical activities 
of any intensity. 
 
Activity Types- These activity type groups are based on previous construct developed by 
Brach et al. (Brach, Simonsick et al. 2004) using current physical activity recommendations 
(U.S. Department of Health and Human Services 1996) (Pate, Pratt et al. 1995) for weekly 
energy expenditure (minimum of 1000 kcals/week) and on distribution of weekly energy 
expenditure in total physical activity in the Health ABC cohort (25th percentile = 2,719 
kcals/week). 
Exercise Active - individuals accumulating greater than 1000 kcals/week in exercise 
activities.  
Lifestyle Active - individuals accumulating at least 2719 kcals/week in physical activity and 
less than 1000 kcals/week in exercise activity. 
Sedentary - individuals accumulating less than 1000 kcals/week in exercise activity and less 
than 2719 kcals/week in physical activity. 
 
Chapter II. MANUSCRIPT ONE: Physical Activity Doses and Incident Metabolic Syndrome 
in Older Adults: The Health ABC Study 
 
Matthew J. Peterson, Miriam C. Morey, Carol Giuliani, Carl F. Pieper, Kelly Evenson, Vicki 
Mercer, Marjolein Visser, Jennifer Brach, Steven Kritchevsky, Bret Goodpaster, Susan 
Rubin, Suzanne Satterfield, and Eleanor Simonsick, for the Health, Aging and Body 
Composition Study Research Group. 
 
Affiliations: 
 
Address for Correspondence: 
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Abstract 
 
Having metabolic syndrome (MS) places an individual at substantial risk for diabetes, 
cardiovascular disease, and cardiovascular disease-related death, and the prevalence of MS in 
older adults is approximately 40%. The optimal doses of physical activity to reduce risk for 
MS are not currently known. PURPOSE: To examine how different doses and types of 
physical activity affect the six year incidence of MS in older adults. METHODS: 1266 
participants from the Health ABC Study were followed for six years. MS status was 
determined by having three of five factors that include high waist circumference, high blood 
pressure, low HDL cholesterol, high triglycerides, and high blood glucose levels. 
Hierarchical physical activity doses at baseline were divided into three categories, 1) time 
(low, recommended, high), 2) intensity (sedentary, light, moderate, vigorous) and, 3) 
activity type (sedentary, lifestyle active, exercise active). Gender specific logistic regression 
models were used to develop odds ratios and 95% confidence intervals for incident MS. 
RESULTS: 20% of men and women developed MS over six years. In men, dose-response 
curves generally were linear, with increasingly lower doses of time, intensity and activity 
type resulting in a higher incidence of MS, with the low time dose being significantly 
different from the high time dose (OR=1.67; 95%CI 1.01-1.74). In women, intermediate 
doses of time (incidence of MS in recommended dose-14% vs. high dose-24%) and intensity 
(incidence of MS in light dose-18% vs. vigorous dose-31%) were associated with the lowest 
incidence of metabolic syndrome, indicating a U-shaped dose-response curve. Within the 
activity types, being exercise active potentially placed a woman at greater risk for metabolic 
syndrome compared to being sedentary (sedentary vs. exercise active OR=0.55; 95%CI 0.28-
16
1.10). CONCLUSIONS: The optimal doses of physical activity in preventing MS are 
different in men and women. In men doses of physical activity beyond the current 
recommendations are of added benefit. In women, meeting the recommended weekly time 
(150-200 minutes/week) and engaging in light intensity activities are optimal in preventing 
MS, resulting in a U-shaped dose-response curve. This indicates that the highest doses of 
physical activity may place an older woman at increased risk for metabolic syndrome 
compared to intermediate dose. However, further studies are needed to add to these findings. 
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Introduction 
 
Metabolic syndrome is a constellation of factors that, when present, substantially 
increase the risk for diabetes mellitus, cardiovascular disease, coronary heart disease and 
cardiovascular disease-related deaths (Ford, Giles et al. 2002). The prevalence of metabolic 
syndrome in the US adult population is estimated to be 25%, however, prevalence increases 
with aging such that up to 40% of adults aged sixty-five years and older have the condition 
(Scuteri, Morrell et al. 2005) (Park, Zhu et al. 2003). The third Adult Treatment Panel defines 
the presence of metabolic syndrome as having a combination of any three factors that include 
increased waist circumference (>102 cm. in men and >88 cm. in women), high triglycerides 
(> 1.7 mmol/l), low HDL cholesterol (<1.04 mmol/l in men and <1.29 mmol/l in women), 
high blood pressure (>130/85 mmHg), and fasting glucose (>6.1 mmol/l) (The Expert Panel 
on Detection 2001).  
 Physical activity is a protective factor for numerous poor health conditions. However, 
the association between physical activity and metabolic syndrome is not clear in the 
literature, particularly when considering the optimal dose of physical activity for reversal, 
prevention, or delay of metabolic syndrome. This may in part be due to the differing dose 
response associations seen with physical activity and the individual metabolic syndrome 
factors. For instance, there is evidence for linear dose-response associations between physical 
activity and dyslipidemia, and obesity measured as total body fat (Kraus, Houmard et al. 
2002) (Slentz, Duscha et al. 2004); however, the dose-response associations between 
physical activity and impaired glucose tolerance, and blood pressure indicates a potential 
threshold of benefit with moderate activity (Houmard, Tanner et al. 2004) (Ishikawa-Takata, 
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Ohta et al. 2003). There is a need for studies to determine the optimal doses of physical 
activity in preventing metabolic syndrome, where the above individual factors interact with 
one another. 
Therefore, the objective of this study was to examine how different doses and types 
of physical activity affect the incidence of metabolic syndrome in older adults. Using data 
from the Health, Aging and Body Composition (Health ABC) Study, we tested the 
hypotheses that, 1) Older adults who engage in vigorous (6+ Mets) physical activity on a 
regular weekly basis have a lower incidence of metabolic syndrome as compared to those 
who engage regularly in physical activities of moderate (3-6 Mets) or light (<3 Mets) 
intensity, or to those who are sedentary, 2) Older adults who engage in greater than the 
recommended amount of weekly time (200+ minutes/week) in physical activity have a lower 
incidence of metabolic syndrome as compared to those who engage in the recommended 
amount (150-200 minutes/week), or less than the recommended weekly amount of time 
(<150 minutes/week), and 3) Older adults who expend weekly energy primarily from 
exercise activities have a lower incidence of metabolic syndrome as compared to those 
whose expenditure is primarily lifestyle activities, or to those who are sedentary.
Methods 
Health ABC Study 
The Health ABC Study is a longitudinal, prospective study with the broad objectives of 
measuring higher functioning older adults to allow examination of health decline and 
improvement over several years, and to allow comparisons with other well-studied 
populations (i.e. EPESE, Women’s Health and Aging Study). Specifically, the study aims 
include investigation of the interrelationships between health conditions, body composition, 
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social and behavioral factors, and functional change (Simonsick, Newman et al. 2001). 
Clinic-based examinations and self-report measures were collected over a seven year period.  
 Study Population 
The Health ABC Study cohort consists of 3075 well-functioning black and white men 
and women aged 70 to 79. White participants were recruited from a random sample of 
Medicare beneficiaries in the zip codes surrounding Pittsburgh, Pennsylvania and Memphis, 
Tennessee. Black participants were recruited from all age-eligible residents of the areas in 
and surrounding Pittsburgh and Memphis. Potential participants were then screened for the 
following inclusion criteria, 1) No reported difficulty: walking ¼ mile, walking up ten steps, 
or performing basic activities of daily living, 2) no known life-threatening cancers, 3) no 
plans to leave the area for three years. The University of Pittsburgh and University of 
Memphis institutional review boards approved the study, and all participants provided 
written informed consent prior to participation. 
For this analysis, participants were excluded due to having metabolic syndrome at 
baseline (N=1169) or to incomplete or unknown follow-up metabolic syndrome status 
(N=640), leaving 1266 participants for this study.  
 Study Measures 
The outcome variable for this study was metabolic syndrome, which is defined as 
having three or more factors identified by the Third Adult Treatment Panel (ATP III) (The 
Expert Panel on Detection 2001). These criteria include a waist circumference of 102 cm. or 
greater for men and 88 cm. or greater for women; a serum triglyceride of 150 mg/dl or 
greater; serum HDL levels of 40 mg/dl or less for men and 50 mg/dl for women; resting 
blood pressure greater than 130/85; serum glucose greater than 110 mg/dl. Individuals on 
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blood pressure or diabetes medications were considered positive for that particular factor. 
The blood assays needed for the metabolic syndrome factors listed above were collected and 
analyzed at baseline and year six in the Health ABC Study. 
The predictor variable of interest, physical activity levels, was collected from 
participants at baseline using a self-report instrument developed specifically for the Health 
ABC Study. The standardized questionnaire was developed using the model of several 
commonly used activity questionnaires, such as the Minnesota leisure-time physical activity 
questionnaire (Taylor, Jacobs et al. 1978). Kilocalories per week (kcals/week) expended in 
common exercise activities (i.e. walking for exercise, exercise classes, weightlifting) and 
lifestyle activities (i.e. gardening, housework, yard work) were collected. Specifically, 
participants were asked if they had engaged in physical and exercise activities at least ten 
times in the last twelve months. Those activities that were identified as positive over the last 
year were further examined regarding time for each activity over the last seven days. Based 
on self-reported weekly time and known metabolic costs for activities (Ainsworth, Haskell et 
al. 2000) a summary variable of kcals/week expended was calculated for each activity. The 
metabolic cost of activities is reported in metabolic equivalents (Mets). One Met is 
equivalent to resting energy expenditure, or 3.5 ml/kg/min.   
For this study, physical activity doses and types were determined to allow for several 
associations to be tested based on current recommendations for weekly energy expenditure 
via physical activity (U.S. Department of Health and Human Services 1996) (American 
College of Sports Medicine 1998). The doses are hierarchical in nature, moving from the 
lowest dose to the highest dose, within each physical activity category. Specifically, time 
doses (low, recommended, high), intensity doses (sedentary, light, moderate, vigorous), and 
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activity types (sedentary, lifestyle active, exercise active) were tested. The format of the 
Health ABC questionnaire did not allow a physical activity weekly frequency dose-response 
to be tested for this study. The physical activity categories and specific doses are shown in 
Table 1. 
Time doses were based on current recommendations for weekly accumulated time spent in 
physical activity (U.S. Department of Health and Human Services 1996) (Pate, Pratt et al. 
1995). Due to availability of data, these doses were constructed using only the sum of 
minutes per week spent walking of any intensity and time spent in exercise. Intensity doses 
were based on American College of Sports Medicine guidelines for determination of activity 
intensities based on Met level cut-offs (Ainsworth, Haskell et al. 2000) and on recommended 
accumulated weekly energy expenditure for health benefits (minimum of 1000 kcals/week) 
(U.S. Department of Health and Human Services 1996).  Activity type groups were based on 
the previous construct developed by Brach et al. (Brach, Simonsick et al. 2004) using current 
physical activity recommendations (U.S. Department of Health and Human Services 1996) 
(Pate, Pratt et al. 1995) for weekly energy expenditure (minimum of 1000 kcals/week) and on 
distribution of weekly energy expenditure in total physical activity in the Health ABC cohort 
(25th percentile = 2,719 kcals/week). 
Covariates that were collected at baseline and controlled for in the analyses include 
age, sex, race, percent body fat, education, marital status, count of chronic diseases 
(cerebrovascular disease, lower limb OA, pulmonary disease, circulation problems in 
extremities, and depression), smoking status and alcohol consumption. Heart disease was 
considered a separate covariate due to its strong association with metabolic syndrome. Race 
was dichotomized into black and white. Chronic diseases were ascertained by asking the 
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participant, “Has a doctor ever told you that you have…,” clinic data, and current medication 
use. Weight (kg) was measured by a standard balance beam scale, and height (m) was 
measured using a wall-mounted stadiometer. Waist circumference was measured by trained 
technicians using a tape measure at the level of the umbilicus directly on the skin. Smoking 
status was categorized as current smoker, former smoker, and never smoker. Weekly alcohol 
consumption was categorized as none, 1-7 drinks/week, and more than seven drinks/week. 
Education was categorized as less than high school, high school graduate, and any post-
secondary education. 
Statistical Analysis 
Baseline characteristics of the cohort were examined using univariate procedures 
including proportions or mean + SD, as appropriate. Binary associations between baseline 
predictors and incident metabolic syndrome at year six were tested using the Chi-square test. 
Three logistic regression models, one each for time, intensity, and activity types, were used 
to determine odds ratios and 95% confidence intervals with the highest dose as the reference 
in all models. Physical activity category x covariate interactions were tested in all three 
logistic models. Linear trends were tested using the chi-square test, with significance 
determined to be at the P<0.05 level. Keeping with the methods of Lee and Skerrett (Lee and 
Skerrett 2001), the total volume of physical activity (kcals/week) was entered as a covariate 
in all models to eliminate the potential confounding of this variable when testing dose-
response associations. All analyses were conducted using SAS v8.2 software (SAS, Cary, 
NC). 
 
Results 
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 Table 2 displays baseline characteristics of the 1266 Health ABC participants with no 
baseline metabolic syndrome and complete six year follow-up data.  Comparing between 
men and women indicates expected findings in anthropometrics, lifestyle characteristics, 
educational levels, and prevalent disease states. Men were taller, heavier, reported higher 
rates of smoking and alcohol consumption, and a higher proportion of post-secondary 
education than did women. Women reported higher rates of osteoarthritis and depression, 
which are also consistent with previous reports (Visser, Goodpastor et al. 2005).  
 When examining baseline prevalence of physical activity categories in men and 
women (Table 3), it is evident that in general men reported higher weekly doses of time spent 
in and intensity of physical activities than did women. However, a similar proportion of men 
and women (~40%) were meeting or exceeding recommended weekly time spent engaging in 
physical activity. A greater proportion of men (38% vs. 20%) reported being exercise active, 
i.e. regularly participating in activities such as walking for exercise, exercise classes, and 
weightlifting. Whereas women reported substantially higher rates of light intensity physical 
activities (52% vs. 30%) and in being lifestyle active (56% vs. 44%).  
 
Six Year Incidence of Metabolic Syndrome 
 Six year incidence of metabolic syndrome, metabolic syndrome factors, and severity 
of metabolic syndrome is reported in Table 4. Women had a slightly higher rate of incidence 
of metabolic syndrome compared to men (22% vs. 18%). Comparison of these rates with 
previous studies is not possible, as to our knowledge this is the first study to report incident 
rates of metabolic syndrome in elder adults. Examination of incidence of metabolic 
syndrome factors indicates that development of a blood pressure factor (BP greater than 
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130/85 mmHg) was similar between genders. Rates of development of the other factors were 
higher in women, except for the glucose factor (fasting glucose >110mg/dl), where 12% of 
men and 9% of women developed this over six years. Table 3 also displays, among those 
men and women who did develop metabolic syndrome, the severity of the condition. The 
severity of metabolic syndrome was very similar between genders; with approximately a five 
to one ratio of those meeting the minimum criteria for metabolic syndrome (three factors) vs. 
all other groups combined.   
Physical Activity and Incident Metabolic Syndrome in Men 
 
Examination of physical activity x gender interactions (not shown) indicated that men 
and women had differing physical activity dose-metabolic syndrome response associations; 
therefore separate models were developed for men and women to estimate odds ratios and 
95% confidence intervals for incident metabolic syndrome. Table 5 displays unadjusted and 
adjusted odds ratios and 95% confidence intervals for incident metabolic syndrome in men. 
Generally, adjustment of the models for confounders resulted in minimal changes in the 
magnitude of the odds ratios and their precision. Men reporting accumulating less than 150 
minutes/week in physical activity (low dose) were 67% more likely (Adjusted OR=1.67; 
95%CI 1.01-2.77) to develop metabolic syndrome than the high dose group (>200 
minutes/week) in the covariate-adjusted model. No differences in risk were noted between 
the high dose and recommended dose of time in weekly physical activity in men. However, a 
significant dose-response trend was observed in the time category (P=0.03). The other 
finding of note in men was that those who reported being sedentary in the intensity category 
were twice as likely as those reporting regular vigorous doses to develop metabolic syndrome 
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(Adjusted OR=2.00; 95%CI 0.96-4.15). A marginal dose-response trend was found in the 
intensity category (P=0.07). 
Physical Activity and Incident Metabolic Syndrome in Women 
 The incidence of metabolic syndrome in women’s physical activity categories 
responded in a very different pattern than in the men. Unadjusted and adjusted odds ratios 
and 95% confidence intervals for incident metabolic syndrome in women are shown in Table 
6. As with the models in the men, adjustment for confounders resulted in minimal changes in 
the magnitude of the odds ratios and their precision. The odds ratios in the women’s models 
demonstrate that in every category of physical activity the lower doses conferred a protective, 
though not always significant, effect against incident metabolic syndrome compared to the 
highest, referent doses. Significant effects were found in the intensity category, which 
showed that compared to the vigorous dose, the light dose group was over 50% less likely to 
have metabolic syndrome at year six (Adjusted OR=0.48; 95%CI 0.28-0.81). In women, 
marginal dose-response associations were observed in the intensity (P=0.11) and activity 
types (P=0.08) categories. However, as indicated previously, the dose-response trends 
indicated a possible increasing protective effect against incident metabolic syndrome with 
lesser doses of physical activity. This was an unexpected finding given our research 
hypotheses. 
 To further examine the dose-response associations between men and women, Figure 1 
provides curves for rates of incident metabolic syndrome within the physical activity 
categories. Generally the dose-response curves in all three physical activity categories in the 
men demonstrate reduced incidence of metabolic syndrome with an increasing dose. 
However, in women the time and intensity doses represent a U-shaped curve, where the 
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optimal dose may lie between the lowest and highest doses. Specifically the recommended 
time dose and the light intensity dose appear to be optimal doses in preventing incident 
metabolic syndrome in women, although the light intensity dose was the only dose found to 
be statistically different from the referent dose. An unexpected finding was that, in the 
women activity types (Figure 1c), the sedentary group had an incidence rate of metabolic 
syndrome that was 50% that of the exercise active group, a difference in risk that approached 
statistical significance (OR=0.55; 95%CI 0.28-1.10). 
 
Discussion 
 
In this six-year prospective study, we found that incidence of metabolic syndrome in 
men and women was approximately 20%, and that doses of time, intensity and activity types 
confer quite different effects on metabolic syndrome when comparing men and women. Dose 
response curves in men generally followed a form that we expected to see, with a decrease in 
incidence of metabolic syndrome with increasingly higher doses of physical activity. 
However in women the time and intensity doses displayed U-shaped dose-response curves, 
indicating that intermediate doses of time and intensity may be optimal in older women to 
prevent metabolic syndrome. Significant findings were that in men, the risk of incident 
metabolic syndrome in those reporting low levels of weekly time spent in physical activity 
was 67% greater than in those men reporting more than 200 minutes/week (high dose). In 
women, regular light intensity doses of physical activity confer a protective effect against 
metabolic syndrome compared to those reporting regular vigorous doses, and the magnitude 
of a 50% reduction in risk observed was quite large.  
 We were able to find only one study that examined the impact of physical activity on 
metabolic syndrome specifically in older adults. Stewart and colleagues conducted a 26-week 
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clinical trial with a three days per week exercise component that included strength training at 
50% of 1-repetition maximum and forty five minutes of aerobic training at 60-90% of 
maximum heart rate(Stewart, Bacher et al. 2005). These exercise levels would be considered 
moderate to vigorous, and the accumulated time would meet weekly time recommendations 
(~180 minutes/week). However the impact of the intervention on the attenuation of metabolic 
syndrome was only borderline significant (P=0.06). Another study examined the associations 
between physical activity and selected metabolic syndrome factors in older adults. Petrella 
examined the long term effects (over ten years) of regular exercise compared with being 
sedentary in two groups who were self-selected (Petrella, Varallo et al. 2005). The training 
consisted of three days per week of aerobic activities (walking, jogging) for forty five 
minutes at 65-75% of maximum heart rate. These training zones are of moderate to vigorous 
intensity and exercisers demonstrated long-term improvements, compared to the sedentary 
controls, in all five metabolic syndrome factors. These studies indicate that in older adults, 
engaging in physical activity of moderate to vigorous intensity for 135-180 minutes per week 
may be adequate doses to prevent metabolic syndrome. Our findings in older men generally 
concur with these studies. However, in older women our findings do not support the above 
doses as optimal. 
The pronounced gender difference in the risk of metabolic syndrome across physical 
activity doses was an unexpected finding and warrants discussion. Not only were the dose-
response curves in women different from the men, but also the curves differed when looking 
within the women’s physical activity categories. In women, time and intensity dose-
responses resembled a U-shaped curve, whereas activity types tended to demonstrate a linear 
response, but in the direction of sedentary as being favorable. Rennie and colleagues (Rennie, 
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IJE, 2003) demonstrated that women had differing dose-response relationships from men 
when examining the profile of metabolic syndrome factors across a continuum of time spent 
in weekly vigorous activity. The group reporting the second lowest levels of any vigorous 
activity (<5 Met hours/week) had the best metabolic syndrome profile, demonstrating a 
similar U-shaped dose-response association to that observed in our study. These findings are 
also in line with previous studies that also demonstrated a U-shaped association between 
physical activity doses and cardiovascular disease risk. For example, Bijnen et al. reported a 
U-shaped dose response association between physical activity and risk for coronary heart 
disease in the Zutphen Elderly Study (Bijnen, Caspersen et al. 1998). Similarly, Shaper and 
colleagues demonstrated that middle-aged men who were vigorously active had a greater risk 
of heart attacks over an eight year follow-up period compared to moderate or moderately-
vigorous exercisers (Shaper, Wannamethee et al. 1992). These studies indicate that the dose-
response curve between physical activity and a cardiovascular-related outcome depends very 
much on the outcome itself, the population studied, and in the case of our results, the gender. 
We later hypothesized that the high dose physical activity groups were perhaps at 
greater risk for metabolic syndrome via a higher baseline prevalence of one or two metabolic 
syndrome factors. Analyses (available upon request) indicated that this was not the case, with 
an equal distribution among physical activity doses of women with one or two baseline 
metabolic syndrome factors. We also examined post-hoc if women who reported high doses 
of physical activity had a higher proportion of individuals involved in strength training 
activities compared to men, as strength training activities would not be expected to impact 
cardiovascular-related outcomes at the level of endurance activities.  Conversely, we found 
that compared to the women, men had double the ratio of kilocalories expended from 
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strength training to the overall kilocalories expended in high dose activities. Therefore, we 
can only speculate when discussing the vast gender differences in dose-response associations 
observed in this study.  
The women’s apparent increased risk of metabolic syndrome in all three of the 
physical activity categories’ highest doses (high time dose, vigorous intensity dose, and 
exercise active) may be a result of musculoskeletal injury secondary to overuse, which could 
have lead to dramatic reductions in levels of physical activity in later years that we were not 
able to measure in this study. Gilchrist reported a dose-response association between 
increasing physical activity doses and increased risk of injury in women (Gilchrist, Jones et 
al. 2000). It is also plausible that unmeasured social or environmental changes could have 
occurred over the six years of follow-up. The women may have experienced the death of a 
spouse, moved to environments less conducive to physical activity, or had financial hardships 
that limited involvement in physical activity that required some level of monetary 
involvement. Of course all these scenarios are not necessarily independent of one another, 
and in fact are often inter-dependent (Savikko, Routasalo et al. 2005). Lastly, while no 
baseline health differences were noted between women in the highest dose groups with the 
respective lower dose groups (data available upon request), it is also plausible that health 
events within the six years of follow-up in the high dose groups could have precipitated a 
significant drop in levels of physical activity and a subsequent decline in health leading to 
metabolic syndrome.  
Limitations to this study include the loss of 640 participants to follow-up. This 
represents one-third of the cohort who were free of metabolic syndrome at baseline and could 
have resulted in biased estimates of risk. Also, use of a self-report questionnaire to derive 
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levels of physical activity is subject to participant reporting and recall errors. Direct activity 
measures, such as accelerometers, could provide more accurate totals of weekly caloric 
expenditure (Bassett 2000). Finally, having only a baseline measure of physical activity 
levels is limiting, as follow-up status would provide an over time average of physical activity 
status. 
 Future studies similar to this one are needed to further understand the relationships 
that exist between differing doses of physical activity and metabolic syndrome. Although the 
evidence is compelling for a dramatic increased risk of diabetes, cardiovascular disease, and 
cardiovascular disease related deaths, metabolic syndrome is a condition that is largely 
understudied in determining optimal prevention strategies. This study suggests that optimal 
doses of physical activity are gender-dependent, such that doses of physical activity beyond 
the current recommendations are of added benefit to men, but not to women. Furthermore, 
high doses of physical activity may place an older woman at increased risk for metabolic 
syndrome. 
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Table 1. Physical activity categories and doses. 
Time Category 
Low Time Dose- individuals accumulating less than 150 minutes/week in physical activities 
of any intensity. 
Recommended Time Dose- individuals accumulating between 150-200 minutes/week in 
physical activities of any intensity. 
High Time Dose- individuals accumulating a minimum of 200 minutes/week in physical 
activities of any intensity. 
------------------------------------------------------------------------------------------------------------ 
Intensity Category 
 
Sedentary Dose- individuals accumulating less than 1000 kcals/week in any physical 
activities. 
Light Intensity Dose- individuals accumulating a minimum of 1000 kcals/week in physical 
activities of an intensity of less than 3 Mets, and less than 1000 kcals/week in vigorous and 
moderate intensity activities. 
Moderate Intensity Dose- individuals accumulating a minimum of 1000 kcals/week in 
physical activities of an intensity of 3-6 Mets, and less than 1000 kcals/week in vigorous 
intensity activities. 
Vigorous Intensity Dose- individuals accumulating a minimum of 1000 kcals/week in 
physical activities of an intensity of 6 Mets or greater. 
------------------------------------------------------------------------------------------------------------ 
Activity Types 
 
Sedentary - individuals accumulating less than 1000 kcals/week in exercise activity and less 
than 2719 kcals/week in physical activity. 
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Lifestyle Active - individuals accumulating at least 2719 kcals/week in physical activity and 
less than 1000 kcals/week in exercise activity. 
Exercise Active - individuals accumulating greater than 1000 kcals/week in exercise 
activities.  
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Table 2. Baseline characteristics of 1266 Health ABC participants with no metabolic  
 syndrome and complete six-year follow-up data. 
 
Men (N = 629)   Women (N = 637) ====.
Characteristics  Mean (SD)    Mean (SD) 
 
Age, y    73.7 (2.8)    73.4 (2.9) 
Height, m   1.73 (0.07)    1.60 (0.06) 
Weight, kg   78.1 (11.8)    66.6 (13.4) 
Waist circ., cm  97.5 (10.2)    94.4 (13.7) 
 
% __ %===============
Race 
 White   65.8     60.1 
 
Smoking status 
 Never   33.6     60.7 
 Former   56.5     30.7 
 Current     9.9       8.6 
 
Alcohol (drinks/wk) 
None    37.7     54.7 
1-7    49.6     41.8 
7+    12.7       3.5 
 
Education 
 Less than HS   23.6     19.9 
 HS graduate   24.5     38.0 
 Post-secondary  52.0     42.1   
 
Disease prevalence (%) 
 Cerebrovascular disease   5.8       7.3 
 Heart disease   20.3       9.1 
 Hypertension   38.5     40.5 
 Lower limb osteoarthritis   5.8     11.9 
 Pulmonary disease     9.3       9.7 
 Diabetes      7.1       2.5 
 Circulatory problems    3.5       2.4 
 Depression     7.9     13.8 
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Table 3. Baseline prevalence of physical activity categories. 
Men     Women 
 N (%)     N (%) 
 
Time  
 Low Dose   354 (55.6)    379 (60.3) 
 Recommended Dose    49 (7.7)      49 (7.8) 
 High Dose   234 (36.7)    201 (32.0) 
 
Intensity  
 Sedentary Dose    97 (15.7)      72 (11.7) 
 Light Dose   183 (29.6)    316 (51.5) 
 Moderate Dose  199 (32.2)    111 (18.1) 
 Vigorous Dose  140 (22.6)    115 (18.7) 
 
Activity Types 
 Sedentary   120 (18.8)    147 (23.4) 
 Lifestyle active  277 (43.5)    354 (56.3) 
 Exercise active  240 (37.7)    128 (20.4) 
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Table 4. Metabolic syndrome (MS) status at year six in the Health ABC Study. 
Men     Women 
N (%)     N (%) 
 
Incidence of MS   115 (18.1)    136 (21.6) 
 
Incidence of factors  
 Blood pressure   117 (18.4)    120 (19.1) 
 Waist circ.     74 (11.6)      93 (14.8) 
 Glucose     78 (12.2)      58 (9.2) 
 HDL      45 (7.1)      58 (9.2) 
 Triglycerides     46 (7.2)      60 (9.5) 
 
Number of factors among  
those with MS  
 3 88 (76.5)    106 (78.0) 
 4 24 (20.9)      27 (19.9) 
 5 3 (2.6)        3 (2.2) 
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Table 5. Unadjusted and adjusted models of baseline physical activity and incident metabolic 
syndrome in men. 
Variable   Unadjusted OR (95%CI) Adjusted OR*(95% CI)  
Time 
 Low dose   1.92 (1.22-3.04)  1.67 (1.01-2.77)   
 Recommended dose  1.13 (0.47-2.75)  0.90 (0.35-2.31)   
 High dose   1.00    1.00    
P for trend   0.004    0.03    
 
Intensity 
 Sedentary dose  1.76 (0.91-3.41)  2.00 (0.96-4.15)   
 Light dose   1.29 (0.71-2.34  1.39 (0.72-2.67)   
 Moderate dose  1.17 (0.65-2.11)  1.27 (0.68-2.39)    
 Vigorous dose  1.00    1.00    
P for trend   0.09    0.07     
 
Activity types 
 Sedentary   1.49 (0.85-2.63)  1.46 (0.74-2.86)   
 Lifestyle active  1.37 (0.86-2.18)  1.33 (0.81-2.18)   
 Exercise active  1.00    1.00     
P for trend   0.13    0.19    
*Adjusted for total kcals, age, percent body fat, gender, race, education, marital status, 
smoking status, drinking status, heart disease, and count of other diagnoses. 
 
37
Table 6. Unadjusted and adjusted models of baseline physical activity and incident metabolic 
syndrome in women. 
Variable   Unadjusted OR (95%CI) Adjusted OR* (95%CI)  
Time 
 Low dose   0.87 (0.58-1.30)  0.81 (0.51-1.27)   
 Recommended dose  0.53 (0.22-1.26)  0.63 (0.26-1.55)   
 High dose   1.00    1.00     
P for trend   0.57    0.25     
 
Intensity 
 Sedentary dose  0.73 (0.38-1.42)  0.91 (0.44-1.88)   
 Light dose   0.47 (0.29-0.77)  0.48 (0.28-0.81)   
 Moderate dose  0.67 (0.37-1.21)  0.75 (0.40-1.39)   
 Vigorous dose  1.00    1.00     
P for trend   0.03    0.11    
 
Activity types 
 Sedentary   0.53 (0.29-0.97)  0.55 (0.28-1.10)   
 Lifestyle active  0.90 (0.57-1.45)  0.84 (0.51-1.38)   
 Exercise active  1.00    1.00     
P for trend   0.04    0.08     
*Adjusted for total kcals, age, percent body fat, gender, race, education, marital status, 
smoking status, drinking status, heart disease, and count of other diagnoses. 
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Figure 1. Proportion (%) of men and women developing metabolic syndrome in each 
physical activity category, by gender.     
 Statistically different from the highest dose group. Rec.=recommended; Sed.=sedentary; 
Mod.=moderate; Vig.=vigorous; L.A.=lifestyle active; E.A.=exercise active 
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Abstract 
 
The development of frailty in older adults places them at risk for adverse health and 
future disability. While physical activity recommendations for health benefits exist, the 
specific types and amounts of physical activity needed to prevent frailty are not known. 
PURPOSE: The purpose of this study was to examine how different doses and types of 
physical activity affect the onset and severity of frailty in older adults. METHODS: 3060 
participants from the Health ABC Study were followed for six years to ascertain long-term 
frailty status. Frailty status was determined using a gait speed cut-off of <0.60 m/s and 
inability to rise from a chair five times, with moderate frailty having one of the two factors 
and severe frailty having both factors. Hierarchical physical activity doses at baseline were 
divided into three categories, 1) time (low, recommended, high), 2) intensity (sedentary, 
light, moderate, vigorous) and, 3) activity type (sedentary, lifestyle active, exercise active). 
Generalized estimating equations were used to develop risk estimates for onset of frailty. 
RESULTS: At baseline, a lower proportion of women than men were meeting the current 
recommendations for physical activity (19% vs. 30%). A majority of women (56%) reported 
regular light activities during the week (i.e. housework, care-giving). By year six, 
approximately 16% and 22% of the remaining men and women, respectively, had developed 
frailty. When examining the development of any frailty, covariate adjusted models indicated 
that time and intensity doses were not significantly different. Within the activity types,
compared to the exercise active, the sedentary were at increased risk for frailty (OR=1.04; 
95%CI 1.00-1.07). To determine predictors of transitioning from moderate to severe frailty in 
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those who had progressed to frailty (N=283), we found the activity types conferred differing 
risks, with the sedentary (OR=1.24; 95%CI 1.03-1.49) and lifestyle active (OR=1.19; 95%CI 
1.05-1.35) at increased risk for severe frailty compared to the exercise active. We also 
observed a significant dose-response association within the activity types (P=0.02), 
suggesting a hierarchical relationship with severe frailty. CONCLUSIONS: Of all the 
physical activity doses and types examined in this study, regularly engaging in exercise 
activities (walking for exercise, weight training, aerobic dancing) appears to be most 
important in preventing and attenuating the severity of frailty. Additionally, the intensity of
activities should be considered when designing interventions for frail, older adults. 
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Introduction 
Older adult age groups are the fastest growing segments of the U.S. population. For 
instance, by the middle of this century those eighty-five and older are expected to increase by 
400% (U.S. Census Bureau Population Division National Projections Program 2004). 
However, paralleling an aging population is an increase in chronic disease-related health 
concerns and a focus on maintaining independent living---or preventing disability (Guralnik 
and Simonsick 1993; Singh 2002). 
 There are several primary conceptual pathways to disability. These include, among 
others, the classic pathway described by Nagi, which describes a transition from pathology, 
to impairment, to functional limitation, to disability (Nagi 1965). A catastrophic pathway to 
disability describes sudden onset of disability caused by a trauma such as spinal chord injury 
or stroke. As described by Fried et al (Fried, Ferrucci et al. 2004), frailty can also be 
considered a primary pathway to disability. Frailty is defined as a pathologic condition that 
results in a constellation of signs and symptoms and is characterized by high susceptibility, 
impending decline in physical function and high risk of death (Ferrucci, Guralnik et al. 
2004). By definition, frailty is a pre-disabled state, and the risk for future disability in the 
frail is approximately double that of the not frail (Fried, Tangen et al. 2001). Although many 
frailty models exist, the majority determines frailty status using some measure of strength 
and mobility (Hogan, MacKnight et al. 2003), factors strongly influenced by physical activity 
(Keysor and Jette 2001). 
 However, the association between physical activity and frailty is not well understood. 
Further, studies comparing specific doses and types of physical activity and long-term risks 
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for subsequent frailty do not currently exist. Studies to date have typically employed a single 
standardized intervention consisting of some combination of strength and endurance 
activities and tested its effectiveness on frailty compared to very low-level activities (i.e. 
stretching activities) or to no activity at all (Gill, Baker et al. 2002) (Brown, Sinacore et al. 
2000) (Binder, Schechtman et al. 2002). Results of these studies have been modest at best. 
To appropriately design physical activity intervention studies that have the greatest 
probability of affecting frailty status, we must first determine the optimal combination of 
doses of frequency, intensity, duration and type of physical activity.  
The objective of this study was to examine how different doses and types of physical 
activity affect the development and severity of frailty status in older adults. Using data from 
the Health, Aging and Body Composition (Health ABC) Study, we tested the hypotheses 
that, 1) Older adults who engage in vigorous (6+ Mets) physical activities on a regular 
weekly basis have a lower incidence of frailty as compared to those who engage regularly in 
physical activities of moderate (3-6 Mets) or light (<3 Mets) intensity, or to those who are 
sedentary, 2) Older adults who engage in greater than the recommended amount of weekly 
time (200+ minutes/week) in physical activities have a lower incidence of frailty as 
compared to those who engage in the recommended amount (150-200 minutes/week), or less 
than the recommended weekly amount of time (<150 minutes/week), and 3) Older adults 
who expend weekly energy primarily from exercise activities have a lower incidence of 
frailty as compared to those whose expenditure is primarily lifestyle activities, or to those 
who are sedentary.
Methods 
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Health ABC Study 
The Health ABC Study is a longitudinal, prospective study with the broad objectives of 
measuring higher functioning older adults to allow examination of health decline and 
improvement over several years, and to allow comparisons with other well-studied 
populations (i.e. EPESE, Women’s Health and Aging Study). Specifically, the study aims 
include investigation of the interrelationships between health conditions, body composition, 
social and behavioral factors, and functional change (Simonsick, Newman et al. 2001). 
Clinic-based examinations and self-report measures were collected over a seven year period.  
 Study Population 
The Health ABC Study cohort consists of 3075 well-functioning black and white men 
and women aged 70 to 79. White participants were recruited from a random sample of 
Medicare beneficiaries in the zip codes surrounding Pittsburgh, Pennsylvania and Memphis, 
Tennessee. Black participants were recruited from all age-eligible residents of the areas in 
and surrounding Pittsburgh and Memphis. Potential participants were then screened for the 
following inclusion criteria, 1) No reported difficulty: walking ¼ mile, walking up ten steps, 
or performing basic activities of daily living, 2) no known life-threatening cancers, 3) no 
plans to leave the area for three years. The University of Pittsburgh and University of 
Memphis institutional review boards approved the study, and all participants provided 
written informed consent prior to participation. 
For this analysis, participants were excluded due to missing baseline functional 
testing data (N=15), leaving 3060 participants at baseline for these analyses. Participants with 
missing baseline health information (N=431) were imputed using standard methods (see 
Statistical Analysis) 
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 Study Measures 
The outcome variable for this study was frailty. Frailty status was ascertained at 
baseline, Year 4 and Year 6. The model of frailty for this study was the Gill frailty model, 
first developed and proposed in 1995 (Gill, Williams et al. 1995) and later refined in 2002 
(Gill, Baker et al. 2002) for a clinical trial with a target population of frail elders. When 
developing and validating his frailty model, Gill found that those older adults, with a gait 
speed of less than 0.60 meters/second (m/s) and the inability to rise from a chair once with 
arms folded, were eight times more likely to develop incident ADL disability compared to 
performing above both cut-points. For this study, frailty was identified using functional 
performance cut-points similar to Gill’s: a gait speed <0.60 m/s and the inability to rise from 
a chair five times with arms folded. We substituted inability to rise once from a chair with 
inability to perform five chair rises due to limited tracking of follow-up performance 
measures in this dataset. Ability to complete five chair rises was recorded and tracked for all 
follow-up tests, whereas ability to stand once was not consistently tracked. One advantage to 
using inability to perform five chair rises is the potential to identify those individuals with 
some functional strength reserve remaining that allows them to at least stand once from a 
chair---a prerequisite to moving on to the five chair stand test. Identifying these individuals 
could result in appropriately designed interventions to prevent further strength deterioration.  
Gill utilized a two-tier frailty severity model, where being positive in any one frailty 
factor indicated moderate frailty and positive in both factors indicated severe frailty. This 
study also used the same ordered frailty severity system. Advantages to the Gill frailty model 
over other models are 1) the widely recognized performance measures (gait speed and chair 
stands) that are utilized as factors, 2) the low participant burden of the measures, 3) the low 
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cost of the measures, 4) the ease of personnel training to administer the tests. In addition, 
poor gait speed and chair stand performance predict several adverse health outcomes, 
including disability, institutionalization, and mortality (Guralnik, Simonsick et al. 1994) 
(Guralnik, Ferrucci et al. 2000). 
The predictor variable of interest, physical activity, was collected from participants at 
baseline using a self-report instrument developed specifically for the Health ABC Study. The 
standardized questionnaire was developed using the model of several commonly used 
activity questionnaires, such as the Minnesota leisure-time physical activity questionnaire 
(Taylor, Jacobs et al. 1978). Kilocalories per week (kcals/week) expended in common 
exercise activities (i.e. walking for exercise, exercise classes, weightlifting) and lifestyle 
activities (i.e. gardening, housework, yard work) were collected. Specifically, participants 
were asked if they had engaged in physical and exercise activities at least ten times in the last 
twelve months. Those activities that were identified as positive over the last year were further 
examined regarding time for each activity over the last seven days. Based on self-reported 
weekly time and known metabolic costs for activities (Ainsworth, Haskell et al. 2000) a 
summary variable of kcals/week expended was calculated for each activity. The metabolic 
cost of activities is reported in metabolic equivalents (Mets). One Met is equivalent to resting 
energy expenditure, or 3.5 ml/kg/min.   
For this study, physical activity doses and types were determined to allow for several 
associations to be tested based on current recommendations for weekly energy expenditure 
via physical activity (U.S. Department of Health and Human Services 1996) (American 
College of Sports Medicine 1998). The doses are hierarchical in nature, moving from the 
lowest dose to the highest dose, within each physical activity category. Specifically, time 
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doses (low, recommended, high), intensity doses (sedentary, light, moderate, vigorous), and 
activity types (sedentary, lifestyle active, exercise active) were tested. The format of the 
Health ABC questionnaire did not allow a physical activity weekly frequency dose-response 
to be tested for this study. Physical activity categories and doses are shown in Table 1. Time 
doses were based on current recommendations for weekly accumulated time spent in physical 
activity (U.S. Department of Health and Human Services 1996) (Pate, Pratt et al. 1995). Due 
to availability of data, these doses were constructed using only the sum of minutes per week 
spent walking of any intensity and time spent in exercise. Intensity doses were based on 
American College of Sports Medicine guidelines for determination of activity intensities 
based on Met level cut-offs (Ainsworth, Haskell et al. 2000) and on recommended 
accumulated weekly energy expenditure for health benefits (minimum of 1000 kcals/week) 
(U.S. Department of Health and Human Services 1996).  Activity type groups were based on 
the previous construct developed by Brach et al. (Brach, Simonsick et al. 2004) using current 
physical activity recommendations (U.S. Department of Health and Human Services 1996) 
(Pate, Pratt et al. 1995) for weekly energy expenditure (minimum of 1000 kcals/week) and on 
distribution of weekly energy expenditure in total physical activity in the Health ABC cohort 
(25th percentile = 2,719 kcals/week). 
Covariates that were collected at baseline and that were controlled for in the analyses 
included age, sex, race, education, waist circumference, marital status, count of chronic 
diseases (cerebrovascular disease, heart disease, hypertension, lower limb OA, pulmonary 
disease, diabetes, circulation problems in extremities, and depression), smoking status and 
alcohol consumption. Race is dichotomized into black and white. Chronic diseases were 
ascertained by asking the participant, “Has a doctor ever told you that you have…,” clinic 
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data, and current medication use. Weight (kg) was measured by a standard balance beam 
scale, and height (m) was measured using a wall-mounted stadiometer. Waist circumference 
was measured by trained technicians using a tape measure at the level of the umbilicus 
directly on the skin. Smoking status was categorized as current smoker, former smoker, and 
never smoker. Weekly alcohol consumption was categorized as none, 1-7 drinks/week, and 
more than seven drinks/week. Education was categorized as less than high school, high 
school graduate, and any post-secondary education. 
Statistical Analysis 
Baseline characteristics of the cohort were examined using univariate procedures 
including proportions or mean + SD, as appropriate. Participants who were missing one or 
more baseline health information variables were imputed using standard methods. For 
variables with less than 1% of the entire cohort missing at baseline, the mean or mode, 
depending on distribution, was imputed for missing values. For those variables missing more 
than 1% in the cohort, multiple imputation methods with bootstrapping were used. 
Prevalence and incidence rates (cases/1000 person years) of frailty were calculated for all 
available waves of data collection (Years 1, 4 and 6). All individuals who were moderately or 
severely frail at baseline (N = 92) were then excluded from the primary analyses to allow for 
temporal associations to be examined. Binary associations between baseline predictors and 
incident frailty at year six were tested using the Chi-square test. The associations between 
baseline physical activity levels and incident frailty over six years were originally examined 
using proportional odds generalized estimating equation (GEE) regression modeling with an 
ordinal outcome (not frail, moderately frail, severely frail). A model was first fit to test for 
proportionality of the association between each physical activity category (intensity, time, 
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type) and incident frailty. Because the proportionality assumption was not met for any of the 
three physical activity categories, two separate GEE logistic regression models were then 
developed: the first model tested the association between physical activity and incident 
moderate or severe frailty. In other words, we wanted to determine if physical activity was 
associated with reduced risk for any type of frailty. The second model tested the association 
between physical activity and incident severe frailty; this tested if physical activity was 
associated with level of severity of frailty in those who do become frail over time. Physical 
activity group x covariate and group x time interactions were tested in both models. Linear 
trends were tested using the chi-square test, with significance determined to be at the P<0.05 
level. Odds ratios and 95% confidence intervals for risk of incident frailty were calculated, 
with the most active group as the referent group in all models. Keeping with the methods of 
Lee and Skerrett (Lee and Skerrett 2001), the total volume of physical activity (kcals/week) 
was entered as a covariate in all models to eliminate the potential confounding of this 
variable when testing dose-response associations. All analyses were conducted using SAS 
v8.2 software (SAS, Cary, NC). 
 
Results 
Baseline Characteristics 
 
The gender-specific baseline characteristics of the 3060 Health ABC participants are 
shown in Table 2. As expected men were taller and heavier then women, although waist 
circumference differed minimally between genders (mean difference = 2.7 cm). The 
proportion of white women was considerably less than the proportion of white men, which is 
consistent with previous Health ABC publications (Visser, Goodpastor et al. 2005). 
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Prevalence of smokers at baseline (~10%) was similar between men and women; however a 
higher proportion of men reported being former smokers (60% vs. 33%). Men tended to 
report more weekly alcohol consumption and have higher levels of education then did 
women. When examining prevalent diseases, men had higher rates of heart disease, diabetes, 
and circulatory problems than did women. And women reported higher rates of hypertension, 
osteoarthritis, and depression than men. These baseline characteristics are consistent with the 
literature (Hahn, Heath et al. 1998).  
 An analysis of those participants whose data were not available for analysis at year 
six (N=872) compared to those whose data were available for analyses at year six (N=2188) 
indicated that drop-outs were more likely to be older, male, have more health conditions, 
have higher rates of frailty, and be sedentary at baseline (All P<0.05) compared to those who 
remained for the duration of the study.  
 Table 3 provides the breakdown of physical activity groups at baseline. Consistent 
with previous reports (Hahn, Heath et al. 1998), women reported lower rates of physical 
activity by weekly time and type. However, the proportion of women classified as sedentary 
in the intensity group was less than men (12% vs. 16%, respectively). In fact, a majority of 
women (56%) reported accumulating at least 1000 kcals/week in activities of light intensity 
(<3 Mets). This activity level consists of light housework, shopping, doing volunteer or light 
paid work, and care-giving. Similar proportions of men and women (~7%) reported engaging 
in the recommended 150-200 minutes per week walking of any intensity, with a higher 
percentage of men exceeding the recommendations (34% vs. 25%). Men reported engaging 
in more physical activities of moderate and vigorous intensity and in exercise activities than 
did women at baseline. When summed, at baseline 30% of men and 19% of women reported 
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the recommended accumulation of at least 150 minutes per week in activities of a moderate 
intensity or greater.  
Frailty Status Over Six Years 
Prevalence and incidence of frailty status in the 2018 men and women with frailty 
information at all waves is shown in Table 4. At baseline approximately 2% of the men and 
3% of the women were moderately or severely frail. In four years 5% and 10% of the men 
and women were frail, respectively. At year six prevalence rates of frailty grew to over 13% 
for men and 18% for women. There were 6111 person years of follow-up at year four and 
9229 person years of follow-up at year six. Incidence rates at four and six years indicated that 
women had overall higher rates of incident moderate and severe frailty compared to men at 
both follow-up time points. The magnitude of the difference in rates of moderate frailty 
between men and women was greatest at four years, as incidence rates in men increased from 
6.2/1000 person years to 10.1/1000 person years from year four to year six, whereas rates in 
women remained rather stable over the same time period.  
Risk of Developing Any Frailty 
 Unadjusted and adjusted odds ratios and 95% confidence intervals (OR: 95%CI) for 
combined any incident frailty over six-years are seen in Table 5. No significant interactions 
were found, so the estimates displayed are from main effects models. Odds ratios within the 
time category indicate that, compared to the high time dose, those in the low dose (<150 
minutes/week in any walking) were 25% more likely to become frail (OR=1.25; 95%CI 1.00-
1.57). This increased risk dissipated completely when controlling for important covariates in 
the adjusted model. Intensity category unadjusted results interestingly showed that compared 
to the vigorous dose, the light intensity dose placed individuals at significantly greater risk of 
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incident frailty (OR=1.41; 95%CI 1.06-1.88). Being sedentary did not appear to confer an 
increased risk of frailty compared to the vigorous dose (OR=1.14; 95%CI 0.78-1.65). 
However, similar to the time category findings, the significant light vs. vigorous intensity 
dose finding was not maintained in the covariate-adjusted model. Finally, the activity type 
comparisons indicated that those who reported regular lifestyle activities (OR=1.38; 95%CI 
1.07-1.88) or those who were sedentary (OR=1.92; 95%CI 1.39-2.64) were more likely to 
develop frailty over a period of six years compared to the exercise active. This significant 
increased risk was maintained in the sedentary when the adjusted model was fit, although the 
magnitude of risk was reduced to be only 4% greater than the exercise active (OR=1.04; 
95%CI 1.00-1.07). All linear trends that were significant in the unadjusted models were 
dissipated in the adjusted models. The activity type linear trend (P=0.08), indicates that 
moving from being sedentary to being lifestyle active (i.e., gardening, heavy housework, 
walking the dog), and then to doing exercise activities (i.e., strength training, walking for 
exercise, exercise classes) may confer an equally stepped decrease in risk for any incident 
frailty. 
Risk of Developing Severe Frailty 
Of those that became and remained frail over six-years (N = 283), we sought to 
determine if higher doses of physical activity could prevent further deterioration to severe 
frailty status. Table 6 displays these findings, and indicates that physical activity doses may 
play an important role in preventing transitioning to severe frailty in those who are already 
frail. The amount of time spent in physical activities does not appear to attenuate the 
progression of frailty, as compared to the high time dose, low and recommended time dose 
odds ratios were 0.96 and 0.91, respectively, with 1.00 being well within both confidence 
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intervals. Within the intensity category, in the adjusted models there was some indication 
that, compared to the vigorous dose, the risk of transitioning to severe frailty in the light 
intensity dose (OR=1.13; 95%CI 0.96-1.34) and the sedentary dose (OR=1.23; 95%CI 0.98-
1.53) was increased. There was a marginal intensity dose-risk response association in the 
intensity category (P=0.06).  
Looking at the adjusted odds ratios within the activity types shows a significantly 
increased risk for severe frailty in the lifestyle active (OR=1.19; 95%CI 1.05-1.35) and the 
sedentary (OR=1.24; 95%CI 1.03-1.49), compared to the exercise active. A significant dose-
response trend was observed between the activity types (P=0.02). 
Discussion 
 This study examined how differing doses and types of physical activity are associated 
with the development and severity of frailty over several years in a high functioning group of 
older adults. We found that regularly engaging in exercise activities was associated with a 
reduced risk of any incident frailty and a reduced risk of transitioning to severe frailty in the 
already frail over a six year follow-up period. These associations were independent of 
important health and lifestyle characteristics that are commonly associated with physical 
activity and functional decline. We also demonstrated a significant dose-response association 
between moving from being sedentary to being a regular “exerciser” and transitioning to 
severe frailty. There was also some suggestion that engaging in increasingly vigorous 
physical activities may assist in preventing a transition to severe frailty in those who are 
already frail.  
 To our knowledge this is the first study to simultaneously examine the longitudinal 
relationships between several specific doses and types of physical activity and frailty. 
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Previous studies have examined the effectiveness of one or two physical activity programs in 
frail elders, with widely varied exposure to doses. Fiatarone found remarkable lower body 
strength improvements with a high-intensity strength training intervention performed three 
days per week in very old, frail adults (Fiatarone, O'Neill et al. 1994). Whereas Latham and 
colleagues were not able to demonstrate improvements in strength with a home-based 
strength-training program for quadriceps strength using ankle weights three days per week 
(Latham, Anderson et al. 2003). Gill reported a significant effect on the trajectory of a 
disability score, measured by the ability to perform daily tasks, in those provided with a low 
intensity conditioning program performed once daily (Gill, Baker et al. 2002). Similarly 
Brown found improvements in a summary disability score with a comparable low-level 
conditioning program provided only three days per week (Brown, Sinacore et al. 2000). 
These studies demonstrate a wide range of interventions on frail elders utilizing varying 
doses and types of physical activity, and as a result the effectiveness of the interventions was 
also varied.  
The availability of our results could guide future studies in designing the optimal 
physical activity doses, and subsequently lead to interventions with a higher probability of 
effectiveness.  For instance, when designing frailty prevention programs or when intervening 
on the progression of frailty, prescribing exercise activities appear to be optimal. This is 
consistent with the literature that suggests high intensity strength training exercises are of 
great importance for maintaining strength and mobility in older adults (Fiatarone, O'Neill et 
al. 1994) (Evans 1999). According our results, lifestyle activities such as housework, 
gardening, and leisurely walking are not sufficient in preventing or attenuating the 
progression of frailty. Our data also indicate that considering the intensity of the physical 
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activities, such as those with a Met level greater than six, may also be important in offsetting 
a transition to severe frailty. Our findings, in conjunction with very recent information 
indicating that frailty is a very dynamic process with good potential for response to 
intervention (Gill, Gahbauer et al. 2006), show promise for future studies. 
 Our findings regarding the potential protective effects of engaging in physical activity 
for the purpose of exercise vs. being lifestyle active or sedentary requires further discussion. 
This finding is in line with the work of Brach and colleagues (Brach, Simonsick et al. 2004), 
who used the same physical activity groups construct in the Health ABC cohort. They found 
that the exercise active group had better functional performance, such as gait speed, chair 
rises, and long distance walk times, than either the lifestyle active or the sedentary groups. 
Based on Brach’s findings, the development of frailty over time, as measured by impaired 
mobility (gait speed) and strength (chair rises), should be more likely in the lifestyle and 
sedentary groups due to their lower physical performance at baseline. This longitudinal study 
lends some support to the idea that older adults who report being regularly exercise active 
maintain higher levels of subsequent functioning (strength and mobility) and are more likely 
to prevent a further decline to severe frailty. Our findings are also in concordance with those 
of Gill and colleagues (Gill, Baker et al. 2002), who found significant differences in the rate 
of functional decline between a moderately frail group who participated in a home 
conditioning program and a moderately frail control group. As stated above, the intervention 
was a once-daily, progressive conditioning program using therabands and competency-based 
exercises. The intensity at which these exercises were performed was not reported. 
In her cross-sectional analyses of the Health ABC cohort, Brach speculated that the 
dose of higher intensity activities in the exercise active group could be the reason for their 
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better functioning (Brach, Simonsick et al. 2004). We found that individuals who regularly 
engaged in activities of intensities ranging from light (i.e., light household chores) to 
vigorous (i.e. weightlifting or aerobic dancing) had no differences in the risk of future frailty. 
However, when examining the risk of transitioning to severe frailty in the sub-group who had 
become frail in subsequent years, there was some indication that participation in activities of 
vigorous intensity (>6 Mets) may be optimal in deferring the transition to severe frailty. This 
indicates that perhaps the intensity of physical activity is not important in preventing frailty, 
but may be important in preventing the progression of frailty. We were constrained by a 
relatively small number of individuals who became and remained frail over time, so analyses 
within the frail group is likely underpowered in this study. Adequately powered studies 
should be undertaken to further test the physical activity intensity-frailty progression link. 
An important strength to this study is that we controlled for the total volume of 
physical activity when modeling our estimates. Lee and Skerrett emphasized the importance 
of this control in their paper published as part of a physical activity dose-response 
symposium several years ago (Lee and Skerrett 2001). The rationale for controlling for total 
volume of physical activity is that dose-response associations are often confounded by the 
total volume of physical activity. For instance, higher intensity activities inherently result in 
higher levels of energy expenditure, thus producing a greater total volume of physical 
activity. Controlling for the volume allows for a true dose-response test of the parameter of 
interest, i.e. intensity, time, duration.  
Limitations to this study include the use of a self-report questionnaire to derive levels 
of physical activity. Direct activity measures, such as accelerometers, could provide more 
accurate totals of weekly caloric expenditure (Bassett 2000). Also, having only a baseline 
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measure of physical activity levels is limiting, as follow-up status would provide an over 
time average of physical activity status, and likely a stronger physical activity effect.  Finally, 
the missing follow-up data from the remaining cohort could lead to estimates not 
representative of the entire group. However, the use of GEE modeling allows for missing 
data, and those with data at only one time point are still used in determining estimates. 
 In conclusion, this study provides concurrent comparisons of differing weekly doses 
of time, intensity, and types of physical activity and their association with incident frailty in 
an initially high-functioning group of older adults. These data suggest that older adults who 
engage in activities for the purpose of exercise are at the lowest risk for developing any 
frailty or for transitioning to severe frailty if they are already frail. A dose-response 
association was also observed between the activity types (sedentary, lifestyle active, and 
exercise active). Additionally, engaging in physical activities of increasing intensity may also 
play a role in attenuating the transition to severe frailty in already frail older adults. Future 
studies are warranted to confirm or refute these findings. 
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Table 1. Physical activity categories and doses. 
Time Category 
Low Time Dose- individuals accumulating less than 150 minutes/week in physical activities 
of any intensity. 
Recommended Time Dose- individuals accumulating between 150-200 minutes/week in 
physical activities of any intensity. 
High Time Dose- individuals accumulating a minimum of 200 minutes/week in physical 
activities of any intensity. 
------------------------------------------------------------------------------------------------------------ 
Intensity Category 
 
Sedentary Dose- individuals accumulating less than 1000 kcals/week in any physical 
activities. 
Light Intensity Dose- individuals accumulating a minimum of 1000 kcals/week in physical 
activities of an intensity of less than 3 Mets, and less than 1000 kcals/week in vigorous and 
moderate intensity activities. 
Moderate Intensity Dose- individuals accumulating a minimum of 1000 kcals/week in 
physical activities of an intensity of 3-6 Mets, and less than 1000 kcals/week in vigorous 
intensity activities. 
Vigorous Intensity Dose- individuals accumulating a minimum of 1000 kcals/week in 
physical activities of an intensity of 6 Mets or greater. 
------------------------------------------------------------------------------------------------------------ 
Activity Types 
 
Sedentary - individuals accumulating less than 1000 kcals/week in exercise activity and less 
than 2719 kcals/week in physical activity. 
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Lifestyle Active - individuals accumulating at least 2719 kcals/week in physical activity and 
less than 1000 kcals/week in exercise activity. 
Exercise Active - individuals accumulating greater than 1000 kcals/week in exercise 
activities.  
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Table 2. Baseline characteristics of Health ABC participants (N = 3060). 
 
Men (N = 1483)   Women (N = 1577) ===.
48%     52% 
 
Characteristics  Mean (SD)    Mean (SD) 
 
Age, y    73.8 (2.9)    73.5 (2.9) 
Height, m   1.73 (0.06)    1.60 (0.06) 
Weight, kg   81.4 (13.3)    70.5 (14.7) 
Waist circ. (cm)  100.9 (12.4)    98.2 (13.8)  
 
% %=================
Race 
 White   63.1     54.2 
 
Smoking status 
 Never   29.6     57.2 
 Former   59.7     32.9 
 Current   10.7     10.0 
 
Alcohol (drinks/wk) 
None    43.0     57.8 
1-7    45.5     38.6 
7+    11.5       3.6 
 
Education 
 Less than HS   27.3     23.0 
 HS graduate   25.3     39.3 
 Post-secondary  47.3     37.8   
 
Disease prevalence (%) 
 Cerebrovascular disease   7.8       8.2 
 Heart disease   26.4     14.6 
 Hypertension   47.0     54.3 
 Lower limb osteoarthritis   7.2     13.6 
 Pulmonary disease   11.6     11.6 
 Diabetes    16.7     13.6 
 Circulatory problems    6.7       3.7 
 Depression     9.6     15.4 
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Table 3. Baseline prevalence of physical activity categories. 
 
Men     Women 
 N (%)     N (%) 
 
Time  
 Low Dose   873 (58.9)             1078 (68.4) 
 Recommended Dose  109 (7.4)    112 (7.1) 
 High Dose   501 (33.8)    387 (24.5) 
 
Intensity  
 Sedentary Dose  222 (15.5)    181 (11.8) 
 Light Dose   472 (33.0)    860 (56.2) 
 Moderate Dose  446 (31.6)    219 (14.3) 
 Vigorous Dose  292 (20.4)    271 (17.7) 
 
Activity Types 
 Sedentary    328 (22.1)    421 (26.7) 
 Lifestyle active  665 (44.8)    899 (57.0) 
 Exercise active  490 (33.0)    257 (16.3) 
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Table 4. Prevalence and incidence of frailty at Year 1, Year 4 and Year 6 in those with  
 complete follow-up data (N=2018). 
 
Men (N=962)    Women (N=1056) 
 Moderately  Severely  Moderately Severely 
Frail  Frail   Frail  Frail 
Prevalence, N (%) 
Year 1      18 (1.8)   1 (0.1)    32 (3.0)   3 (0.3) 
 Year 4     38 (4.0) 13 (1.4)    78 (7.4) 23 (2.2) 
 Year 6             109 (11.3) 20 (2.1)  153 (14.5) 41 (3.9) 
 
Incidence* 
 Year 4     6.2  2.1   12.8  3.8 
 Year 6   10.1  1.0   11.8  2.0 
*Per 1000 person years 
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Table 5. Odds of incident moderate or severe frailty by physical activity category. 
Unadjusted OR (95%CI) Adjusted OR* (95%CI) 
Time  
Low     1.25 (1.00 – 1.57)  0.99 (0.97 – 1.02) 
 Recommended   0.96 (0.62 – 1.48)  0.98 (0.94 – 1.03) 
 High     1.00    1.00 
P for trend    0.04    0.40 
 
Intensity  
 Sedentary    1.14 (0.78 – 1.65)  1.01 (0.97 – 1.05) 
 Light       1.41 (1.06 – 1.88)  1.01 (0.99 – 1.04) 
 Moderate    0.88 (0.63 – 1.22)  0.99 (0.96 – 1.02) 
 Vigorous    1.00    1.00 
P for trend    0.02    0.26 
 
Activity Types 
 Sedentary    1.92 (1.39 – 2.64)  1.04 (1.00 – 1.07) 
 Lifestyle active   1.38 (1.07 – 1.78)  1.00 (0.97 – 1.02) 
 Exercise active   1.00    1.00 
P for trend    <0.0001   0.08 
*Adjusted for test wave, total kcals, age, gender, race, education, marital status, smoking 
status, drinking status, waist circumference and count of diagnoses. 
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Table 6. In the frail, odds of incident severe frailty by physical activity category. 
Unadjusted OR (95%CI) Adjusted OR* (95%CI) 
Time  
Low     0.88 (0.47 – 1.65)  0.96 (0.85 – 1.10) 
 Recommended   0.67 (0.23 – 1.94)  0.91 (0.75 – 1.11) 
 High     1.00    1.00 
P for trend    0.77    0.64 
 
Intensity  
 Sedentary    2.83 (0.94 – 8.53)  1.23 (0.98 – 1.53) 
 Light       1.85 (0.77 – 4.45)  1.13 (0.96 – 1.34) 
 Moderate    1.23 (0.41 – 3.71)  1.05 (0.85 – 1.29) 
 Vigorous    1.00    1.00 
P for trend    0.06    0.06 
 
Activity Types 
 Sedentary    2.67 (0.90 – 7.95)  1.24 (1.03 – 1.49) 
 Lifestyle active   2.37 (0.99 – 5.66)  1.19 (1.05 – 1.35) 
 Exercise active   1.00    1.00 
P for trend    0.09    0.02 
*Adjusted for test wave, total kcals, age, gender, race, education, marital status, smoking 
status, drinking status, waist circumference and count of diagnoses. 
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Chapter IV. SYNTHESIS OF THIS RESEARCH 
 
The work undertaken in this dissertation was done so to provide researchers and 
exercise professionals with information regarding the effect of differing doses and types of 
physical activity on two health conditions that are prevalent and deleterious to older adults. 
The two studies presented in this document can begin to assist in the designing of effective 
physical activity programs aimed at preventing or attenuating metabolic syndrome and frailty 
in older adults. Based on this research, specific summary conclusions include: 
Physical Activity Levels in Older Adults 
1) A higher percentage of men are meeting the recommendations for physical activity, 
although the percentage meeting the recommendations is still very low in both 
genders (30% in men and 19% in women). 
2) A majority of older women (56%) are meeting the weekly recommendations for 
physical activity energy expenditure (<1000 kcals/week) by engaging in light 
intensity activities (i.e. light housework, shopping), but are not meeting the 
recommendations of engaging in moderate intensity activities. 
Physical Activity and Metabolic Syndrome 
1) The six-year incidence of metabolic syndrome in a high functioning group of men 
and women in their seventies is approximately 20%.  
2) Older men and women differ considerably in their response to differing doses of 
physical activity when considering metabolic syndrome as an outcome. 
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3) The optimal doses of physical activity for reducing the risk of metabolic syndrome in 
older men are likely to be accomplished by spending on average more than thirty 
minutes per day (more than 200 minutes/week) in vigorous activities, such as heavy 
outdoor chores, climbing stairs, aerobic dance, or strength training. Additionally, 
physical activities done with the intent of being part of a structured exercise program 
may be optimal for older men. 
4) The optimal doses of physical activity for reducing the risk of metabolic syndrome in 
older women are likely to be accomplished by meeting the current recommendations 
for time spent in weekly physical activity (150-200 minutes/week) in activities of 
light intensity such as light housework, shopping, or volunteering. Structured exercise 
activities do not appear to provide additional risk reduction for metabolic syndrome in 
older women. 
 
Physical Activity and Frailty 
1) Women are more likely than men to develop frailty over a period of six years (22% 
vs. 16%, respectively). 
2) Men and women are similar in their responses to doses of physical activity and their 
effect on frailty. 
3) Physical activity plays a bigger role in preventing the transition to severe frailty in 
those who are already frail than in actually preventing frailty altogether. 
4) Accumulating a minimum of 1000 kcals per week energy expenditure by engaging in 
physical activities that are done with the intent of exercising, such as walking for 
exercise, strength training or aerobic dance, are the optimal activity types to reduce 
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the risk of frailty. Although the risk is reduced to a greater degree when attempting to 
prevent a transition to severe frailly in those who are already frail compared to the 
risk reduction when attempting to prevent any frailty. 
5) Differing doses of time spent in physical activity and intensities of physical activity 
do not appear to be important considerations when attempting to prevent the onset or 
further transitioning of frailty to a more severe level. 
 
Future Research Needs Based on These Findings 
1) These findings are in a cohort of older men and women who were functioning at a 
high level at baseline. Future physical activity dose-response studies are needed in 
groups at higher risk of metabolic syndrome and frailty.  
a. With metabolic syndrome as an outcome, specific groups to study should 
include the obese, those with insulin resistance or diabetes, those with known 
cardiovascular disease to study secondary prevention, hypertensive groups, 
and those with dyslipidemia.  
b. Frailty outcome studies are needed in arthritics, Parkinson’s patients and 
cancer patients. 
c. Lastly, metabolic syndrome and frailty outcome studies are needed in elder 
veterans who utilize Veteran’s Health Administration services, who are 
known to be in poorer health than comparable aged men and women who 
receive health care outside the VA system. 
2) Studies utilizing objective measures of physical activity are needed to assist in more 
accurately determining doses of physical activity in older adults. 
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3) Studies are warranted with consistent longitudinal tracking of physical activity levels 
to allow for a more accurate representation of changes in physical activity levels and 
the subsequent impact on metabolic syndrome and frailty. 
4) Studies are needed to investigate the effect of physical activity frequency doses 
concurrently with time and intensity doses. 
 
This research work is the first of a series of needed studies in older adults to quantify 
physical activity doses and their impact on high risk health states such as metabolic 
syndrome and frailty. This line of inquiry should continue forward to provide the health care 
community with the knowledge needed to best position our aging population to live their 
remaining years independently with a quality of life not compromised by health conditions. 
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APPENDIX A. Metabolic Syndrome Review of Literature 
 
Metabolic Syndrome
Metabolic syndrome (MS), synonymously referred to as Syndrome X or insulin-
resistance syndrome, is a constellation of factors that increase one’s risk for diabetes 
mellitus, cardiovascular disease (CVD), coronary heart disease (CHD) and CVD/CHD-
related deaths. The prevalence of MS in the US adult population is estimated to be 25%, 
however, prevalence increases with aging such that up to 40% of adults aged sixty-five years 
and older have the condition (Scuteri, Morrell et al. 2005) (Park, Zhu et al. 2003). The third 
Adult Treatment Panel (The Expert Panel on Detection 2001), a group of medical experts 
commissioned by the National Institutes of Health, define the presence of MS as being 
positive in any three of the following factors: increased waist circumference (>102 cm. in 
men and >88 cm. in women), high triglycerides (> 1.7 mmol/l), low HDL cholesterol (<1.04 
mmol/l in men and <1.29 mmol/l in women), high blood pressure (>130/85 mmHg or 
pharmacological treatment of hypertension), and fasting glucose (>6.1 mmol/l).  
 As mentioned previously, MS is often referred to in the literature as Syndrome X or 
insulin-resistance syndrome. However, there is clear distinction between MS and these two 
other terms upon further exploration of their beginnings and current status in medical 
research. Their divergent lines of inquiry are highlighted in the publications of Dr. Gerald 
Reaven, the physician who coined the term Syndrome X in 1988 (Reaven 1988). Reaven’s 
numerous reviews on the topic of Syndrome X specifically distinguish between Syndrome X 
and MS, particularly when diagnosing the condition. He believes the pathophysiologic 
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condition that truly requires attention is insulin resistance (Reaven 2005), while recognizing 
the consistent association between insulin resistance and dyslipidemia, obesity, and 
hypertension- all factors for MS. His rationale for the focus on insulin resistance as a 
predictor of diabetes and adverse health outcomes is justified; however, the clustering of MS 
factors as a clinical indicator of increased risk for CVD and CVD-related death is also of 
significance.  
 Lakka (Lakka, Laaksonen et al. 2002) found that middle-aged Finnish men (42-60 
years at baseline) with MS were 2.9 and 2.6 times more likely to die of CHD, and of all 
causes, respectively, over a 11-year follow-up, compared to those without MS at baseline. 
This association persisted even after controlling for traditional CHD risk factors such as age, 
LDL cholesterol, smoking, family history of CHD, fibrogen levels, alcohol consumption, and 
socio-economic status. Similarly, Malik (Malik, Wong et al. 2004) showed a thirteen-year 
doubling of risk for CVD and CHD-related deaths in men and women (~50 years at baseline) 
in the NHANES II cohort. In this analysis, covariates included for adjustment were physical 
activity levels and gender. 
Few studies have examined the longitudinal impact of MS in older adults. Of those, 
Lempiainen et al. (Lempiainen, Mykkanen et al. 1999) studied the seven-year incidence of 
CHD deaths in 1069 older Finnish men and women (~69 years at baseline). They found that 
high triglycerides, high systolic blood pressure, and low HDL levels were the factors that 
consistently predicted CHD deaths in older men and women. Interestingly, insulin resistance 
was not a consistent predictor of MS across genders, suggesting that perhaps the clustering of 
risk factors present in MS that are epitomized by insulin resistance in the middle-aged are not 
driven by insulin resistance in older adults. In a prospective study of slightly older adults 
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(~75 years at baseline), Scuteri et al. (Scuteri, Morrell et al. 2005) found that those with MS 
at baseline were 38% more likely to develop CVD than those without MS (27.5% vs. 17.8%, 
respectively). An interesting point with their analysis is the associations seen between MS 
and CVD were significant after adjusting for individual MS factors, indicating that the 
clustering of MS factors is a better predictor of CVD than any individual factor alone. This 
finding is contrary to the joint report of the American Diabetes Association and the European 
Association for the Study of Diabetes(Kahn, Buse et al. 2005), who contended that the 
clustering of MS risk factors adds no further prognostic value than independently focusing on 
the individual factors. These two papers were both published in 2005, so it is possible that the 
joint consensus authors did not have access to Scuteri’s findings at the time of their writing. 
These studies demonstrate that 1) MS predicts CVD, CHD, and CVD-related deaths in older 
men and women, 2) Presence of clusters of MS add predictive value to adverse health that 
individual factors alone do not provide, and 3) the crux of MS in middle-aged adults, insulin 
resistance, is not necessarily the catalyst behind MS in older adults. In fact, Goodpastor et al. 
(Goodpastor, Krishnaswami et al. 2005) found that the distribution of adiposity, particularly 
higher inter-muscular visceral tissue, is independently associated with MS in older adults. 
This suggests that obesity and the distribution of fat mass later in life may be key in the 
development of MS in older adults. Studies are needed to further examine these associations 
in older adults. 
Some of the criticism of current criteria for MS revolves around the measurements of 
the specific factors. For instance, the cut-off for fasting glucose intolerance (>6.1 mmol/l) is 
reported to have very poor sensitivity (~10%) when compared to diagnosed diabetes, 
indicating that many individuals without insulin resistance could be inappropriately identified 
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as positive for that MS factor (Reaven 2005). Some clinicians and researchers support the use 
of an impaired glucose tolerance test (with a previous load of ingested glucose) to measure 
insulin sensitivity. (Tai, Goh et al. 2004). Also, the use of waist circumference as an indicator 
of obesity is arguable. There is marked variability within and between the person’s taking the 
measurement, and Reaven, supporting the use of body mass index as a more practical 
measure of obesity, suggests that waist circumference is a burdensome measure for busy 
clinicians. Large epidemiologic studies show a very strong correlation (r > 0.90) between 
waist circumference and body mass index (Ford, Mokdad et al. 2003). However, from a 
prognostic viewpoint, the advantage to using waist circumference as an MS factor is the 
strong link between central adiposity and CHD/CVD (need ref). BMI is only an indicator of 
obesity, and cannot distinguish regional fat distribution. 
Physical Activity and Metabolic Syndrome 
 
Physical activity (PA) as a preventative factor for CVD/CHD and related mortality is 
well established (Blair, Kampert et al. 1996) (Leon, Connett et al. 1987; Berlin and Colditz 
1990). Increased levels of PA are also associated with reduced risk for type II diabetes 
(Simonsick, Lafferty et al. 1993; Wei, Gibbons et al. 1999), itself a risk factor for CVD 
(Reaven 1988). The association between PA and MS are not as clear, particularly when 
considering the optimal dose of PA for reversal, prevention, or delay of MS status. This is in 
part due to the differing dose response associations seen with PA and the individual MS 
factors. For instance, there is clear, linear dose-response associations between PA and 
dyslipidemia, and obesity (Kraus, Houmard et al. 2002) (Slentz, Duscha et al. 2004); 
however, the dose-response association between PA and impaired glucose tolerance 
(Houmard, Tanner et al. 2004) and blood pressure is reported to have a curvilinear form, with 
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a threshold for benefit at moderate doses (Ishikawa-Takata, Ohta et al. 2003). The known 
dose response associations between PA and individual MS factors are shown below. 
 
The black arrows represent linear dose-response associations. In other words increasing 
volume and/or intensity of PA above and beyond current recommendations (150 
minutes/week moderate intensity PA) (U.S. Department of Health and Human Services 
1996)confers even greater response in lowered blood pressure, improved lipid profiles, and 
weight loss (MSSE dose-response supplement). However, Houmard (Houmard, Tanner et al. 
2004) demonstrated that doses of PA above and beyond current recommendations did not 
result in greater sensitivity to insulin (red arrow), indicating moderate doses of PA are 
equally beneficial to higher doses. The differing dose-response associations between MS 
factors and PA present a unique challenge when studying the factors in a clustered fashion. 
How do these factors interact when observing their combined response to differing doses of 
PA? To date this question remains unanswered. General PA and MS associations have been 
reported in the literature. The epidemiologic data will be presented first, followed by 
interventions. 
Physical Activity
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 Several studies examining the associations between PA and MS have been published 
using the Aerobic Center Longitudinal Study (ACLS) data at the Cooper Clinic. It is 
important to note that these studies used middle-aged men and women of higher socio-
economic status, thus not necessarily generalizeable to older adults. In cross-sectional 
analyses, Whaley (Whaley, Kambert et al. 1999) found that men in the lowest category of 
aerobic fitness (a by-product of regular PA) were ten times more likely to have MS compared 
to the highest fit group. The comparison between the least and moderately fit groups 
produced an odds ratio of 3.0. The large increase in odds of MS moving from the moderately 
to most fit groups could suggest a curvilinear association with a functional shape of the 
relationship resembling an exponential dose-response curve seen below.  
 
Odds of no MS 
 
Least fit Mod. Fit Most Fit  
 
The associations were not the same in women, with odds of MS comparing least fit to 
moderately and most fit at 2.7 and 4.9, respectively. These associations resemble a spaced, 
linear association between PA and MS. The role that gender plays in modifying the PA and 
MS relationship needs further examination. In a similar examination of the ACLS data in 
men only, Jurca et al. (Jurca, Lamonte et al. 2004) examined the potential modifying role of 
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muscle strength between the PA and MS association. They found muscular strength added to 
the protective effect of aerobic fitness in men with low and moderate fitness levels, 
indicating that engaging in strength training and even low levels of aerobic training can lower 
risk of MS in middle-aged men. The cross-sectional nature of these data cannot determine 
temporality, however. For example, it is plausible that having the factors of MS led to 
reduced levels of PA and subsequent low fitness levels in these men. Using prospective data 
from the ACLS, Katzmarzyk (Katzmarzyk, Church et al. 2004) reported that middle-aged 
men with MS were 30% more likely than healthy men to die of all causes before adjustment 
for fitness levels (Odds ratio=1.29), whereas after adjustment the association was non-
significant (Odds ratio=0.98). Katzmarzyk also found a significant dose-response association 
between increasing fitness levels and reduced risk of CVD and all-cause mortality in men 
with MS at baseline. This indicates that, in men with MS, being moderately active can reduce 
the risk of death significantly, and engaging in higher levels of PA confers an even greater 
protective effect. In a similar study, Katzmarzyk studied the influence of obesity on the 
above mentioned associations (Katzmarzyk, Church et al. 2005). He found obesity levels, as 
determined by BMI, to have no added value in predicting mortality in men with MS. Since 
MS already has a measure of obesity (waist circumference), it is possible that adding BMI to 
the model added no further information due to the strong association between the two 
measures. Fitness persisted as a significant protective factor in this analysis, regardless of 
baseline MS status. The ACLS study adds a significant amount of information regarding the 
inter-relationships between MS, PA and mortality. Specifically, increasing levels of PA are 
associated with reduced prevalence of MS; however, not necessarily in a linear fashion. Very 
similar conclusions have been drawn in different middle-aged cohort studies (Carroll, Cooke 
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et al. 2000) (Ford, Kohl et al. 2005) (Rennie, McCarthy et al. 2003). Additionally, middle-
aged men who regularly engage in strength training, but not necessarily endurance training, 
are less likely to have MS compared to men who do not participate in a regular program of 
strengthening. Lastly, middle aged men who are diagnosed with MS and engage in moderate 
to high levels of PA have substantially reduced risk of mortality compared to those who are 
sedentary. Of course epidemiologic data is subject to bias, confounding and temporality 
issues that randomized clinical trials can eliminate.  
 In the earliest such clinical trial found in the literature, Torjesen et al. (Torjesen, 
Hjermann et al. 1997) reported on the effect of a twelve-month endurance exercise 
intervention on individual MS factors in middle-aged adults. They showed a significant 
improvement in blood pressure and triglycerides with the exercise intervention, but no 
improvement in fasting glucose, BMI, and HDL cholesterol. Interestingly, another trial arm 
that participated in an exercise + diet intervention showed significant improvements in all 
MS factors. It was not reported what proportion of the participants, if any, had MS at 
baseline or how MS status was changed over the one year intervention. 
 Katzmarzyk and colleagues (Katzmarzyk, Leon et al. 2003) were the first to report 
the impact of exercise training on MS status in middle-aged adults. Reporting data from the 
Heritage study (621 white and black participants), they found that 20 weeks of three days per 
week aerobic training reduced the proportion of MS by approximately 30% in all subgroups 
(men/women; black/white). The MS factors most susceptible to change were triglycerides 
(43% improved this factor), blood pressure (38%), waist circumference (28%), HLD 
cholesterol (16%) and serum glucose (9%). This large intervention study demonstrated the 
efficacy of moderate-intensity (55-75% VO2max) aerobic training in reversing MS status in 
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otherwise healthy adults. Interestingly, serum glucose, the MS factor most closely tied to 
insulin resistance, which is postulated to be the underlying cause of MS, was least likely to 
be affected by the aerobic based intervention.  
 Based on the basic science evidence showing muscle strength as a potent means to 
improve muscle glucose uptake (Cartee 1994), Castaneda et al. tested the effect of 16 weeks 
of strength training on MS factors in older (mean age=66 years), Latino men and women 
with diabetes. This population was studied because Latinos have double the rate of diabetes 
compared to whites. Sixteen weeks of high resistance strength training produced improved 
systolic blood pressure, muscle glycogen stores (an indirect measure of insulin sensitivity), 
and lean mass and fat mass. This study indicated that strength training is a viable means of 
affecting not only glucose levels as an MS factor, but also blood pressure and obesity MS 
factors. This study adds to the previously mentioned study of Jurca et al. (Jurca, Lamonte et 
al. 2004), who reported associations between increased muscle strength and reduced MS 
prevalence. 
 Stewart conducted a 26-week exercise training study, with a strength training 
component, in older adults with elevated blood pressure (Stewart, Bacher et al. 2005). 
Individual MS factors and MS status were examined as outcome measures.  At follow-up, 
there was a strong suggestion that the exercise group had reduced proportions of MS status 
compared to the control group (P=0.06). Also of interest was that, while strength and 
endurance improved significantly in the exercise group, the changes in individual MS factors 
were more strongly associated with changes in improved body fat and lean tissue measures in 
the exercise group (and blood glucose was not affected by the intervention). These results 
support the findings of Goodpastor (Goodpastor, Krishnaswami et al. 2005), who reported 
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body fat and its distribution to be strongly associated with MS status in older adults. Also, in 
a very recent clinical trial, Orchard found obesity (waist circumference) to be the MS factor 
most prevalent in older adults (>60 y.o.), and most likely to be attenuated by long-term PA 
intervention (three-years), which significantly lowered the risk of incident MS compared to 
metformin therapy and control groups.  
 In summary, there is epidemiologic evidence linking low levels of PA to higher 
prevalence and incidence of MS. Most interventions aimed at MS were in middle-aged adults 
or focused on individual MS factors rather than on attenuating MS status. PA interventions 
focused on older adults with MS report a strong association between changes in body 
composition and change in MS status with negligible changes in blood glucose levels, 
suggesting that 1) reduced insulin sensitivity may not be the common denominator driving 
MS in older adults, but body composition may be the driving factor, 2) Those factors that 
have linear associations with PA levels (blood pressure, HDL cholesterol, triglycerides, and 
obesity) may be more susceptible to change than glucose levels, which has a reported 
curvilinear association with PA. This could indicate that levels of PA above and beyond 
moderate levels may provide additional protective effects against the progression of 
development of MS in older adults. In fact, Whaley’s data suggests an exponential type 
association between increasing levels of PA and reduced risk of MS. This review of literature 
provides further justification for studies examining the specific PA dose-MS response 
associations in older adults. 
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APPENDIX B. Frailty Review of Literature 
Frailty
As aging occurs there is a physiologic loss of the capacity of the body and its 
systems. While these losses are extremely heterogeneous and variable, all the available 
modern medicine and technology cannot stop some of the aging-related departures from our 
twenty year old bodies. The crux of gerontologic research for many decades has been in 
understanding why aging changes are so variable from one individual to the next. Why is it 
that one seventy year old is playing golf every day and enjoying retirement, while another 
seventy year old is struggling to maintain daily independence at home? Most, but not all, 
researchers focus there attention on the second seventy year old (or groups of similar people), 
and develop conceptual models to explain the accelerated loss in the body’s functional 
capacity and reserves.  
 Geriatric clinicians have for many years tried to explain the pathways that lead to 
unsuccessful aging. The terms used for this concept have changed and morphed over the last 
twenty years. Earlier terms used were chronic sick, debilitated, incapacitated or functionally 
dependent (Hogan, MacKnight et al. 2003). Since these terms were first used to describe 
older adults with seemingly accelerated aging processes, the clinical and research 
communities have come together in an attempt to better describe a population of older adults 
who are on a “functional slippery slope.” The first of these gatherings was the Task Force on 
the Frail Elderly, initiated by the Federal Council on Aging in 1974. The Task Force was 
charged with defining, characterizing and setting forth health policy guidelines for a group of 
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older adults who needed special attention by the medical community. The Task Force used 
the term “frail elderly” to identify a group of older adults who have physical debilities, 
emotional impairment, and debilitating physical and social environments (Tavani 1978). The 
purpose of identifying this special population of older adults was to develop services, care 
plans and case management in the health care systems. Interestingly, the reception to the 
Task Force’s recommendation was met with criticism by the medical community, largely due 
to the overwhelming lack of evidence from which the recommendations were based.  
 Since the FCA’s coining of the phrase “frail elderly” in the 1970s there has been a 
boom in research on frail older adults, albeit with numerous definitions and models of frailty. 
The MeSH heading “frail elderly” had 0 articles in the early 1980s and within fifteen years 
had grown to almost 800 articles using that MeSH term. Clearly there is interest in 
identifying and treating frail older adults, with the end purpose of making their lives better 
and preventing frailty in future populations of older adults.  
 This appendix will first introduce a conceptual model of frailty. In addition I will 
provide a review of frailty definitions and working models that have accumulated in the 
literature, synthesize the evidence for the use of the models in epidemiologic and clinical 
research, and discuss the advantages of distinguishing frailty from similar aging-related terms 
such as functional decline or disability.  
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Conceptualizing Frailty 
 
The figure shown above provides a conceptual model of frailty, which is a result of decreased 
physiologic reserve and greater fluxuations in internal or environmental stressors (Fries 
1980). When these fluxuations overtake physiologic reserve the individual could be 
considered impaired in that particular system. An example of this concept is demonstrated by 
considering that the fluxuations seen in the figure are daily walking habits of an individual. 
One of the physiologic systems needed to walk is strength, particularly in the lower body. 
Consider a loss of strength with aging (sarcopenia) to the point where the strength reserve 
needed to normally ambulate throughout the day is no longer sufficient. At this point the 
individual has an impairment in strength that places him/her at risk for mobility disability (a 
significant risk in the frail), and the individual would most likely adapt their behavior to 
compensate for the strength impairment, i.e. curtail mobility activities requiring sufficient 
strength reserves. This conceptual model is important to understand when further discussing 
the definitions and working models of frailty, which are detailed below. 
Frailty Definitions 
Aging
Physiologic Reserve
Adapted from Fries et al. NEJM, 1980
Frailty
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Three broad classes of frailty definitions have emerged from the literature over the 
last twenty years. These are 1) Dependency definitions, 2) Vulnerability definitions, and 3) 
Disease states definitions, as presented by the CIFA working group (Hogan, MacKnight et al. 
2003). The importance of developing a working definition of frailty is its link between a 
conceptual and the working model. This is due to the fact that most well developed frailty 
definitions contain measurable aspects of the conceptual model that allow for structuring the 
methods of data collection for the working model. This definition link is where many of the 
above mentioned conceptual models fail to move beyond a theoretical concept to a working 
model in the clinical and research realm. For example, a biomedical/psychosocial model that 
states frailty occurs when medical, functional, and social dimensions become compromised 
may be conceptually sound, but a working definition of more specific medical, functional, 
and social constructs that should be measured is needed to put the model into use. As 
Rockwood states, “…the success of any definition of frailty will depend on it being useful to 
researchers and clinicians.”(Rockwood 2005) 
Definitions classes and their particular strengths and weaknesses will be discussed 
below. Specific examples within the three definition classes will be provided for further 
clarification. I will also discuss the importance of making a clear distinction between 
disability and frailty in this section of the paper. 
Dependency Frailty Definitions 
 There are at least twelve definitions of frailty in the literature that are dependency 
driven. These definitions include a requirement of the frail individual to be dependent in one 
or more ADLs or IADLs, or to have an impairment in physical abilities that predispose 
him/her to disability. These definitions fit very well in the larger umbrella of functional 
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decline and are sometimes synonymous with functional limitations. This provides an initial 
opportunity for discussion on separating frailty from disability.  
Dependency definitions for frailty inherently are very similar to disability definitions 
(also a term lacking in consensus of definition and measurement). For instance, Bowsher and 
colleagues(Bowsher, Bramlett et al. 1993)defined frailty as “…those over age 65 with one or 
more functional, cognitive or social impairments.” Of course an impairment or inability to 
perform socially defined roles is the working definition of disability in the Nagi model (Nagi 
1965). These overlaps are common in the frailty and disability literature and impede a clear 
understanding of either term. Risk factors common between frailty and disability in the 
literature are cognitive impairment, physical inactivity, smoking, social isolation, and 
comorbidities (Strawbridge, Shema et al. 1998; Stuck, Walthert et al. 1999). The working 
definition of frailty in this context is dependency driven and states frailty is “…involving 
problems or difficulties in two or more functional domains (physical, nutritive, cognitive, and 
sensory).” Similarly, disability is assumed to arise from functional decline, which is the 
outcome in exploring the above risk factors (Stuck, Walthert et al. 1999).  
Perhaps the frailty/disability overlap is a result of researchers’ liberal use of both 
terms, particularly disability. As stated previously, Nagi clearly defined disability as having a 
social component, thus moving beyond physical limitations to the interaction between these 
limitations and the individual’s environment. The terms “mobility” or “functional” 
disability” are used in the literature with rather liberal definition (Chou and Chi 2005; Wang, 
Olson et al. 2005). Is difficulty in climbing stairs a disability? That question can only truly be 
answered on an individual basis. An older adult who resides in a first floor garden apartment 
may not feel disabled, while someone needing to climb twelve stairs to get to their bedroom 
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may feel disabled. That individual may be considered frail and susceptible to incident 
disability. However, difficulty or needing assistance with an ADL (bathing, dressing, 
toileting) may indeed infer disability, as ADL items are typically necessary for an individual 
to perform their normal role in society (Gill, Williams et al. 1995). Herein lies the distinction 
between frailty and disability, as frailty can be considered to be a “pre-disability” state before 
one loses independence in ADLs. In fact in a consensus paper written by leading researchers 
in frailty and disability (Fried, Ferrucci et al. 2004), it was clearly stated that frailty is a cause 
of disability, and that frailty should be defined and modeled without using disability items to 
assist in disentangling the two concepts. The current state of disability in the literature is that 
it is a process with multiple pathways(Jette 2003). Frailty can be considered a particular 
pathway to disability. Frail older adults are in fact more likely to become ADL disabled 
compared to non-frail older adults (Fried, Tangen et al. 2001).   
For the purposes of this paper, frailty models with ADL dependency as a factor will 
not be discussed in depth, as these models capture a state of functional decline beyond frailty. 
For instance, Rockwood developed a frailty model referred to often in the literature 
(Rockwood, Stadnyk et al. 1999) and has very recently simplified his model for the clinician 
(Rockwood, Song et al. 2005); however, his frailty factors include overt disability (totally 
dependent on basic ADLs such as self-care and transferring). These individuals are severely 
disabled, and research indicates that this population would not respond to an intervention as 
favorably as the non-disabled (Ferrucci, Guralnik et al. 2004). However, focusing on 
identifying individuals who are in a pre-disabled state, and then intervening on those 
individuals, is an area in need of a focused effort (Fried, Ferrucci et al. 2004). 
Vulnerability frailty definitions 
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 The CIFA (Hogan, MacKnight et al. 2003) identified nineteen vulnerability 
definitions from the literature. Most of these definitions included the term “vulnerable” or 
“vulnerability/susceptibility” to functional loss, functional decline, environmental challenges, 
or disease. The mechanism responsible for this vulnerability is often at the impairment level, 
or deficits in the body’s systems. For example, Ferrucci defined frailty as, “a pathologic 
condition that results in a constellation of signs and symptoms and is characterized by high 
susceptibility, impending decline in physical function and high risk of death.” The quantity of 
research in the systems area lends these definitions to a general acceptance of their validity. 
Moreover, this class of definitions fits very well with the concurrent deficits in systems 
models described previously, and the result is well-constructed and measurable working 
models of frailty (discussed in detail below). There is still, however, a considerable amount 
of disagreement as to which model is superior in predicting poor health outcomes.   
Disease states frailty definitions 
 The third and final definition class is disease states. This class is the least researched 
in the frailty literature, partly due to a preponderance of evidence in the broader medical 
literature that clearly establishes the link between disease and poor health outcomes. 
Researchers have established that disease is certainly a contributing factor to frailty 
(Newman, Gottdiener et al. 2001), particularly when severity (symptoms) of disease or 
concurrent diseases is considered. It is my opinion that disease states definitions are too 
restrictive, as not all diseases or even multiple diseases lead to frailty and subsequent decline. 
The sensitivity and specificity of these definitions alone are questionable, but certainly 
should be considered when considering a broader definition of frailty.  
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Working models of frailty 
 The working models of frailty are what allow clinicians and researchers to move from 
a theoretical model, to defining a population, to collecting information or intervening on that 
population using the working model. There are numerous working models of frailty in the 
literature, and their ability to detect individuals at risk for poor health outcomes vary greatly. 
The advantages and disadvantages of using these working models in epidemiologic and 
clinical research will be discussed in this section. Because of the inability to determine 
specifics of the model and its criteria, working frailty models in abstract form will not be 
discussed 
 Some of the first studies with working models of frailty were the FICSIT (Frailty and 
Injuries: Cooperative Studies of Intervention Techniques) studies, which were very well-
designed and carried out collaborative studies. The working definition of frailty in these 
studies was “severely impaired strength, mobility, balance, and endurance.” (Ory, 
Schechtman et al. 1993)Because each site targeted and recruited different populations for 
their interventions, the inclusion criteria varied from site to site. However a meta-analysis of 
the studies allowed for a cross-sectional snapshot of inclusion criteria and a “thematic” 
working model of frailty from similarities seen across studies. Five criteria for a working 
model of frailty appeared in the FICSIT studies. These criteria were 1) age ~75 y.o. 2) 
Community dwelling 3) Ambulatory (i.e. able to ambulate around the home) 4) history of/or 
risk for falls 5) no illnesses with impending, steep functional decline (i.e. Parkinson’s, severe 
dementia, crippling arthritis) (Judge, Schechtman et al. 1996). When analyzing the pooled 
data from all studies, the use of the FICSIT model to identify frail elders who would most 
benefit from interventions resulted in reduced falls risk of 17% with balance training and 
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10% with exercise training (of varying modalities and intensities) (Province, Hadley et al. 
1995). An interesting observation is that the five criteria listed represent a broad theoretical 
model spectrum. Of the theoretical models discussed previously, the aging model, concurrent 
systems model, biomedical/psychosocial model, and primary pathways model are 
represented in the FICSIT working model. The FICSIT studies demonstrate, at a relatively 
early stage in frailty research, that the strength of combining multiple theoretical models to 
develop a working frailty model are quite effective in affecting a multi-dimensional outcome 
such as falls.   
 Developed at about the same time as the FICSIT model was the model by Winograd 
and colleagues (Winograd, Gerety et al. 1991). The purpose of their model was to evaluate 
older, hospitalized adults for frailty and to refer these frail patients to a comprehensive 
geriatric evaluation clinic. Their working model for frailty included prevalence of one of a 
variety of illnesses, limitations, or functional deficits (physical and cognitive). After one year 
the frail group had increased length of stay at the hospital, nursing home admissions, and 
mortality compared to the independent group. The authors concluded that “geriatric 
syndromes” are of more utility than specific diagnoses for screening older adults for adverse 
outcomes. The underlying issues with this model are that most of the syndromes referred to 
are clinically detectable and are, in most cases, affecting an older adult who has already 
become disabled (i.e. prolonged bed-rest, pressure sores, dependence in ADLs). Similar to 
the Geriatric Evaluation and Management trials criteria (Cohen, Feussner et al. 2002), this 
specific model identifies older individuals who are beyond pre-clinically frail. 
 Because of the amount of literature on sarcopenia as a primary pathway to frailty, 
several investigators have advanced this concept to a working model of frailty. For instance, 
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knee extensor strength predicted four year mortality rates in community–dwelling older 
adults aged 75 and up (Laukkanen, Heikkinen et al. 1995). These investigators suggest that 
maximal isometric knee extensor force of less than ~27 kg (~60 lbs.) is a meaningful cut 
point for concern. Handgrip strength has also been shown to predict incident disability in 
older men. One study found that a handgrip strength measure of less than 30 kg in men 
greater than 77 years can be considered criteria for frailty and predictive of future disability 
(Giampaoli, Ferrucci et al. 1999). A low handgrip strength measure in midlife (<37 kg) is 
also predictive of future mobility limitations and ADL disability (Rantanen, Guralnik et al. 
1999). This suggests that perhaps strength (or sarcopenia) is better conceptualized as a life 
course model (long-term disuse) in explaining frailty rather than a primary pathways model. 
Exercise advocates would undoubtedly agree with this notion. 
 Weight loss has been suggested as a primary pathways model of frailty. A 5% weight 
loss over three years was predictive of mortality in a group of community-dwelling older 
adults. Similarly, a low weight at baseline was also predictive of mortality (Newman, Yanez 
et al. 2001). Along similar lines, a low BMI has also been examined as a single frailty factor. 
A BMI less than 23 is one threshold point that has shown to be predictive of higher mortality 
in older adults (Deschamps, Astier et al. 2002). Weight loss as a stand-alone frailty factor is 
questionable as are most primary pathways models. Chin A Paw has used BMI or 
unintentional weight loss as factors in several frailty models (discussed below).  
 Owens and colleagues developed a seven-item model to detect frailty in older adults 
(75+) who were presenting to emergency rooms for treatment. Poor cognition, impaired 
mobility (unable to walk to across room), >6 lbs. weight loss in past year, four or more 
medications, overnight hospitalization in past 30 days, and age over 85 years old were 
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individually considered frailty factors and would thus initiate a consult by a geriatric 
pharmacist (Owens, Fretwell et al. 1994). Almost nine out of ten patients admitted to the 
hospital from the ER, over age 75, were positive for one of the frailty factors. This model is 
the only one to include multiple medications as frailty factor. It would be interesting to study 
the relevant strengths and weaknesses of multiple medications vs. multiple morbidities as 
frailty factors.  
 A relatively small study used balance and strength measures to delineate between frail 
and non-frail (as determined by the WHO functional capacity score) (Dayhoff, Suhrheinrich 
et al. 1998) . The results indicated that a postural sway measure with eyes closed on a 
compliant surface dorsiflexor strength were predictive of frailty in this group of community 
dwellers (mean age = 74). Specifically, cut –off scores were a sway score of 30% (using 
Smart Balance Master scoring) and a peak dorsiflexion force of ~ 40 pounds. These cut-
points identified frail individuals 67% of the time and identified non-frail individuals 64% of 
the time. The sensitivity and specificity of these measures are quite good given the small 
sample size in the study. It appears that balance and strength may play key roles in working 
frailty models. 
 In a large study (6,928 persons) using data from the Alameda County Study 
(Strawbridge, Shema et al. 1998), Strawbridge identified a frailty model from four broad 
domains---physical functioning, nutritive functioning, cognitive functioning, and sensory 
functioning. Individual physical functioning items within the physical functioning domain 
were sudden loss of balance, weakness in arms or legs, and dizziness when standing up. 
Nutritive items were loss of appetite and unexplained weight loss. Cognitive functioning 
items were attentiveness, memory, forgetfulness, and speech recall. Finally, sensory items 
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consisted of visual and hearing loss. If an individual reported “often” or “very often” having 
problems in the last 12 months in any of the items, then the domain from which it represented 
was also classified as a positive frailty domain. If two domains were positive then that 
individual was classified as frail. In cross-sectional analyses, frailty was associated with 
decreases social activities (eating out, visiting friends), decreases life satisfaction, and poorer 
mental health and well-being. The major concern with this frailty model revolves around all 
the issues of self-report to determine frailty factors. 
 Stressing the importance of physical inactivity in the progression of functional 
decline, Chin A Paw (Chin A Paw, Dekker et al. 1999) developed and compared three frailty 
models, all with physical inactivity as a primary frailty factor, in predicting functional 
decline and mortality in older, community-dwelling, Dutch men. The three working frailty 
models were physical inactivity (<210 min/week + low energy intake (<7.6 MJ/day), 
physical inactivity + weight loss (>9 lbs. in last 5 years), and physical inactivity + low BMI 
(<23.5). The model that best predicted functional decline (incident dependency in ADLs) and 
mortality was physical inactivity and 5 yr. weight loss. The authors recognized that a 5 year 
weight loss measure may not be as sensitive as a one year measure, but the physical 
inactivity/weight loss frailty model had significant odds ratios nonetheless (OR of 4-5 for 
decline and mortality).  
Chin A Paw later used this model to identify frail older adults with targeted exercise 
programs and nutritional supplementation. Two separate interventions aimed at improving 
physical function and well-being, respectively, in frail older adults (Chin A Paw, de Jong et 
al. 2002; Chin A Paw, de Jong et al. 2002). Interestingly, these two interventions used 
involuntary weight loss or low BMI (<25) in conjunction with physical inactivity to define 
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frailty. It is possible that the model was broadened to include more older adults in the study 
and reach a target number of participants not possible with just a 9 pound weight loss 
criterion. In the population used to develop their model, only 6% were identified as fitting the 
criterion of involuntary weight loss, however, by adding low BMI as an additional factor in 
the model, the percent frail doubled to 12%. This raises an issue when targeting frail older 
adults for an intervention using a CSV model, as prevalence rates of frailty using the model 
may be low (4-7%) and recruitment and sample size become issues. However, how does one 
balance using a scientifically grounded working model with tweaking the model to cast a 
wider net when conducting intervention trials?  
 Gill and colleagues developed a model in 1999 to predict incident functional 
dependence in community-dwelling older adults independent in ADLs at baseline (Gill, 
Williams et al. 1999). Frailty factors were defined as a fast gait speed <0.60 m/s, MMSE 
score <24, and age >85 years. In just one year ADL dependence developed in 40% of the 
frail group, compared to 7% in the non-frail group.  However, in a validation group with 
similar baseline characteristics, only 28% of the frail group became disabled at one year, 
compared with 5% in the non-frail group.  
 Several years later Gill revised his frailty model to include only two factors, both 
physical performance measures, to identify frail older adults to participate in two separate 
home exercise intervention trials (Gill, Baker et al. 2002; Gill, Baker et al. 2003). In these 
trials Gill identified frailty by a fast gait speed of <0.60 m/sec (same as above) and inability 
to rise from a chair without arm assistance. Pre-frailty was identified by one of these factors 
being present. The interventions were affective in reducing functional decline over time, but 
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the impact of the intervention on the individual frailty factors (i.e. gait speed, chair rise score) 
was not reported. Thus it is not known how the exercise intervention affected frailty status. 
 Brown used scores from the modified physical performance test (PPT) to 
trichotomize community-dwelling older adults into not frail, mildly frail, and moderately 
frail groups (Brown, Sinacore et al. 2000). The splits in scores were determined as 32-26 not 
frail, 25-31 mildly frail, and 17-24 moderately frail. The moderately frail group had a fast 
gait speed of 1.00 m/sec, which is a velocity of concern for a normal gait speed (MJ Peterson 
(Abstract), Gerontologist, Nov. 2004). The moderately frail group also had poor balance as 
measured by the Berg balance test and a full tandem stand (mean time was 1.9 sec.). Brown 
later conducted a three-month randomized trial of exercise vs. home flexibility training in 
mildly frail groups (Brown, Sinacore et al. 2000). The exercise group had significant changes 
in PPT scores (29 to 31), compared to the home group who remained unchanged (29 to 29). 
Interestingly, on average the exercise group approached the not frail category by the end of 
the short intervention period. Long term sustained effects of the intervention were not 
reported. 
 Using a large, nationally representative sample of men and women (65+) from the 
Cardiovascular Health Study, Fried proposed a frailty “phenotype,” an interaction between 
genetic and environmental factors that predispose functional decline (Fried, Tangen et al. 
2001). Fried’s model included five characteristics, 1) unintentional weight loss (>10 lbs. lost 
unintentionally in previous year), 2) poor endurance/ exhaustion (self-report from two items 
on CES-D), 3) slowness (gait velocity <0.65 m/s if ht. <173 cm.; <0.76 m/s if ht. >173 cm.), 
weakness (lowest 20% in sex and BMI adjusted grip strength) and, 5) low physical activity: 
(kcal expenditure/week from CHAMPS questionnaire; men <383 kcals/week, women <270 
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kcals/week). Presence of three or more factors constituted frailty, and presence of one or two 
factors deemed that individual as intermediate frail. Compared to the not frail group, 
intermediate frail and frail groups were more likely to fall, have worsening mobility, 
worsening ADL disability, be hospitalized, and die over three and seven years. A couple 
potential issues with the Fried model are that physical inactivity, weakness, and slowness are 
distribution dependent (i.e. 20th percentile for that group). Using these cut-offs in sub-
populations (oldest-old, minorities, low SES) may be difficult. Also, a fairly high prevalence 
of disability (~37%) was reported in the Cardiovascular Health Study cohort. A more precise 
model of frailty may have been developed by excluding those with disability at baseline, as 
Fried’s frailty factors were developed using individuals further along the functional decline 
continuum. 
 Following Fried’s research, we recently developed a proxy model to Fried’s to 
determine the efficacy of a six-month telephone exercise counseling in affecting the frailty 
status of older veterans (Peterson, Sloane et al. In process). We substituted a BMI of <18 for 
weight loss, lowest 20% in chair stands for grip strength, and lowest 20% in 6-minute walk 
for poor endurance. Using our proxy model, we found an 18% relative reduction in the 
proportion of frail compared to the control groups. The frailty factor that was most likely to 
determine frailty status at baseline and follow-up was chair stands (lower body strength). 
This supports the large body of literature that exists in showing sarcopenia as an important 
frailty factor. Low BMI was a poor substitute for weight loss in our study, as no participants 
had a BMI <18. Fried and colleagues have recently reported that obesity, as opposed to 
weight loss, may be a superior frailty factor and better predictive of functional decline 
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(Blaum, Xue et al. 2005). More prospective work is needed to support the use of obesity as a 
frailty factor. 
 Timonen used gait mobility and balance limitations (dizziness or difficulty in walking 
independently) as frailty factors to target women hospitalized for acute illness for a post-
hospitalization rehabilitation program(Timonen, Rantanen et al. 2002). Baseline maximal 
gait speed averaged near 0.80 m/s in both groups; however, after 3-months the exercise group 
had a mean increase in gait speed of 0.12 m/sec where the control group had no change. This 
intervention showed that the frailty factor can be affected by a targeted program of lower 
extremity strengthening and functional training (chair stands). The frailty factors were 
somewhat subjective in the study as difficulty with mobility was not defined, and an 
objective measure (timed gait speed) was not utilized. 
Summary 
 Almost thirty years of research has resulted in many lines of thought on frailty and 
how it should be measured. Investigators in this area recently have convened to summarize 
the vast frailty literature and to make recommendations on defining frailty and designing 
trials aimed at frail older adults (Ferrucci, Guralnik et al. 2004). Interestingly, the end 
product of these consensus groups often results in more questions than answers. Needs for 
future research include continuing to develop a working model of frailty and the factors that 
should be included. Based one reviewing the models in existence and on consensus group 
opinion, physical factors should be measured with objective performance tests. The optimal 
measures of cognition and social factors remain unknown and in need of further study. 
Frailty investigators from varying disciplines need further collaboration to take advantage of 
the frailty knowledge that has accumulated in the fields of basic medicine, biostatistics, 
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applied physiology and geriatric medicine. Continued multi-disciplinary work will advance 
the taxonomy of frailty, with the end result of improving quality of life of the frail older 
adult. 
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APPENDIX C. Secondary Analyses 
Stability of Physical Activity Levels over Time 
Secondary, exploratory analyses were conducted within the construct of this study, 
primarily for learning purposes compulsory with a dissertation project. First, stability and 
reliability of physical activity across time was tested using an intraclass correlation 
coefficient (ICC) test from all available waves for each participant. Because of the dramatic 
change in the format of the Health ABC physical activity questionnaire from year to year, the 
weekly time spent in physical activity (time spent walking of any intensity) was the only 
consistent variable collected at multiple time points (Years one, two, three and five). Results 
from this analyses indicated that there is a great deal of variability within individuals from 
year to year in their weekly time spent walking as a physical activity. The ICC value of 0.36 
demonstrates a weak to moderate degree of stability in these older individuals walking 
patterns throughout their seventh decade. Further analyses with general linear modeling 
revealed that as a group, time spent walking steadily declined over time from an average of 
138 minutes at baseline, to 128 minutes at year two, down to 100 minutes per week at year 
five. The drop in average time spent walking during the week from year one to year five (~38 
minutes) was statistically significant (P<0.05). These results indicate that there is a 
substantial degree of variability within older individuals in their yearly physical activity 
patterns and that, on average, physical activity levels decline significantly over several years 
in older adults. 
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Homogeneity of Physical Activity Effects between Baseline Strata 
We also wanted to determine if physical activity affected subsequent metabolic syndrome 
and frailty differently between those with and without the respective conditions at baseline. 
This information could be of significant public health interest if it is found that physical 
activity has differing effects on those with and without these conditions. To test this, a weight 
odds ratio was calculated by considering the size of the effect estimates in relation to the 
standard errors of the estimates in both strata. The equation to calculate the weight odds ratio 
is as follows: 
Beta1(1/s.e.1) + Beta2(1/s.e.2)
1/(s.e.1)2 + 1/(s.e.2)2
With a variance of: 
1/(1/s.e.1)2 + (1/s.e.2)2
From this information a 95% confidence interval is calculated for the weight odds ratio. 
Finally, to test for homogeneity of the effects a mantel-haentzel chi-square statistic is 
calculated and tested on one degree of freedom. This is synonymous with methods common 
in meta-analysis to determine homogeneity of effects sizes from multiple studies. If the chi-
square statistic is significant (>3.84) then we must assume heterogeneity between the strata, 
indicating that physical activity has differing effects on long-term metabolic syndrome or 
frailty status in those with the condition. The tables below provide the weighted odds ratios 
and the test for homogeneity of the effects.  
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Table 1. Weighted odds ratios for incident metabolic syndrome in those with and without  
 the condition at baseline. 
 Weighted OR  95%CI  Test for homogeneity 
Men
Time  
 Low Dose   1.44      1.10-1.89  Yes 
 Recommended Dose  0.68   0.44-1.03  Yes 
 High Dose   1.00   reference   
 
Intensity  
 Sedentary Dose  1.28   0.91-1.80  Yes 
 Light Dose   1.25   0.93-1.67  Yes 
 Moderate Dose  0.84   0.64-1.09  Yes  
 Vigorous Dose  1.00   reference   
 
Activity Types 
 Sedentary    1.15   0.84-1.57  Yes 
 Lifestyle active  1.04   0.83-1.30  Yes 
 Exercise active  1.00   reference   
Women
Time  
 Low Dose   0.95      0.74-1.23  Yes 
 Recommended Dose  0.93   0.62-1.39  Yes 
 High Dose   1.00   reference   
 
Intensity  
 Sedentary Dose  0.82   0.57-1.18  Yes 
 Light Dose   0.81   0.64-1.03  No 
 Moderate Dose  1.17   0.84-1.63  Yes  
 Vigorous Dose  1.00   reference   
 
Activity Types 
 Sedentary    0.73   0.54-0.97  Yes 
 Lifestyle active  1.11   0.90-1.38  Yes 
 Exercise active  1.00   reference   
Yes=homogeneity; No=heterogeneity 
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Table 2. Weighted odds ratios for incident frailty in those with and without  
 the condition at baseline. 
 Weighted OR  95%CI  Test for homogeneity 
Time  
 Low Dose   0.99      0.97-1.01  Yes 
 Recommended Dose  0.98   0.94-1.02  Yes 
 High Dose   1.00   reference   
 
Intensity  
 Sedentary Dose  0.99   0.96-1.03  Yes 
 Light Dose   0.99   0.96-1.02  Yes 
 Moderate Dose  0.99   0.96-1.02  Yes  
 Vigorous Dose  1.00   reference   
 
Activity Types 
 Sedentary    1.03   1.00-1.07  Yes 
 Lifestyle active  1.00   0.98-1.02  Yes 
 Exercise active  1.00   reference   
Yes=homogeneity; No=heterogeneity 
In general the weighted odds ratios were very similar in magnitude and precision 
(95%CI) compared to the unweighted odds ratios presented in chapters two and three. The 
important finding in this analysis is the heterogeneity in the light intensity dose effect on 
metabolic syndrome in women with and without metabolic syndrome (Table 1). This 
indicates that light intensity doses were protective in healthy women from developing 
metabolic syndrome compared to vigorous intensity doses. These were the findings presented 
in chapter two. However, in women with metabolic syndrome at baseline, light intensity 
doses placed women at slightly higher risk for continuing to have metabolic syndrome at year 
six compared to vigorous intensity doses (OR=1.10). These results suggest that the status of 
metabolic syndrome may be an important determinant in the prescription of physical activity 
doses in women. Where higher intensity doses may be beneficial in reversing metabolic 
syndrome in those with it, and the same high intensity doses prescribed to an older woman 
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without metabolic syndrome may be inferior in effect to light intensity doses. Much work is 
needed to fully understand the differing effects of physical activity between disease states. 
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Volume of Physical Activity and Metabolic Syndrome/Frailty 
 
Since volume of physical activity (PA volume) is a continuous variable (kcals/week), 
it was divided into quartiles, based on distribution, to allow for easier interpretation of the 
models. The quartiles were divided as follows: 
 
Group 1: <25th percentile 
 Group 2: 25th-50th percentile 
 Group 3: 50th-75th percentile 
 Group 4 (referent group): >75th percentile 
 
Table 3. Volume of physical activity by quartiles and subsequent metabolic syndrome in  
 men and women. 
 Odds Ratio   95% CI 
Men (N=629) 
 Quartile 1   0.83    0.48-1.42 
 Quartile 2   0.42    0.22-0.78 
 Quartile 3   0.83    0.49-1.43 
 Quartile 4   1.00 
P for trend   0.19 
 
Women (N=637) 
 Quartile 1   0.48    0.27-0.84 
 Quartile 2   0.72    0.43-1.21 
 Quartile 3   0.80    0.48-1.33 
 Quartile 4   1.00 
P for trend   0.01 
In men, with the highest quartile as the referent group, the models indicated a U-
shaped dose-response association between PA volume and incident metabolic syndrome. 
Men in the 25th-50th percentile range had an odds ratio of 0.42 (95%CI 0.22-0.78), indicating 
a significantly reduced odds of metabolic syndrome compared to men in the highest PA 
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volume group. Examination of the association between PA volume and metabolic syndrome 
within women showed that those in the lowest quartile had an odds ratio of 0.48 (95%CI 
0.27-0.84) compared to women in the highest PA volume group. These findings are 
unexpected, as lower doses of PA volume have consistently been shown to be associated 
with higher rates of adverse health outcomes. Interim data in this cohort are needed to help 
explain these associations. 
 
Table 4. Volume of physical activity by quartiles and any subsequent frailty over six  
 years. 
 Odds Ratio   95% CI 
Quartile 1   1.85    1.44-2.38 
Quartile 2   1.26    0.97-1.64 
Quartile 3   1.09    0.84-1.42 
Quartile 4   1.00      --------- 
P for trend   <0.0001 
Table 5. Volume of physical activity by quartiles and subsequent severe frailty over six  
 years. 
 Odds Ratio   95% CI 
Quartile 1   1.11    0.10-12.6 
Quartile 2   0.87    0.12-6.12 
Quartile 3   1.01    0.24-4.29 
Quartile 4   1.00     --------- 
P for trend   0.83 
PA volume had significant associations with the development of any frailty over six 
years (Table 4). First, those in the lowest quartile had significantly greater odds of frailty, 
with an 85% increased likelihood compared to the highest quartile (OR=1.85; 95%CI 1.44-
2.38). There was also a dose-response association (P<0.0001) between increasing PA volume 
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and decreased likelihood of developing any frailty. Examination of PA volume and risk of 
developing severe frailty (Table 5) revealed no significant associations, indicating that PA 
volume did not predict subsequent severity of frailty over six years in this cohort. 
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Impact of Physical Activity on Individual Metabolic Syndrome Factors 
 
Gender specific models were constructed to determine the physical activity 
categories’ associations with the development of the five individual metabolic syndrome 
factors. The results displayed in Tables 6 and 7 indicate that overall there were few 
associations between physical activity doses and individual factors. Generally, in men, the 
lower doses of physical activities had higher odds of developing each factor compared to the 
highest doses, however the magnitude and precision of the odds ratios were unremarkable. 
There were two significant findings in men. First, those reporting low doses of time spent in 
physical activity were twice as likely to develop the waist circumference factor (OR=2.03; 
95%CI 1.29-3.18), compared to the high time group. Second, men reporting low intensity 
physical activity doses were less likely to develop the fasting glucose factor compared to the 
vigorous intensity group (OR=0.53; 95%CI 0.29-0.97). The odds ratios in the intensity group 
when predicting development of a glucose factor were unlike any of the other dose-responses 
in men.  
 In women there were no significant findings (Table 7), however, dose-response 
associations in the intensity category when predicting development of elevated blood 
pressure as a factor does possibly provide insight into the significant findings in manuscript 
one, where light intensity doses were protective of metabolic syndrome compared to the 
vigorous intensity dose, and the highest incident factor at year six was blood pressure. These 
associations could have driven the significant findings detailed in manuscript one. Similarly, 
the dose response associations observed between the activity types and incident waist 
circumference factor resemble the findings seen when modeling the full metabolic syndrome 
incidence. These results indicate that, in women, it is possible that the association between 
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physical activity doses and one particularly prevalent metabolic syndrome factor could be 
responsible for the overall association between physical activity and metabolic syndrome. 
More work is needed to further explore this hypothesis.
Table 6. Baseline physical activity doses and incident metabolic syndrome factors in men.
Variable Waist Circ. Triglyc. HDL BP Glucose
Time
Low dose 2.03 (1.29-3.18) 1.08 (0.63-1.83) 1.09 (0.65-1.81) 1.08 (0.67-1.76) 1.14 (0.73-1.78)
Recommended dose 1.55 (0.71-3.38) 0.88 (0.34-2.29) 0.76 (0.29-1.96) 0.72 (0.33-1.56) 1.05 (0.48-2.32)
High dose 1.00 1.00 1.00 1.00 1.00
P for trend 0.002 0.77 0.73 0.72 0.57
Intensity
Sedentary dose 1.15 (0.58-2.26) 1.34 (0.59-3.03) 1.35 (0.63-2.91) 1.35 (0.64-2.84) 0.72 (0.37-1.42)
Light dose 1.27 (0.71-2.27) 1.38 (0.67-2.82) 1.47 (0.75-2.88) 1.11 (0.59-2.10) 0.53 (0.29-0.97)
Moderate dose 1.31 (0.75-2.27) 1.19 (0.60-2.36) 0.99 (0.52-1.89) 1.06 (0.59-1.92) 0.82 (0.47-1.41)
Vigorous dose 1.00 1.00 1.00 1.00 1.00
P for trend 0.69 0.40 0.23 0.44 0.12
Activity types
Sedentary 1.23 (0.65-2.32) 1.02 (0.48-2.17) 1.11 (0.52-2.38) 1.35 (0.66-2.76) 1.04 (0.56-1.94)
Lifestyle active 1.36 (0.87-2.13) 1.14 (0.66-1.96) 1.33 (0.79-2.23) 0.95 (0.59-1.55) 1.07 (0.68-1.69)
Exercise active 1.00 1.00 1.00 1.00 1.00
P for trend 0.34 0.85 0.56 0.55 0.86
*Adjusted for total kcals, age, percent body fat, gender, race, education, marital status, smoking status, drinking status, heart disease,
and count of other diagnoses
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Table 7. Baseline physical activity doses and incident metabolic syndrome factors in women.
Variable Waist Circ. Triglyc. HDL BP Glucose
Time
Low dose 1.01 (0.65-1.58) 0.78 (0.47-1.31) 0.83 (0.48-1.45) 1.05 (0.62-1.79) 1.60 (0.85-3.01)
Recommended dose 1.17 (0.55-2.51) 1.26 (0.56-2.87) 0.44 (0.12-1.56) 0.59 (0.26-1.34) 1.11 (0.34-3.60)
High dose 1.00 1.00 1.00 1.00 1.00
P for trend 0.98 0.33 0.58 0.79 0.14
Intensity
Sedentary dose 1.27 (0.59-2.73) 0.90 (0.40-2.02) 0.72 (0.27-1.92) 0.44 (0.18-1.10) 1.35 (0.50-3.59)
Light dose 1.00 (0.56-1.79) 0.60 (0.32-1.10) 0.73 (0.38-1.41) 0.54 (0.26-1.12) 1.09 (0.53-2.26)
Moderate dose 0.98 (0.51-1.87) 0.71 (0.35-1.45) 0.97 (0.45-2.07) 0.55 (0.24-1.24) 1.06 (0.44-2.53)
Vigorous dose 1.00 1.00 1.00 1.00 1.00
P for trend 0.63 0.37 0.30 0.08 0.62
Activity types
Sedentary 0.64 (0.33-1.24) 0.71 (0.32-1.56) 0.70 (0.31-1.60) 1.38 (0.65-2.93) 1.27 (0.54-2.96)
Lifestyle active 0.76 (0.45-1.26) 1.16 (0.65-2.06) 0.84 (0.46-1.55) 1.34 (0.76-2.35) 1.08 (0.54-2.14)
Exercise active 1.00 1.00 1.00 1.00 1.00
P for trend 0.18 0.48 0.40 0.35 0.59
*Adjusted for total kcals, age, percent body fat, gender, race, education, marital status, smoking status, drinking status, heart disease,
and count of other diagnoses.
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Reduced Models of Physical Activity and Subsequent Metabolic Syndrome/Frailty 
 
Reduced models, via stepwise regression modeling, resulted in minimal differences from the 
fully adjusted models. Specifically, step-wise backward elimination was conducted, 
assessing whether dropping the variable of interest changed the main effect estimates by 
more than 10%. If the estimate did change by more than 10%, the variable was retained in 
the reduced model. 
The models are provided below in Tables 8 through 11. Percent body fat was a 
confounder of the association between physical activity doses and incident metabolic 
syndrome in both genders. Additional confounders in men were education and age. In the 
frailty model number of diagnoses (comorbidities) was the only significant confounder of 
development of any frailty and transitioning to severe frailty 
Table 8. Unadjusted, full adjusted, and reduced models of baseline physical activity and incident metabolic syndrome in men.
Variable Unadjusted OR (95%CI) Adjusted OR*(95% CI) Reduced Model OR** (95%CI)
Time
Low dose 1.92 (1.22-3.04) 1.67 (1.01-2.77) 1.64 (1.02-2.64)
Recommended dose 1.13 (0.47-2.75) 0.90 (0.35-2.31) 0.94 (0.37-2.38)
High dose 1.00 1.00 1.00
P for trend 0.004 0.03 0.04
Intensity
Sedentary dose 1.76 (0.91-3.41) 2.00 (0.96-4.15) 1.76 (0.88-3.53)
Light dose 1.29 (0.71-2.34 1.39 (0.72-2.67) 1.28 (0.69-2.37)
Moderate dose 1.17 (0.65-2.11) 1.27 (0.68-2.39) 1.19 (0.65-2.20)
Vigorous dose 1.00 1.00 1.00
P for trend 0.09 0.07 0.12
Activity types
Sedentary 1.49 (0.85-2.63) 1.46 (0.74-2.86) 1.33 (0.73-2.42)
Lifestyle active 1.37 (0.86-2.18) 1.33 (0.81-2.18) 1.32 (0.81-2.15)
Exercise active 1.00 1.00 1.00
P for trend 0.13 0.19 0.30
*Adjusted for total kcals, age, percent body fat, gender, race, education, marital status, smoking status, drinking status, heart disease,
and count of other diagnoses.
**Adjusted for percent body fat, age and education.
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Table 9. Unadjusted, full adjusted, and reduced models of baseline physical activity and incident metabolic syndrome in women.
Variable Unadjusted OR (95%CI) Adjusted OR* (95%CI) Reduced Model OR** (95%CI)
Time
Low dose 0.87 (0.58-1.30) 0.81 (0.51-1.27) 0.74 (0.49-1.13)
Recommended dose 0.53 (0.22-1.26) 0.63 (0.26-1.55) 0.56 (0.23-1.35)
High dose 1.00 1.00 1.00
P for trend 0.57 0.25 0.20
Intensity
Sedentary dose 0.73 (0.38-1.42) 0.91 (0.44-1.88) 0.89 (0.45-1.78)
Light dose 0.47 (0.29-0.77) 0.48 (0.28-0.81) 0.48 (0.29-0.79)
Moderate dose 0.67 (0.37-1.21) 0.75 (0.40-1.39) 0.75 (0.41-1.38)
Vigorous dose 1.00 1.00 1.00
P for trend 0.03 0.11 0.06
Activity types
Sedentary 0.53 (0.29-0.97) 0.55 (0.28-1.10) 0.55 (0.30-1.01)
Lifestyle active 0.90 (0.57-1.45) 0.84 (0.51-1.38) 0.81 (0.50-1.32)
Exercise active 1.00 1.00 1.00
P for trend 0.04 0.08 0.05
*Adjusted for total kcals, age, percent body fat, gender, race, education, marital status, smoking status, drinking status, heart disease,
and count of other diagnoses.
**Adjusted for percent body fat.
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Table 10. Unadjusted, full adjusted, and reduced models of baseline physical activity and development of any frailty.
Unadjusted OR (95%CI) Adjusted OR* (95%CI) Reduced Model OR** (95%CI)
Time
Low 1.25 (1.00 – 1.57) 0.99 (0.97 – 1.02) 1.02 (1.00-1.05)
Recommended 0.96 (0.62 – 1.48) 0.98 (0.94 – 1.03) 1.00 (0.96-1.04)
High 1.00 1.00 1.00
P for trend 0.04 0.40 0.03
Intensity
Sedentary 1.14 (0.78 – 1.65) 1.01 (0.97 – 1.05) 1.03 (0.99-1.07)
Light 1.41 (1.06 – 1.88) 1.01 (0.99 – 1.04) 1.04 (1.02-1.07)
Moderate 0.88 (0.63 – 1.22) 0.99 (0.96 – 1.02) 1.00 (0.97-1.03)
Vigorous 1.00 1.00 1.00
P for trend 0.02 0.26 0.002
Activity Types
Sedentary 1.92 (1.39 – 2.64) 1.04 (1.00 – 1.07) 1.08 (1.04-1.11)
Lifestyle active 1.38 (1.07 – 1.78) 1.00 (0.97 – 1.02) 1.03 (1.00-1.05)
Exercise active 1.00 1.00 1.00
P for trend <0.0001 0.08 <0.0001
*Adjusted for test wave, total kcals, age, gender, race, education, marital status, smoking status, drinking status, waist circumference
and count of diagnoses.
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Table 11. Unadjusted, full adjusted, and reduced models of baseline physical activity and development of severe frailty.
Unadjusted OR (95%CI) Adjusted OR* (95%CI) Reduced Model OR** (95%CI)
Time
Low 0.88 (0.47 – 1.65) 0.96 (0.85 – 1.10) 1.00 (0.88-1.14)
Recommended 0.67 (0.23 – 1.94) 0.91 (0.75 – 1.11) 0.92 (0.75-1.13)
High 1.00 1.00 1.00
P for trend 0.77 0.64 0.88
Intensity
Sedentary 2.83 (0.94 – 8.53) 1.23 (0.98 – 1.53) 1.23 (1.02-1.49)
Light 1.85 (0.77 – 4.45) 1.13 (0.96 – 1.34) 1.12 (0.98-1.29)
Moderate 1.23 (0.41 – 3.71) 1.05 (0.85 – 1.29) 1.04 (0.85-1.27)
Vigorous 1.00 1.00 1.00
P for trend 0.06 0.06 0.03
Activity Types
Sedentary 2.67 (0.90 – 7.95) 1.24 (1.03 – 1.49) 1.24 (1.09-1.42)
Lifestyle active 2.37 (0.99 – 5.66) 1.19 (1.05 – 1.35) 1.19 (1.05-1.34)
Exercise active 1.00 1.00 1.00
P for trend 0.09 0.02 0.01
*Adjusted for test wave, total kcals, age, gender, race, education, marital status, smoking status, drinking status, waist circumference
and count of diagnoses.
**Adjusted for count of diagnoses.
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APPENDIX D: SAS PROGRAMS 
 
Program for Metabolic Syndrome Analyses 
 
OPTIONS PAGESIZE=50 LINESIZE=96 NODATE NONUMBER NOFMTERR; 
 
*INITIATED 01-03-2006; 
*UPDATED; 
LIBNAME ABC V6 'C:\Documents and Settings\peter076\My 
Documents\Dissertation\ABC DATA';
LIBNAME DEF V6 'C:\Documents and Settings\peter076\My 
Documents\Dissertation\ABC DATA\FRAILTY';
RUN;
*IMPUTING MISSING VALUES HERE; 
DATA MET1;  
SET ABC.MS; 
 
IF EDUC NOT IN(1,2,3) THEN EDUC=.;
IF EDUC =. THEN EDUC=3;
IF SMK1=. THEN SMK1=2;
IF CURDRNK1=. THEN CURDRNK1=1;
IF Y1PCBVD NOT IN(0,1,2) THEN Y1PCBVD=.;
IF Y1PCBVD=. THEN Y1PCBVD=0;
IF Y1PDIAB1 NOT IN(0,1) THEN Y1PDIAB1=.;
IF Y1PDIAB1=. THEN Y1PDIAB1=0;
IF Y1POAKN=. THEN Y1POAKN=0;
IF Y1POAHIP=. THEN Y1POAHIP=0;
IF Y1PHBP1 NOT IN(0,1,2) THEN Y1PHBP1=.;
IF Y1PHBP1=. THEN Y1PHBP1=0;
IF Y1PDEPR1 NOT IN(0,1,2,3) THEN Y1PDEPR1=.;
IF Y1PDEPR1=. THEN Y1PDEPR1=0;
IF Y1PPULCD NOT IN(0,1,2,3) THEN Y1PPULCD=.;
IF Y1PPULCD=. THEN Y1PPULCD=0;
IF TSMARSTA IN(0,2,3,4) THEN TSMARSTA=2;
IF Y1PCHD1 IN(1,2) THEN Y1PCHD1=1;
IF Y1PCHD1 NOT IN(0,1) THEN Y1PCHD1=.;
IF Y1PCHD1=. THEN Y1PCHD1=0;
IF Y1PPAD NOT IN(0,1) THEN Y1PPAD=.;
IF Y1PPAD=. THEN Y1PPAD=0;
RUN;
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PROC MI DATA=MET1 OUT=IMPUT2 NIMPUTE=1 MINIMUM=0 MAXIMUM=1 NOPRINT; 
VAR Y1PCHD1 Y1PPAD; 
RUN;
DATA MET2; 
MERGE MET1 IMPUT2; 
BY HABCID; 
RUN;
PROC LOGISTIC DATA=MET2;  
OUTPUT OUT=OUTPUT P=PRED; 
MODEL TSMARSTA=CV1AGE GENDER RACE EDUC SMK1  
CURDRNK1 Y1PCHD1 Y1PCBVD Y1PPAD Y1PDIAB1 Y1POAKN Y1POAHIP Y1PHBP1 Y1PDEPR1 
Y1PPULCD/ 
SELECTION=STEPWISE; 
RUN;
DATA MARITAL; 
SET OUTPUT; 
IF TSMARSTA NOT IN(1,2) THEN NEWMAR=RANBIN(666,2,PRED); 
ELSE NEWMAR=TSMARSTA; 
RUN;
DATA MET3; 
MERGE MET2 MARITAL; 
BY HABCID; 
IF NEWMAR=0 THEN NEWMAR=2;
RUN;
PROC FORMAT;
VALUE MINGROUP 1='LOW- 150 MIN/WEEK' 
2='MOD- 150-200 MIN/WEEK' 
3='XTRA- 200+ MIN/WEEK';
VALUE INTGROUP  0='ASEDENTARY' 
1='LIGHT INTENSITY GROUP' 
2='MODERATE INTENSITY GROUP' 
3='VIGOROUS INTENTSITY GROUP';
VALUE BRACHGROUP 0='ASEDENTARY' 
1='LIFESTYLE ACTIVE' 
2='XERCISE ACTIVE';
RUN;
DATA CHECK1; 
SET MET3; 
IF Y1METSYN=1 THEN DELETE;
RUN;
DATA MET4; 
SET MET3; 
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TOTMIN=Y1WKTIME+HIGHXMIN; 
IF TOTMIN>=200 THEN MINGROUP=3;
IF 150<=TOTMIN<200 THEN MINGROUP=2;
IF TOTMIN<150 THEN MINGROUP=1;
DIFFWALK=Y6WKTIME-Y1WKTIME; 
IF DIFFWALK<=-90 THEN WKGROUP=1;
IF DIFFWALK>-90 THEN WKGROUP=0;
IF Y6METSAB NOT IN(0,1) THEN DELETE;
IF Y6METSHD NOT IN(0,1) THEN DELETE;
IF Y6METSTG NOT IN(0,1) THEN DELETE;
IF Y6METSBP NOT IN(0,1)THEN DELETE;
IF Y6METSGL NOT IN(0,1) THEN DELETE;
IF Y1METSYN=1 THEN DELETE;
IF Y6METSAB +Y6METSHD+ Y6METSTG+ Y6METSBP+ Y6METSGL>=3 THEN Y6METS=1;
IF Y6METSAB+ Y6METSHD+ Y6METSTG+ Y6METSBP+ Y6METSGL<3 THEN Y6METS=0;
IF Y6METSAB +Y6METSHD+ Y6METSTG+ Y6METSBP+ Y6METSGL=0 THEN Y6NUMBER=0;
IF Y6METSAB +Y6METSHD+ Y6METSTG+ Y6METSBP+ Y6METSGL=1 THEN Y6NUMBER=1;
IF Y6METSAB +Y6METSHD+ Y6METSTG+ Y6METSBP+ Y6METSGL=2 THEN Y6NUMBER=2;
IF Y6METSAB +Y6METSHD+ Y6METSTG+ Y6METSBP+ Y6METSGL=3 THEN Y6NUMBER=3;
IF Y6METSAB +Y6METSHD+ Y6METSTG+ Y6METSBP+ Y6METSGL=4 THEN Y6NUMBER=4;
IF Y6METSAB +Y6METSHD+ Y6METSTG+ Y6METSBP+ Y6METSGL=5 THEN Y6NUMBER=5;
IF Y1METSAB+ Y1METSHD+ Y1METSTG+ Y1METSBP+ Y1METSGL=2 THEN METSRISK=2;
IF Y1METSAB+ Y1METSHD+ Y1METSTG+ Y1METSBP+ Y1METSGL=1 THEN METSRISK=1;
IF Y1METSAB=0 AND Y6METSAB=1 THEN CHANGEAB=1;
ELSE CHANGEAB=0;
IF Y1METSHD=0 AND Y6METSHD=1 THEN CHANGEHD=1;
ELSE CHANGEHD=0;
IF Y1METSTG=0 AND Y6METSTG=1 THEN CHANGETG=1;
ELSE CHANGETG=0;
IF Y1METSBP=0 AND Y6METSBP=1 THEN CHANGEBP=1;
ELSE CHANGEBP=0;
IF Y1METSGL=0 AND Y6METSGL=1 THEN CHANGEGL=1;
ELSE CHANGEGL=0;
GAITDIFF=SIXMPACE-Y16MPACE; 
 
Y1OUTDRKK=FPPAKKWK*P2WTK; 
Y1HEAVYKK=FPHCKKWK*P2WTK; 
Y1HOUSEKK=FPLWKKWK*P2WTK; 
Y1SHOPKK=FPGSKKWK*P2WTK; 
Y1WASHKK=FPLDKKWK*P2WTK; 
Y1STAIRSKK=FPFSKKWK*P2WTK; 
Y1EXWLKKK=FPEWKKWK*P2WTK; 
Y1NOEXWLKKK=FPOWKKWK*P2WTK; 
Y1DANCEKK=FPACKKWK*P2WTK; 
Y1LIFTKK=FPTRKKWK*P2WTK; 
Y1MODEXKK=FPMIKKWK*P2WTK; 
Y1PAYWRKKK=FPPWKKWK*P2WTK; 
Y1VOLWRKKK=FPVWKKWK*P2WTK; 
Y1CAREKK=FPCWKKWK*P2WTK; 
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Y1EXKK=EXKKWK*P2WTK; 
TOTKCAL=TOTKKWK*P2WTK; 
Y1LIFEKK=(HHKKWK+Y1WSKKWK+Y1WVCKKW)*P2WTK; 
EXWLKKK=(FPEWKKWK+EXKKWK)*P2WTK; 
IF Y1HEAVYKK+Y1STAIRSKK+Y1DANCEKK+Y1LIFTKK>=1000 THEN INTGROUP=3;
IF INTGROUP=3 THEN VIGGROUP=1;
IF Y1OUTDRKK+Y1EXWLKKK+Y1NOEXWLKKK+Y1MODEXKK>=1000 AND VIGGROUP=. THEN 
INTGROUP=2;
IF INTGROUP=2 THEN MODGROUP=1;
IF Y1OUTDRKK+Y1EXWLKKK+Y1NOEXWLKKK+Y1MODEXKK<1000 AND VIGGROUP=1 THEN 
INTGROUP=3;
IF Y1OUTDRKK+Y1EXWLKKK+Y1NOEXWLKKK+Y1MODEXKK>=1000 AND VIGGROUP=1 THEN 
INTGROUP=3;
IF Y1HOUSEKK+Y1SHOPKK+Y1WASHKK+Y1PAYWRKKK+Y1VOLWRKKK+Y1CAREKK>=1000 AND 
VIGGROUP=.
AND MODGROUP=. THEN INTGROUP=1;
IF Y1HOUSEKK+Y1SHOPKK+Y1WASHKK+Y1PAYWRKKK+Y1VOLWRKKK+Y1CAREKK>=1000 AND 
VIGGROUP=.
AND MODGROUP=1 THEN INTGROUP=2;
IF Y1HOUSEKK+Y1SHOPKK+Y1WASHKK+Y1PAYWRKKK+Y1VOLWRKKK+Y1CAREKK>=1000 AND 
VIGGROUP=1
THEN INTGROUP=3;
IF Y1HOUSEKK+Y1SHOPKK+Y1WASHKK+Y1PAYWRKKK+Y1VOLWRKKK+Y1CAREKK<1000 AND 
VIGGROUP=1
THEN INTGROUP=3;
IF Y1HOUSEKK+Y1SHOPKK+Y1WASHKK+Y1PAYWRKKK+Y1VOLWRKKK+Y1CAREKK<1000 AND 
MODGROUP=1
THEN INTGROUP=2;
IF Y1HEAVYKK+Y1STAIRSKK+Y1DANCEKK+Y1LIFTKK+ 
Y1OUTDRKK+Y1EXWLKKK+Y1NOEXWLKKK+ 
Y1MODEXKK+Y1HOUSEKK+Y1SHOPKK+Y1WASHKK+Y1PAYWRKKK+Y1VOLWRKKK+Y1CAREKK<1000 
THEN INTGROUP=0;
IF EXWLKKK>=1000 THEN BRACHGROUP=2;
IF Y1LIFEKK>=2719 AND EXWLKKK<1000 THEN BRACHGROUP=1;
IF Y1LIFEKK<2719 AND EXWLKKK<1000 THEN BRACHGROUP=0;
IF MINGROUP IN (2,3) AND INTGROUP IN(2,3) THEN SUMGROUP=1;
FORMAT MINGROUP MINGROUP.;
FORMAT INTGROUP INTGROUP.;
FORMAT BRACHGROUP BRACHGROUP.;
RUN;
DATA METFINAL; 
SET MET4; 
IF CURDRNK1 IN(2,3) THEN CURDRNK1=2;
IF CURDRNK1 IN(4) THEN CURDRNK1=3;
IF SMK1 IN(1) THEN SMK1=4;
IF SMK1 IN(2) THEN SMK1=3;
IF Y1PCBVD IN(1,2) THEN Y1PCBVD=1;
IF Y1POAKN IN(1,2,3) THEN Y1POAKN=1;
IF Y1POAHIP IN(1,2,3) THEN Y1POAHIP=1;
IF Y1PDEPR1 IN(1,2,3) THEN Y1PDEPR1=1;
IF Y1PPULCD IN(1,2,3) THEN Y1PPULCD=1;
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IF Y1PHBP1 IN(1,2) THEN Y1PHBP1=1;
IF Y1POAKN+Y1POAHIP=0 THEN LOWEROA=0;
ELSE LOWEROA=1;
COUNTDX=Y1PCBVD+LOWEROA+Y1PDEPR1+Y1PPULCD+Y1PPAD; 
IF GENDER=1 AND TOTPF=. THEN TOTPF=28.3;
IF GENDER=2 AND TOTPF=. THEN TOTPF=39.9;
RUN;
PROC SORT DATA=METFINAL; 
BY GENDER; 
RUN;
PROC UNIVARIATE DATA=METFINAL; 
BY GENDER; 
VAR TOTPF; 
RUN;
PROC MEANS DATA=METFINAL; 
BY GENDER; 
RUN;
PROC FREQ DATA=METFINAL; 
BY GENDER; 
TABLES MINGROUP INTGROUP BRACHGROUP; 
RUN;
PROC FREQ DATA=METFINAL; 
BY GENDER; 
TABLES CV1AGE GENDER RACE EDUC NEWMAR SMK1 CURDRNK1 Y1PCHD1 Y1PCBVD Y1PPAD  
Y1PDIAB1 LOWEROA Y1PHBP1 Y1PDEPR1 Y1PPULCD COUNTDX METSRISK Y6METSAB 
Y6METSHD  
Y6METSTG Y6METSBP Y6METSGL Y6METSYN Y6METS Y6NUMBER; 
RUN;
PROC FREQ DATA=METFINAL; 
BY GENDER; 
TABLES CHANGEAB CHANGEHD CHANGETG CHANGEBP CHANGEGL; 
RUN;
PROC FREQ DATA=METFINAL; 
TABLES MINGROUP*Y6METS/CMH;
TABLES INTGROUP*Y6METS/CMH;
TABLES BRACHGROUP*Y6METS/CMH;
RUN;
*RUNNING LOGIT MODELS BY GENDER; 
DATA MEN; 
SET METFINAL; 
IF GENDER=1;
RUN;
PROC FREQ DATA=MEN; 
TABLES MINGROUP*Y6METS; 
TABLES INTGROUP*Y6METS; 
TABLES BRACHGROUP*Y6METS; 
RUN;
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*ALREADY LOOKED AT SATURATED MODELS. NOW NEED TO LOOK AT JUST PBF SINCE I 
JUST ADDED IT IN 
THE MODEL; 
PROC LOGISTIC DATA=MEN DESCENDING;
MODEL Y6METS=TOTKCAL MINGROUP|TOTPF CV1AGE RACE EDUC NEWMAR SMK1 CURDRNK1 
COUNTDX Y1PCHD1; 
RUN;
PROC LOGISTIC DATA=MEN DESCENDING;
MODEL Y6METS= TOTKCAL INTGROUP|TOTPF CV1AGE RACE EDUC NEWMAR SMK1 CURDRNK1 
COUNTDX Y1PCHD1; 
RUN;
PROC LOGISTIC DATA=MEN DESCENDING;
MODEL Y6METS= TOTKCAL BRACHGROUP|TOTPF CV1AGE RACE EDUC NEWMAR SMK1 
CURDRNK1 COUNTDX Y1PCHD1; 
RUN;
*FINAL MODELS; 
PROC LOGISTIC DATA=MEN DESCENDING;
CLASS MINGROUP; 
MODEL Y6METS=MINGROUP TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 CURDRNK1 
COUNTDX Y1PCHD1; 
RUN;
PROC LOGISTIC DATA=MEN DESCENDING;
CLASS INTGROUP; 
MODEL Y6METS=INTGROUP TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 CURDRNK1 
COUNTDX Y1PCHD1; 
RUN;
PROC LOGISTIC DATA=MEN DESCENDING;
CLASS BRACHGROUP; 
MODEL Y6METS=BRACHGROUP TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 
CURDRNK1 COUNTDX Y1PCHD1; 
RUN;
DATA WOMEN; 
SET METFINAL; 
IF GENDER=2;
IF Y6METSAB +Y6METSHD+ Y6METSTG+ Y6METSGL=0 THEN Y6WOBP=0;
IF Y6METSAB +Y6METSHD+ Y6METSTG+ Y6METSGL=1 THEN Y6WOBP=1;
IF Y6METSAB +Y6METSHD+ Y6METSTG+ Y6METSGL=2 THEN Y6WOBP=2;
IF Y6METSAB +Y6METSHD+ Y6METSTG+ Y6METSGL=3 THEN Y6WOBP=3;
IF Y6METSAB +Y6METSHD+ Y6METSTG+ Y6METSGL=4 THEN Y6WOBP=4;
IF Y6WOBP=>3 THEN Y6MSWOBP=1;
ELSE Y6MSWOBP=0;
RUN;
PROC FREQ DATA=WOMEN; 
TABLES MINGROUP*Y6METS; 
TABLES INTGROUP*Y6METS; 
TABLES BRACHGROUP*Y6METS; 
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RUN;
PROC FREQ DATA=WOMEN; 
TABLES MINGROUP*METSRISK/CMH;
TABLES INTGROUP*METSRISK/CMH;
TABLES BRACHGROUP*METSRISK/CMH;
RUN;
PROC FREQ DATA=WOMEN; 
TABLES MINGROUP*METSRISK/CMH;
TABLES INTGROUP*METSRISK/CMH;
TABLES BRACHGROUP*METSRISK/CMH;
TABLES Y1PCHD1*BRACHGROUP/CMH;
TABLES Y1PCBVD*BRACHGROUP/CMH;
TABLES Y1PPAD*BRACHGROUP/CMH;
TABLES Y1PDIAB1*BRACHGROUP/CMH;
TABLES LOWEROA*BRACHGROUP/CMH;
TABLES Y1PHBP1*BRACHGROUP/CMH;
TABLES Y1PDEPR1*BRACHGROUP/CMH;
TABLES Y1PPULCD*BRACHGROUP/CMH;
TABLES COUNTDX*BRACHGROUP/CMH;
RUN;
DATA LIFTGUY; 
SET MEN; 
LIFTINT=Y1LIFTKK/(Y1HEAVYKK+Y1STAIRSKK+Y1DANCEKK+Y1LIFTKK); 
LIFTBRACH=Y1LIFTKK/EXWLKKK; 
 
RUN;
PROC MEANS DATA=LIFTGUY; 
VAR LIFTINT LIFTBRACH; 
RUN;
DATA LIFTGAL; 
SET WOMEN; 
LIFTINT=Y1LIFTKK/(Y1HEAVYKK+Y1STAIRSKK+Y1DANCEKK+Y1LIFTKK); 
LIFTBRACH=Y1LIFTKK/EXWLKKK; 
 
RUN;
PROC MEANS DATA=LIFTGAL; 
VAR LIFTINT LIFTBRACH; 
RUN;
*ALREADY LOOKED AT SATURATED MODELS. NOW NEED TO LOOK AT JUST PBF SINCE I 
JUST ADDED IT IN 
THE MODEL; 
PROC LOGISTIC DATA=WOMEN DESCENDING;
MODEL Y6METS= TOTKCAL MINGROUP|TOTPF CV1AGE RACE EDUC NEWMAR SMK1 CURDRNK1 
COUNTDX Y1PCHD1; 
RUN;
PROC LOGISTIC DATA=WOMEN DESCENDING;
MODEL Y6METS= TOTKCAL INTGROUP|TOTPF CV1AGE RACE EDUC NEWMAR SMK1 CURDRNK1 
COUNTDX Y1PCHD1; 
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RUN;
PROC LOGISTIC DATA=WOMEN DESCENDING;
MODEL Y6METS= TOTKCAL BRACHGROUP|TOTPF CV1AGE RACE EDUC NEWMAR SMK1 
CURDRNK1 COUNTDX Y1PCHD1; 
RUN;
*FINAL MODELS; 
PROC LOGISTIC DATA=WOMEN DESCENDING;
CLASS MINGROUP; 
MODEL Y6METS=MINGROUP METSRISK TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 
CURDRNK1 COUNTDX Y1PCHD1; 
RUN;
PROC LOGISTIC DATA=WOMEN DESCENDING;
CLASS INTGROUP; 
MODEL Y6METS=INTGROUP METSRISK TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 
CURDRNK1 COUNTDX Y1PCHD1; 
RUN;
PROC LOGISTIC DATA=WOMEN DESCENDING;
CLASS BRACHGROUP; 
MODEL Y6METS=BRACHGROUP METSRISK TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR 
SMK1 CURDRNK1 COUNTDX Y1PCHD1; 
RUN;
*LOOKING AT SEDENTARY AS REF GROUP; 
PROC LOGISTIC DATA=WOMEN DESCENDING;
CLASS MINGROUP (REF=FIRST); 
MODEL Y6METS=MINGROUP TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 CURDRNK1 
COUNTDX Y1PCHD1; 
RUN;
PROC LOGISTIC DATA=WOMEN DESCENDING;
CLASS INTGROUP (REF=FIRST); 
MODEL Y6METS=INTGROUP TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 CURDRNK1 
COUNTDX Y1PCHD1; 
RUN;
PROC LOGISTIC DATA=WOMEN DESCENDING;
CLASS BRACHGROUP (REF=FIRST);  
MODEL Y6METS=BRACHGROUP TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 
CURDRNK1 COUNTDX Y1PCHD1; 
RUN;
*LOOKING AT MS WITHOUT BP AS A FACTOR; 
PROC LOGISTIC DATA=WOMEN DESCENDING;
CLASS MINGROUP; 
MODEL Y6MSWOBP=MINGROUP TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 
CURDRNK1 COUNTDX Y1PCHD1; 
RUN;
PROC LOGISTIC DATA=WOMEN DESCENDING;
CLASS INTGROUP; 
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MODEL Y6MSWOBP=INTGROUP TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 
CURDRNK1 COUNTDX Y1PCHD1; 
RUN;
PROC LOGISTIC DATA=WOMEN DESCENDING;
CLASS BRACHGROUP; 
MODEL Y6MSWOBP=BRACHGROUP TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 
CURDRNK1 COUNTDX Y1PCHD1; 
RUN;
*CHECKING TO SEE IF THERE ARE DIFFERENCES IN INCIDENCE OF MS FACTORS 
BETWEEN LOW AND HIGH 
INTENSITY GROUPS; 
DATA LOWINT; 
SET METFINAL; 
IF GENDER=2;
IF INTGROUP=1;
IF METSRISK=2;
RUN;
PROC FREQ DATA=LOWINT; 
TABLES CHANGEAB CHANGEHD CHANGETG CHANGEBP CHANGEGL; 
RUN;
DATA HIGHINT; 
SET METFINAL; 
IF GENDER=2;
IF INTGROUP=3;
IF METSRISK=2;
RUN;
DATA X; 
MERGE LOWINT HIGHINT; 
BY HABCID; 
RUN;
PROC LOGISTIC DATA=X DESCENDING;
CLASS MINGROUP; 
MODEL Y6METS=MINGROUP TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 CURDRNK1 
COUNTDX Y1PCHD1; 
RUN;
PROC LOGISTIC DATA=X DESCENDING;
CLASS INTGROUP; 
MODEL Y6METS=INTGROUP TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 CURDRNK1 
COUNTDX Y1PCHD1; 
RUN;
PROC LOGISTIC DATA=X DESCENDING;
CLASS BRACHGROUP; 
MODEL Y6METS=BRACHGROUP TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 
CURDRNK1 COUNTDX Y1PCHD1; 
RUN;
*TESTING FOR HOMOGENEITY BETWEEN STRATA; 
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*MODELS OF NO MS TO MS; 
PROC LOGISTIC DATA=MEN DESCENDING;
CLASS MINGROUP; 
MODEL Y6METS=MINGROUP TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 CURDRNK1 
COUNTDX Y1PCHD1; 
RUN;
PROC LOGISTIC DATA=MEN DESCENDING;
CLASS INTGROUP; 
MODEL Y6METS=INTGROUP TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 CURDRNK1 
COUNTDX Y1PCHD1; 
RUN;
PROC LOGISTIC DATA=MEN DESCENDING;
CLASS BRACHGROUP; 
MODEL Y6METS=BRACHGROUP TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 
CURDRNK1 COUNTDX Y1PCHD1; 
RUN;
PROC LOGISTIC DATA=WOMEN DESCENDING;
CLASS MINGROUP; 
MODEL Y6METS=MINGROUP METSRISK TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 
CURDRNK1 COUNTDX Y1PCHD1; 
RUN;
PROC LOGISTIC DATA=WOMEN DESCENDING;
CLASS INTGROUP; 
MODEL Y6METS=INTGROUP METSRISK TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 
CURDRNK1 COUNTDX Y1PCHD1; 
RUN;
PROC LOGISTIC DATA=WOMEN DESCENDING;
CLASS BRACHGROUP; 
MODEL Y6METS=BRACHGROUP METSRISK TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR 
SMK1 CURDRNK1 COUNTDX Y1PCHD1; 
RUN;
*MODELS OF MS TO MS; 
DATA MET5; 
SET MET3; 
TOTMIN=Y1WKTIME+HIGHXMIN; 
IF TOTMIN>=200 THEN MINGROUP=3;
IF 150<=TOTMIN<200 THEN MINGROUP=2;
IF TOTMIN<150 THEN MINGROUP=1;
DIFFWALK=Y6WKTIME-Y1WKTIME; 
IF DIFFWALK<=-90 THEN WKGROUP=1;
IF DIFFWALK>-90 THEN WKGROUP=0;
IF Y6METSAB NOT IN(0,1) THEN DELETE;
IF Y6METSHD NOT IN(0,1) THEN DELETE;
IF Y6METSTG NOT IN(0,1) THEN DELETE;
IF Y6METSBP NOT IN(0,1)THEN DELETE;
IF Y6METSGL NOT IN(0,1) THEN DELETE;
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IF Y1METSYN=0 THEN DELETE;
IF Y6METSAB +Y6METSHD+ Y6METSTG+ Y6METSBP+ Y6METSGL>=3 THEN Y6METS=1;
IF Y6METSAB+ Y6METSHD+ Y6METSTG+ Y6METSBP+ Y6METSGL<3 THEN Y6METS=0;
IF Y6METSAB +Y6METSHD+ Y6METSTG+ Y6METSBP+ Y6METSGL=0 THEN Y6NUMBER=0;
IF Y6METSAB +Y6METSHD+ Y6METSTG+ Y6METSBP+ Y6METSGL=1 THEN Y6NUMBER=1;
IF Y6METSAB +Y6METSHD+ Y6METSTG+ Y6METSBP+ Y6METSGL=2 THEN Y6NUMBER=2;
IF Y6METSAB +Y6METSHD+ Y6METSTG+ Y6METSBP+ Y6METSGL=3 THEN Y6NUMBER=3;
IF Y6METSAB +Y6METSHD+ Y6METSTG+ Y6METSBP+ Y6METSGL=4 THEN Y6NUMBER=4;
IF Y6METSAB +Y6METSHD+ Y6METSTG+ Y6METSBP+ Y6METSGL=5 THEN Y6NUMBER=5;
IF Y1METSAB+ Y1METSHD+ Y1METSTG+ Y1METSBP+ Y1METSGL=2 THEN METSRISK=2;
IF Y1METSAB+ Y1METSHD+ Y1METSTG+ Y1METSBP+ Y1METSGL=1 THEN METSRISK=1;
Y1OUTDRKK=FPPAKKWK*P2WTK; 
Y1HEAVYKK=FPHCKKWK*P2WTK; 
Y1HOUSEKK=FPLWKKWK*P2WTK; 
Y1SHOPKK=FPGSKKWK*P2WTK; 
Y1WASHKK=FPLDKKWK*P2WTK; 
Y1STAIRSKK=FPFSKKWK*P2WTK; 
Y1EXWLKKK=FPEWKKWK*P2WTK; 
Y1NOEXWLKKK=FPOWKKWK*P2WTK; 
Y1DANCEKK=FPACKKWK*P2WTK; 
Y1LIFTKK=FPTRKKWK*P2WTK; 
Y1MODEXKK=FPMIKKWK*P2WTK; 
Y1PAYWRKKK=FPPWKKWK*P2WTK; 
Y1VOLWRKKK=FPVWKKWK*P2WTK; 
Y1CAREKK=FPCWKKWK*P2WTK; 
Y1EXKK=EXKKWK*P2WTK; 
TOTKCAL=TOTKKWK*P2WTK; 
Y1LIFEKK=(HHKKWK+Y1WSKKWK+Y1WVCKKW)*P2WTK; 
EXWLKKK=(FPEWKKWK+EXKKWK)*P2WTK; 
IF Y1HEAVYKK+Y1STAIRSKK+Y1DANCEKK+Y1LIFTKK>=1000 THEN INTGROUP=3;
IF INTGROUP=3 THEN VIGGROUP=1;
IF Y1OUTDRKK+Y1EXWLKKK+Y1NOEXWLKKK+Y1MODEXKK>=1000 AND VIGGROUP=. THEN 
INTGROUP=2;
IF INTGROUP=2 THEN MODGROUP=1;
IF Y1OUTDRKK+Y1EXWLKKK+Y1NOEXWLKKK+Y1MODEXKK<1000 AND VIGGROUP=1 THEN 
INTGROUP=3;
IF Y1OUTDRKK+Y1EXWLKKK+Y1NOEXWLKKK+Y1MODEXKK>=1000 AND VIGGROUP=1 THEN 
INTGROUP=3;
IF Y1HOUSEKK+Y1SHOPKK+Y1WASHKK+Y1PAYWRKKK+Y1VOLWRKKK+Y1CAREKK>=1000 AND 
VIGGROUP=.
AND MODGROUP=. THEN INTGROUP=1;
IF Y1HOUSEKK+Y1SHOPKK+Y1WASHKK+Y1PAYWRKKK+Y1VOLWRKKK+Y1CAREKK>=1000 AND 
VIGGROUP=.
AND MODGROUP=1 THEN INTGROUP=2;
IF Y1HOUSEKK+Y1SHOPKK+Y1WASHKK+Y1PAYWRKKK+Y1VOLWRKKK+Y1CAREKK>=1000 AND 
VIGGROUP=1
THEN INTGROUP=3;
IF Y1HOUSEKK+Y1SHOPKK+Y1WASHKK+Y1PAYWRKKK+Y1VOLWRKKK+Y1CAREKK<1000 AND 
VIGGROUP=1
THEN INTGROUP=3;
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IF Y1HOUSEKK+Y1SHOPKK+Y1WASHKK+Y1PAYWRKKK+Y1VOLWRKKK+Y1CAREKK<1000 AND 
MODGROUP=1
THEN INTGROUP=2;
IF Y1HEAVYKK+Y1STAIRSKK+Y1DANCEKK+Y1LIFTKK+ 
Y1OUTDRKK+Y1EXWLKKK+Y1NOEXWLKKK+ 
Y1MODEXKK+Y1HOUSEKK+Y1SHOPKK+Y1WASHKK+Y1PAYWRKKK+Y1VOLWRKKK+Y1CAREKK<1000 
THEN INTGROUP=0;
IF EXWLKKK>=1000 THEN BRACHGROUP=2;
IF Y1LIFEKK>=2719 AND EXWLKKK<1000 THEN BRACHGROUP=1;
IF Y1LIFEKK<2719 AND EXWLKKK<1000 THEN BRACHGROUP=0;
IF MINGROUP IN (2,3) AND INTGROUP IN(2,3) THEN SUMGROUP=1;
FORMAT MINGROUP MINGROUP.;
FORMAT INTGROUP INTGROUP.;
FORMAT BRACHGROUP BRACHGROUP.;
RUN;
DATA METFINAL2; 
SET MET5; 
IF CURDRNK1 IN(2,3) THEN CURDRNK1=2;
IF CURDRNK1 IN(4) THEN CURDRNK1=3;
IF SMK1 IN(1) THEN SMK1=4;
IF SMK1 IN(2) THEN SMK1=3;
IF Y1PCBVD IN(1,2) THEN Y1PCBVD=1;
IF Y1POAKN IN(1,2,3) THEN Y1POAKN=1;
IF Y1POAHIP IN(1,2,3) THEN Y1POAHIP=1;
IF Y1PDEPR1 IN(1,2,3) THEN Y1PDEPR1=1;
IF Y1PPULCD IN(1,2,3) THEN Y1PPULCD=1;
IF Y1PHBP1 IN(1,2) THEN Y1PHBP1=1;
IF Y1POAKN+Y1POAHIP=0 THEN LOWEROA=0;
ELSE LOWEROA=1;
COUNTDX=Y1PCBVD+LOWEROA+Y1PDEPR1+Y1PPULCD+Y1PPAD; 
IF GENDER=1 AND TOTPF=. THEN TOTPF=28.3;
IF GENDER=2 AND TOTPF=. THEN TOTPF=39.9;
RUN;
PROC SORT DATA=METFINAL2; 
BY GENDER; 
RUN;
DATA MEN2; 
SET METFINAL2; 
IF GENDER=1;
RUN;
PROC LOGISTIC DATA=MEN2 DESCENDING;
CLASS MINGROUP; 
MODEL Y6METS=MINGROUP TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 CURDRNK1 
COUNTDX Y1PCHD1; 
RUN;
PROC LOGISTIC DATA=MEN2 DESCENDING;
CLASS INTGROUP; 
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MODEL Y6METS=INTGROUP TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 CURDRNK1 
COUNTDX Y1PCHD1; 
RUN;
PROC LOGISTIC DATA=MEN2 DESCENDING;
CLASS BRACHGROUP; 
MODEL Y6METS=BRACHGROUP TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 
CURDRNK1 COUNTDX Y1PCHD1; 
RUN;
DATA WOMEN2; 
SET METFINAL2; 
IF GENDER=2;
RUN;
PROC LOGISTIC DATA=WOMEN2 DESCENDING;
CLASS MINGROUP; 
MODEL Y6METS=MINGROUP TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 CURDRNK1  
COUNTDX Y1PCHD1; 
RUN;
PROC LOGISTIC DATA=WOMEN2 DESCENDING;
CLASS INTGROUP; 
MODEL Y6METS=INTGROUP TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 CURDRNK1  
COUNTDX Y1PCHD1; 
RUN;
PROC LOGISTIC DATA=WOMEN2 DESCENDING;
CLASS BRACHGROUP; 
MODEL Y6METS=BRACHGROUP TOTKCAL TOTPF CV1AGE RACE EDUC NEWMAR SMK1 
CURDRNK1  
COUNTDX Y1PCHD1; 
RUN;
data odds (keep=group est1 est2 est logest low_ci up_ci var Z  q); 
input group $  est1 se1 est2 se2 ; 
 
var1=se1** 2;
var2=se2** 2;
wt=(1 /var1) + (1 /var2); 
logest= ((est1*(1 /var1)) + (est2*(1 /var2))) / wt ; 
var=1 /wt; 
z=logest/sqrt(var); 
est=exp(logest); 
up_ci=exp(logest +1.96 *sqrt(var)); 
low_ci=exp(logest -1.96 *sqrt(var)); 
 
* homogeneity; 
q=(((est1-logest)** 2 )/var1) + (((est2-logest)** 2)/var2); 
 
cards ; 
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Mlotime .3917 .1878 .3352 .2049 
Mmodtime -.2433 .2990 -.5479 .3121 
Msedint .3626 .2199 .0448 .2851 
Mlightint .0355 .1876 .5423 .2447 
Mmodint -.0938 .1797 -.2890 .2019 
Msedbrach .1713 .2038 .0965 .2517 
Mlifbrach .0682 .1530 .00301 .1748 
Wlotime .00962 .1829 -.1110 .1836 
Wmodtime -.2707 .2942 .1199 .2861 
Wsedint .0674 .2455 -.5261 .2750 
Wlightint -.4636 .1654 .0950 .1820 
Wmodint .0164 .2072 .4439 .2903 
Wsedbrach -.4277 .2060 -.2016 .2091 
Wlifbrach .0540 .1478 .1699 .1611 
;
proc print ; 
run ; 
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Program for Metabolic Syndrome Analyses 
 
OPTIONS PAGESIZE=50 LINESIZE=96 NODATE NONUMBER NOFMTERR; 
 
*INITIATED 01-03-2006; 
*UPDATED; 
LIBNAME ABC V6 'C:\Documents and Settings\peter076\My 
Documents\Dissertation\ABC DATA';
LIBNAME DEF V6 'C:\Documents and Settings\peter076\My 
Documents\Dissertation\ABC DATA\FRAILTY';
RUN;
*IMPUTING MISSING VALUES HERE; 
DATA A;  
SET ABC.FRAILTY; 
IF Y16MPACE=. THEN DELETE;
IF Y1ABL5CS=. THEN DELETE;
IF Y1ABL5CS IN(0,1); 
IF EDUC NOT IN(1,2,3) THEN EDUC=.;
IF EDUC =. THEN EDUC=3;
IF SMK1=. THEN SMK1=2;
IF CURDRNK1=. THEN CURDRNK1=1;
IF Y1PCBVD NOT IN(0,1,2) THEN Y1PCBVD=.;
IF Y1PCBVD=. THEN Y1PCBVD=0;
IF Y1PDIAB1 NOT IN(0,1) THEN Y1PDIAB1=.;
IF Y1PDIAB1=. THEN Y1PDIAB1=0;
IF Y1POAKN=. THEN Y1POAKN=0;
IF Y1POAHIP=. THEN Y1POAHIP=0;
IF Y1PHBP1 NOT IN(0,1,2) THEN Y1PHBP1=.;
IF Y1PHBP1=. THEN Y1PHBP1=0;
IF Y1PDEPR1 NOT IN(0,1,2,3) THEN Y1PDEPR1=.;
IF Y1PDEPR1=. THEN Y1PDEPR1=0;
IF Y1PPULCD NOT IN(0,1,2,3) THEN Y1PPULCD=.;
IF Y1PPULCD=. THEN Y1PPULCD=0;
IF TSMARSTA IN(0,2,3,4) THEN TSMARSTA=2;
IF Y1PCHD1 IN(1,2) THEN Y1PCHD1=1;
RUN;
PROC FREQ DATA=A; 
TABLES TSMARSTA; 
RUN;
PROC LOGISTIC DATA=A NOPRINT;
MODEL Y1PCHD1=CV1AGE GENDER RACE EDUC SMK1  
CURDRNK1 TSMARSTA Y1PCBVD Y1PPAD Y1PDIAB1 Y1POAKN Y1POAHIP Y1PHBP1 
Y1PDEPR1 Y1PPULCD/ 
SELECTION=STEPWISE; 
RUN;
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PROC LOGISTIC DATA=A NOPRINT;
MODEL Y1PPAD=CV1AGE GENDER RACE EDUC SMK1  
CURDRNK1 TSMARSTA Y1PCBVD Y1PCHD1 Y1PDIAB1 Y1POAKN Y1POAHIP Y1PHBP1 
Y1PDEPR1 Y1PPULCD/ 
SELECTION=STEPWISE; 
RUN;
*THESE MODELS INDICATE THAT HEART DISEASE AND PERIPHERAL ARTERY DISEASE 
ARE CLOSELY LINKED.  
SO I WILL NEED TO DO PROC MI METHODS FOR IMPUTING; 
PROC MI DATA=A OUT=IMPUT NIMPUTE=1 MINIMUM=0 MAXIMUM=1 NOPRINT; 
VAR Y1PCHD1 Y1PPAD; 
RUN;
DATA FRAIL0; 
MERGE A IMPUT; 
BY HABCID; 
RUN;
PROC UNIVARIATE DATA=FRAIL0 NOPRINT;
VAR Y1PCHD1 Y1PPAD; 
RUN;
DATA FRAIL;  
SET FRAIL0; 
IF Y1PCHD1 NOT IN(0,1) THEN Y1PCHD1=0;
IF Y1PPAD NOT IN(0,1) THEN Y1PPAD=0;
RUN;
PROC LOGISTIC DATA=FRAIL;  
OUTPUT OUT=OUTPUT P=PRED; 
MODEL TSMARSTA=CV1AGE GENDER RACE EDUC SMK1  
CURDRNK1 Y1PCHD1 Y1PCBVD Y1PPAD Y1PDIAB1 Y1POAKN Y1POAHIP Y1PHBP1 Y1PDEPR1 
Y1PPULCD/ 
SELECTION=STEPWISE; 
RUN;
PROC PRINT DATA=OUTPUT; 
VAR HABCID PRED; 
RUN;
DATA MARITAL; 
SET OUTPUT; 
IF TSMARSTA NOT IN(1,2) THEN NEWMAR=RANBIN(666,2,PRED); 
ELSE NEWMAR=TSMARSTA; 
RUN;
DATA COMPLETE; 
MERGE FRAIL MARITAL; 
BY HABCID; 
IF NEWMAR=0 THEN NEWMAR=2;
RUN;
PROC FREQ DATA=COMPLETE; 
TABLES NEWMAR; 
RUN;
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PROC FORMAT;
VALUE MINGROUP 1='LOW- 150 MIN/WEEK' 
2='MOD- 150-200 MIN/WEEK' 
3='XTRA- 200+ MIN/WEEK';
VALUE INTGROUP  0='ASEDENTARY' 
1='LIGHT INTENSITY GROUP' 
2='MODERATE INTENSITY GROUP' 
3='VIGOROUS INTENTSITY GROUP';
VALUE BRACHGROUP 0='ASEDENTARY' 
1='LIFESTYLE ACTIVE' 
2='XERCISE ACTIVE';
VALUE FRAIL6Y  1='NOT FRAIL' 
2='MODERATELY FRAIL' 
3='SEVERELY FRAIL';
VALUE FRAIL4Y  1='NOT FRAIL' 
2='MODERATELY FRAIL' 
3='SEVERELY FRAIL';
VALUE FRAIL1Y  1='NOT FRAIL' 
2='MODERATELY FRAIL' 
3='SEVERELY FRAIL';
VALUE BMICAT 1='HEALTHY WEIGHT' 
2='OVERWEIGHT' 
3='OBESE';
RUN;
DATA FRAIL; 
SET COMPLETE; 
TOTMIN=Y1WKTIME+HIGHXMIN; 
IF TOTMIN>=200 THEN MINGROUP=3;
IF 150<=TOTMIN<200 THEN MINGROUP=2;
IF TOTMIN<150 THEN MINGROUP=1;
IF (Y2BWTIME+Y2WKTIME)>=200 THEN Y2MINGROUP=3;
IF 150<=(Y2BWTIME+Y2WKTIME)<200 THEN Y2MINGROUP=2;
IF (Y2BWTIME+Y2WKTIME)<150 THEN Y2MINGROUP=1;
IF (Y3BWTIME+Y3WKTIME)>=200 THEN Y3MINGROUP=3;
IF 150<=(Y3BWTIME+Y3WKTIME)<200 THEN Y3MINGROUP=2;
IF (Y3BWTIME+Y3WKTIME)<150 THEN Y3MINGROUP=1;
IF (Y5BWTIME+Y5WKTIME)>=200 THEN Y5MINGROUP=3;
IF 150<=(Y5BWTIME+Y5WKTIME)<200 THEN Y5MINGROUP=2;
IF (Y5BWTIME+Y5WKTIME)<150 THEN Y5MINGROUP=1;
IF Y6ABL5CS=1 AND Y66MPACE>0.60 THEN FRAILY6=1;
IF Y6ABL5CS=0 AND Y66MPACE>0.60 THEN FRAILY6=2;
IF Y6ABL5CS=1 AND Y66MPACE<=0.60 THEN FRAILY6=2;
IF Y6ABL5CS=0 AND Y66MPACE<=0.60 THEN FRAILY6=3;
IF Y4ABL5CS=1 AND Y46MPACE>0.60 THEN FRAILY4=1;
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IF Y4ABL5CS=0 AND Y46MPACE>0.60 THEN FRAILY4=2;
IF Y4ABL5CS=1 AND Y46MPACE<=0.60 THEN FRAILY4=2;
IF Y4ABL5CS=0 AND Y46MPACE<=0.60 THEN FRAILY4=3;
IF Y1ABL5CS=1 AND Y16MPACE>0.60 THEN FRAILY1=1;
IF Y1ABL5CS=0 AND Y16MPACE>0.60 THEN FRAILY1=2;
IF Y1ABL5CS=1 AND Y16MPACE<=0.60 THEN FRAILY1=2;
IF Y1ABL5CS=0 AND Y16MPACE<=0.60 THEN FRAILY1=3;
Y1OUTDRKK=FPPAKKWK*P2WTK; 
Y1HEAVYKK=FPHCKKWK*P2WTK; 
Y1HOUSEKK=FPLWKKWK*P2WTK; 
Y1SHOPKK=FPGSKKWK*P2WTK; 
Y1WASHKK=FPLDKKWK*P2WTK; 
Y1STAIRSKK=FPFSKKWK*P2WTK; 
Y1EXWLKKK=FPEWKKWK*P2WTK; 
Y1NOEXWLKKK=FPOWKKWK*P2WTK; 
Y1DANCEKK=FPACKKWK*P2WTK; 
Y1LIFTKK=FPTRKKWK*P2WTK; 
Y1MODEXKK=FPMIKKWK*P2WTK; 
Y1PAYWRKKK=FPPWKKWK*P2WTK; 
Y1VOLWRKKK=FPVWKKWK*P2WTK; 
Y1CAREKK=FPCWKKWK*P2WTK; 
Y1EXKK=EXKKWK*P2WTK; 
TOTKCAL=TOTKKWK*P2WTK; 
Y1LIFEKK=(HHKKWK+Y1WSKKWK+Y1WVCKKW)*P2WTK; 
EXWLKKK=(FPEWKKWK+EXKKWK)*P2WTK; 
IF Y1HEAVYKK+Y1STAIRSKK+Y1DANCEKK+Y1LIFTKK>=1000 THEN INTGROUP=3;
IF INTGROUP=3 THEN VIGGROUP=1;
IF Y1OUTDRKK+Y1EXWLKKK+Y1NOEXWLKKK+Y1MODEXKK>=1000 AND VIGGROUP=. THEN 
INTGROUP=2;
IF INTGROUP=2 THEN MODGROUP=1;
IF Y1OUTDRKK+Y1EXWLKKK+Y1NOEXWLKKK+Y1MODEXKK<1000 AND VIGGROUP=1 THEN 
INTGROUP=3;
IF Y1OUTDRKK+Y1EXWLKKK+Y1NOEXWLKKK+Y1MODEXKK>=1000 AND VIGGROUP=1 THEN 
INTGROUP=3;
IF Y1HOUSEKK+Y1SHOPKK+Y1WASHKK+Y1PAYWRKKK+Y1VOLWRKKK+Y1CAREKK>=1000 AND 
VIGGROUP=.
AND MODGROUP=. THEN INTGROUP=1;
IF Y1HOUSEKK+Y1SHOPKK+Y1WASHKK+Y1PAYWRKKK+Y1VOLWRKKK+Y1CAREKK>=1000 AND 
VIGGROUP=.
AND MODGROUP=1 THEN INTGROUP=2;
IF Y1HOUSEKK+Y1SHOPKK+Y1WASHKK+Y1PAYWRKKK+Y1VOLWRKKK+Y1CAREKK>=1000 AND 
VIGGROUP=1
THEN INTGROUP=3;
IF Y1HOUSEKK+Y1SHOPKK+Y1WASHKK+Y1PAYWRKKK+Y1VOLWRKKK+Y1CAREKK<1000 AND 
VIGGROUP=1
THEN INTGROUP=3;
IF Y1HOUSEKK+Y1SHOPKK+Y1WASHKK+Y1PAYWRKKK+Y1VOLWRKKK+Y1CAREKK<1000 AND 
MODGROUP=1
THEN INTGROUP=2;
IF Y1HEAVYKK+Y1STAIRSKK+Y1DANCEKK+Y1LIFTKK+ 
Y1OUTDRKK+Y1EXWLKKK+Y1NOEXWLKKK+ 
Y1MODEXKK+Y1HOUSEKK+Y1SHOPKK+Y1WASHKK+Y1PAYWRKKK+Y1VOLWRKKK+Y1CAREKK<1000 
THEN INTGROUP=0;
IF EXWLKKK>=1000 THEN BRACHGROUP=2;
IF Y1LIFEKK>=2719 AND EXWLKKK<1000 THEN BRACHGROUP=1;
IF Y1LIFEKK<2719 AND EXWLKKK<1000 THEN BRACHGROUP=0;
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IF MINGROUP IN (2,3) AND INTGROUP IN(2,3) THEN SUMGROUP=1;
IF BMI<=25 THEN BMICAT=1;
IF 25<BMI<30 THEN BMICAT=2;
IF BMI>=30 THEN BMICAT=3;
FORMAT FRAILY6 FRAIL6Y.;
FORMAT FRAILY4 FRAIL4Y.;
FORMAT FRAILY1 FRAIL4Y.;
FORMAT MINGROUP MINGROUP.;
FORMAT INTGROUP INTGROUP.;
FORMAT BRACHGROUP BRACHGROUP.;
FORMAT BMICAT BMICAT.;
RUN;
DATA FINALFRAIL; 
SET FRAIL; 
IF CURDRNK1 IN(2,3) THEN CURDRNK1=2;
IF CURDRNK1 IN(4) THEN CURDRNK1=3;
IF SMK1 IN(1) THEN SMK1=4;
IF SMK1 IN(2) THEN SMK1=3;
IF Y1PCBVD IN(1,2) THEN Y1PCBVD=1;
IF Y1POAKN IN(1,2,3) THEN Y1POAKN=1;
IF Y1POAHIP IN(1,2,3) THEN Y1POAHIP=1;
IF Y1PDEPR1 IN(1,2,3) THEN Y1PDEPR1=1;
IF Y1PPULCD IN(1,2,3) THEN Y1PPULCD=1;
IF Y1PHBP1 IN(1,2) THEN Y1PHBP1=1;
IF Y1POAKN+Y1POAHIP=0 THEN LOWEROA=0;
ELSE LOWEROA=1;
COUNTDX=Y1PCHD1+Y1PCBVD+LOWEROA+Y1PDEPR1+Y1PPULCD+Y1PHBP1+Y1PPAD+Y1PDIAB1; 
RUN;
PROC SORT DATA=FINALFRAIL; 
BY GENDER; 
RUN;
PROC FREQ DATA= FINALFRAIL; 
BY GENDER; 
TABLES SUMGROUP MINGROUP INTGROUP BRACHGROUP FRAILY1 FRAILY4 FRAILY6 
CV1AGE GENDER RACE EDUC  
NEWMAR SMK1 CURDRNK1 Y1PCHD1 Y1PCBVD Y1PPAD Y1PDIAB1 LOWEROA Y1PHBP1 
Y1PDEPR1 Y1PPULCD COUNTDX; 
RUN;
PROC MEANS DATA=FINALFRAIL; 
BY GENDER; 
RUN;
PROC FREQ DATA=FINALFRAIL; 
TABLES MINGROUP*FRAILY6/CMH;
TABLES INTGROUP*FRAILY6/CMH;
TABLES BRACHGROUP*FRAILY6/CMH;
TABLES CV1AGE*FRAILY6/CMH;
TABLES GENDER*FRAILY6/CMH;
TABLES RACE*FRAILY6/CMH;
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TABLES EDUC*FRAILY6/CMH;
TABLES NEWMAR*FRAILY6/CMH;
TABLES SMK1*FRAILY6/CMH;
TABLES CURDRNK1*FRAILY6/CMH;
TABLES Y1PCHD1*FRAILY6/CMH;
TABLES Y1PCBVD*FRAILY6/CMH;
TABLES Y1PPAD*FRAILY6/CMH;
TABLES Y1PDIAB1*FRAILY6/CMH;
TABLES LOWEROA*FRAILY6/CMH;
TABLES Y1PHBP1*FRAILY6/CMH;
TABLES Y1PDEPR1*FRAILY6/CMH;
TABLES Y1PPULCD*FRAILY6/CMH;
TABLES COUNTDX*FRAILY6/CMH;
RUN;
PROC GLM DATA=FINALFRAIL; 
CLASS MINGROUP; 
MODEL TOTKCAL=MINGROUP; 
LSMEANS MINGROUP; 
RUN;
PROC GLM DATA=FINALFRAIL; 
CLASS INTGROUP; 
MODEL TOTKCAL=INTGROUP; 
LSMEANS INTGROUP; 
RUN;
PROC GLM DATA=FINALFRAIL; 
CLASS BRACHGROUP; 
MODEL TOTKCAL=BRACHGROUP; 
LSMEANS BRACHGROUP; 
RUN;
*TESTING PROPORTIONALITY ASSUMPTION WITH THE FOLLOWING LOGISTIC MODELS; 
DATA FRAIL2; 
SET FINALFRAIL; 
IF FRAILY1 IN(2,3) THEN DELETE;
PROC LOGISTIC DATA=FRAIL2; 
CLASS MINGROUP; 
MODEL FRAILY6=MINGROUP; 
RUN;
PROC LOGISTIC DATA=FRAIL2; 
WHERE INTGROUP NOT=.;
CLASS INTGROUP; 
MODEL FRAILY6=INTGROUP; 
RUN;
PROC LOGISTIC DATA=FRAIL2; 
CLASS BRACHGROUP; 
MODEL FRAILY6=BRACHGROUP; 
RUN;
*PROPORTIONALITY ASSUMPTION NOT MET SO I AM DO ORTHOGANOL OR'S NOW. THIS 
IS ODDS OF BECOMING 
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EITHER MODERATELY OR SEVERELY FRAIL AT YEAR 6. FIRST UNADJUSTED THEN 
ADJUSTED MODELS; 
DATA FRAIL3; 
SET FINALFRAIL; 
IF FRAILY1 IN(2,3) THEN DELETE;
IF FRAILY6 IN (2,3) THEN FRAILY6=2;
RUN;
*UNADJUSTED MODELS; 
PROC LOGISTIC DATA=FRAIL3; 
CLASS MINGROUP; 
MODEL FRAILY6=MINGROUP TOTKCAL; 
RUN;
PROC LOGISTIC DATA=FRAIL3; 
MODEL FRAILY6=INTGROUP TOTKCAL; 
RUN;
PROC LOGISTIC DATA=FRAIL3; 
MODEL FRAILY6=BRACHGROUP TOTKCAL; 
RUN;
*SATURATED MODELS LOOKING FOR INTERACTIONS FIRST WITH CV1AGE GENDER RACE 
EDUC NEWMAR SMK1  
CURDRNK1 Y1PCHD1 Y1PCBVD Y1PPAD Y1PDIAB1 LOWEROA Y1PHBP1 Y1PDEPR1 
Y1PPULCD; 
PROC LOGISTIC DATA=FRAIL3; 
MODEL FRAILY6=  MINGROUP|CV1AGE MINGROUP|GENDER MINGROUP|RACE 
MINGROUP|EDUC  
MINGROUP|NEWMAR MINGROUP|SMK1 MINGROUP|CURDRNK1 
MINGROUP|Y1PCHD1 MINGROUP|Y1PCBVD MINGROUP|Y1PPAD MINGROUP|Y1PDIAB1 
MINGROUP|LOWEROA 
MINGROUP|Y1PHBP1 MINGROUP|Y1PDEPR1 MINGROUP|Y1PPULCD; 
RUN;
PROC LOGISTIC DATA=FRAIL3; 
MODEL FRAILY6= INTGROUP|CV1AGE INTGROUP|GENDER INTGROUP|RACE INTGROUP|EDUC  
INTGROUP|NEWMAR INTGROUP|SMK1 INTGROUP|CURDRNK1 
INTGROUP|Y1PCHD1 INTGROUP|Y1PCBVD INTGROUP|Y1PPAD INTGROUP|Y1PDIAB1 
INTGROUP|LOWEROA  
INTGROUP|Y1PHBP1 INTGROUP|Y1PDEPR1 INTGROUP|Y1PPULCD; 
RUN;
PROC LOGISTIC DATA=FRAIL3; 
MODEL FRAILY6=  BRACHGROUP|CV1AGE BRACHGROUP|GENDER BRACHGROUP|RACE 
BRACHGROUP|EDUC  
BRACHGROUP|NEWMAR BRACHGROUP|SMK1 BRACHGROUP|Y1PPAD BRACHGROUP|Y1PDIAB1 
BRACHGROUP|LOWEROA  
BRACHGROUP|Y1PHBP1 BRACHGROUP|Y1PDEPR1 BRACHGROUP|Y1PPULCD; 
RUN;
*FINAL ADJUSTED MODELS WITH REDUCED FIT TO ONLY INCLUDE SIGNIFICANT 
INTERACTIONS- 
WHICH WERE NONE WHEN REDUCING THE MODEL BACK DOWN- AND OTHER A PRIORI 
COVARIATES. ALSO 
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ADDED COUNTDX INSTEAD OF INDIVIDUAL DX; 
PROC LOGISTIC DATA=FRAIL3; 
CLASS MINGROUP; 
MODEL FRAILY6= MINGROUP TOTKCAL CV1AGE GENDER RACE EDUC NEWMAR SMK1 
CURDRNK1 COUNTDX; 
RUN;
PROC LOGISTIC DATA=FRAIL3; 
CLASS INTGROUP; 
MODEL FRAILY6= INTGROUP TOTKCAL Y1PCHD1  CV1AGE GENDER RACE EDUC  
NEWMAR SMK1 CURDRNK1 COUNTDX; 
RUN;
PROC LOGISTIC DATA=FRAIL3; 
CLASS BRACHGROUP; 
MODEL FRAILY6= BRACHGROUP TOTKCAL CV1AGE GENDER RACE EDUC NEWMAR SMK1 
COUNTDX; 
RUN;
*TESTING ODDS OF LEVEL OF FRAILTY IN THOSE NOT FRAIL AT BASELINE. THIS IS 
ODDS OF  
INCIDENT LEVEL OF SEVERITY OF FRAILTY; 
DATA FRAIL4; 
SET FINALFRAIL; 
IF FRAILY1 IN(2,3) THEN DELETE;
IF FRAILY6=1 THEN DELETE;
RUN;
*UNADJUSTED MODELS; 
PROC LOGISTIC DATA=FRAIL4 DESCENDING;
CLASS MINGROUP; 
MODEL FRAILY6=MINGROUP TOTKCAL; 
RUN;
PROC LOGISTIC DATA=FRAIL4 DESCENDING;
CLASS INTGROUP; 
MODEL FRAILY6=INTGROUP TOTKCAL; 
RUN;
PROC LOGISTIC DATA=FRAIL4 DESCENDING;
CLASS BRACHGROUP; 
MODEL FRAILY6=BRACHGROUP TOTKCAL; 
RUN;
*SATURATED MODELS LOOKING FOR INTERACTIONS FIRST WITH CV1AGE GENDER RACE 
EDUC NEWMAR SMK1  
CURDRNK1 Y1PCHD1 Y1PCBVD Y1PPAD Y1PDIAB1 LOWEROA Y1PHBP1 Y1PDEPR1 
Y1PPULCD; 
PROC LOGISTIC DATA=FRAIL4; 
MODEL FRAILY6=  MINGROUP|CV1AGE MINGROUP|GENDER MINGROUP|RACE 
MINGROUP|EDUC  
MINGROUP|NEWMAR MINGROUP|SMK1 MINGROUP|CURDRNK1 
MINGROUP|Y1PCHD1 MINGROUP|Y1PCBVD MINGROUP|Y1PPAD MINGROUP|Y1PDIAB1 
MINGROUP|LOWEROA 
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MINGROUP|Y1PHBP1 MINGROUP|Y1PDEPR1 MINGROUP|Y1PPULCD; 
RUN;
PROC LOGISTIC DATA=FRAIL4; 
MODEL FRAILY6= INTGROUP|CV1AGE INTGROUP|GENDER INTGROUP|RACE INTGROUP|EDUC  
INTGROUP|NEWMAR INTGROUP|SMK1 INTGROUP|CURDRNK1 
INTGROUP|Y1PCHD1 INTGROUP|Y1PCBVD INTGROUP|Y1PPAD INTGROUP|Y1PDIAB1 
INTGROUP|LOWEROA  
INTGROUP|Y1PHBP1 INTGROUP|Y1PDEPR1 INTGROUP|Y1PPULCD; 
RUN;
PROC LOGISTIC DATA=FRAIL4; 
MODEL FRAILY6=  BRACHGROUP|CV1AGE BRACHGROUP|GENDER BRACHGROUP|RACE 
BRACHGROUP|EDUC  
BRACHGROUP|NEWMAR BRACHGROUP|SMK1 BRACHGROUP|Y1PPAD BRACHGROUP|Y1PDIAB1 
BRACHGROUP|LOWEROA  
BRACHGROUP|Y1PHBP1 BRACHGROUP|Y1PDEPR1 BRACHGROUP|Y1PPULCD; 
RUN;
*FINAL ADJUSTED MODELS WITH REDUCED FIT TO ONLY INCLUDE SIGNIFICANT 
INTERACTIONS- 
WHICH WERE NONE WHEN REDUCING THE MODEL BACK DOWN- AND OTHER A PRIORI 
COVARIATES. ALSO 
ADDED COUNTDX INSTEAD OF INDIVIDUAL DX; 
PROC LOGISTIC DATA=FRAIL4; 
CLASS MINGROUP; 
MODEL FRAILY6= MINGROUP TOTKCAL CV1AGE GENDER RACE EDUC NEWMAR SMK1 
CURDRNK1 COUNTDX; 
RUN;
PROC LOGISTIC DATA=FRAIL4; 
CLASS INTGROUP; 
MODEL FRAILY6= INTGROUP TOTKCAL Y1PCHD1  CV1AGE GENDER RACE EDUC  
NEWMAR SMK1 CURDRNK1 COUNTDX; 
RUN;
PROC LOGISTIC DATA=FRAIL4; 
CLASS BRACHGROUP; 
MODEL FRAILY6= BRACHGROUP TOTKCAL GENDER CV1AGE RACE EDUC NEWMAR SMK1 
CURDRNK1 COUNTDX; 
RUN;
*-------------------------------------------------------------------------
--------------; 
*TESTING ODDS OF LEVEL OF FRAILTY USING GEE MODELING. THIS IS SETTING UP 
ODDS OF  
BECOMING NOT FRAIL V. MODERATELY/SEVERELY FRAIL; 
DATA FRAIL5; 
SET FINALFRAIL; 
IF FRAILY1 IN(2,3) THEN DELETE;
IF FRAILY4 IN (2,3) THEN FRAILY4=2;
IF FRAILY6 IN(2,3) THEN FRAILY6=2;
RUN;
DATA FRAIL6;  
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SET FRAIL5; 
WAVE=4;
FRAILGROUP=FRAILY4; 
OUTPUT;
WAVE=6;
FRAILGROUP=FRAILY6; 
OUTPUT;
KEEP HABCID WAVE MINGROUP INTGROUP BRACHGROUP FRAILY1 FRAILGROUP COUNTDX 
TOTKCAL CV1AGE GENDER 
RACE EDUC NEWMAR SMK1 CURDRNK1 Y1PCHD1 Y1PCHF Y1PCBVD Y1PPAD Y1PDIAB1 
LOWEROA Y1PHBP1 Y1PDEPR1 Y1PPULCD Y1PCANCR P3ABI; 
RUN;
*UNADJUSTED MODELS-ALREADY TESTED FOR PA X WAVE INTERACTIONS AND THEY WERE 
NONSIGNIFICANT 
IN ALL MODELS; 
PROC GENMOD DATA=FRAIL6 DESCENDING;
CLASS HABCID MINGROUP WAVE; 
MODEL FRAILGROUP=MINGROUP WAVE TOTKCAL/DIST=BIN; 
REPEATED SUBJECT=HABCID /TYPE=EXCH COVB CORRW;
run;
PROC GENMOD DATA=FRAIL6 DESCENDING;
CLASS HABCID INTGROUP WAVE; 
MODEL FRAILGROUP=INTGROUP WAVE TOTKCAL/DIST=BIN; 
REPEATED SUBJECT=HABCID /TYPE=EXCH COVB CORRW;
run;
PROC GENMOD DATA=FRAIL6 DESCENDING;
CLASS HABCID BRACHGROUP WAVE; 
MODEL FRAILGROUP=BRACHGROUP WAVE TOTKCAL/DIST=BIN; 
REPEATED SUBJECT=HABCID /TYPE=EXCH COVB CORRW;
run;
*SATURATED MODELS LOOKING FOR INTERACTIONS FIRST WITH CV1AGE GENDER RACE 
EDUC NEWMAR SMK1  
CURDRNK1 Y1PCHD1 Y1PCBVD Y1PPAD Y1PDIAB1 LOWEROA Y1PHBP1 Y1PDEPR1 
Y1PPULCD; 
PROC GENMOD DATA=FRAIL6 DESCENDING;
CLASS HABCID; 
MODEL FRAILGROUP=  WAVE MINGROUP|CV1AGE MINGROUP|GENDER MINGROUP|RACE 
MINGROUP|EDUC  
MINGROUP|NEWMAR MINGROUP|SMK1 MINGROUP|CURDRNK1 
MINGROUP|Y1PCHD1 MINGROUP|Y1PCBVD MINGROUP|Y1PPAD MINGROUP|Y1PDIAB1 
MINGROUP|LOWEROA 
MINGROUP|Y1PHBP1 MINGROUP|Y1PDEPR1 MINGROUP|Y1PPULCD; 
REPEATED SUBJECT=HABCID/TYPE=EXCH COVB CORRW;
RUN;
PROC GENMOD DATA=FRAIL6 DESCENDING;
CLASS HABCID; 
MODEL FRAILGROUP= WAVE INTGROUP|CV1AGE INTGROUP|GENDER INTGROUP|RACE 
INTGROUP|EDUC  
INTGROUP|NEWMAR INTGROUP|SMK1 INTGROUP|CURDRNK1 
INTGROUP|Y1PCHD1 INTGROUP|Y1PCBVD INTGROUP|Y1PPAD INTGROUP|Y1PDIAB1 
INTGROUP|LOWEROA  
INTGROUP|Y1PHBP1 INTGROUP|Y1PDEPR1 INTGROUP|Y1PPULCD; 
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REPEATED SUBJECT=HABCID/TYPE=EXCH COVB CORRW;
RUN;
PROC GENMOD DATA=FRAIL6 DESCENDING;
CLASS HABCID; 
MODEL FRAILGROUP= WAVE BRACHGROUP|CV1AGE BRACHGROUP|GENDER BRACHGROUP|RACE 
BRACHGROUP|EDUC  
BRACHGROUP|NEWMAR BRACHGROUP|SMK1 BRACHGROUP|Y1PPAD BRACHGROUP|Y1PDIAB1 
BRACHGROUP|LOWEROA  
BRACHGROUP|Y1PHBP1 BRACHGROUP|Y1PDEPR1 BRACHGROUP|Y1PPULCD; 
REPEATED SUBJECT=HABCID/TYPE=EXCH COVB CORRW;
RUN;
*FINAL ADJUSTED MODELS WITH REDUCED FIT TO ONLY INCLUDE SIGNIFICANT 
INTERACTIONS- 
WHICH WERE NONE WHEN REDUCING THE MODEL BACK DOWN- AND OTHER A PRIORI 
COVARIATES. ALSO 
ADDED COUNTDX INSTEAD OF INDIVIDUAL DX; 
PROC GENMOD DATA=FRAIL6 DESCENDING;
CLASS HABCID WAVE; 
MODEL FRAILGROUP= MINGROUP WAVE TOTKCAL CV1AGE GENDER RACE EDUC NEWMAR 
SMK1 CURDRNK1 P3ABI  
COUNTDX; 
REPEATED SUBJECT=HABCID/TYPE=EXCH COVB CORRW;
RUN;
PROC GENMOD DATA=FRAIL6 DESCENDING;
CLASS HABCID WAVE; 
MODEL FRAILGROUP= INTGROUP TOTKCAL CV1AGE GENDER RACE EDUC  
NEWMAR SMK1 CURDRNK1 P3ABI COUNTDX; 
REPEATED SUBJECT=HABCID/TYPE=EXCH COVB CORRW;
RUN;
PROC GENMOD DATA=FRAIL6 DESCENDING;
CLASS HABCID WAVE; 
MODEL FRAILGROUP= BRACHGROUP TOTKCAL GENDER CV1AGE RACE EDUC NEWMAR SMK1 
CURDRNK1  
P3ABI COUNTDX; 
REPEATED SUBJECT=HABCID/TYPE=EXCH COVB CORRW;
RUN;
*LOOKING TO SEE IF PA GROUPS PREDICT SEVERITY OF FOLLOW UP FRAILTY STATUS; 
DATA FRAIL7; 
SET FINALFRAIL; 
IF FRAILY1 IN (2,3) THEN DELETE;
IF FRAILY4=1 THEN DELETE;
IF FRAILY6=1 THEN DELETE;
WAVE=4;
FRAILGROUP=FRAILY4; 
OUTPUT;
WAVE=6;
FRAILGROUP=FRAILY6; 
OUTPUT;
KEEP HABCID WAVE MINGROUP INTGROUP BRACHGROUP FRAILY1 FRAILGROUP TOTKCAL 
CV1AGE GENDER 
RACE EDUC NEWMAR SMK1 CURDRNK1 Y1PCHD1 Y1PCHF Y1PCBVD Y1PPAD Y1PDIAB1 
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LOWEROA COUNTDX Y1PHBP1 Y1PDEPR1 Y1PPULCD Y1PCANCR P3ABI; 
RUN;
PROC GENMOD DATA=FRAIL7 DESCENDING;
CLASS HABCID MINGROUP WAVE; 
MODEL FRAILGROUP=MINGROUP WAVE TOTKCAL/DIST=BIN; 
REPEATED SUBJECT=HABCID/TYPE=EXCH COVB CORRW;
run;
PROC GENMOD DATA=FRAIL7 DESCENDING;
CLASS HABCID INTGROUP WAVE; 
MODEL FRAILGROUP=INTGROUP WAVE TOTKCAL/DIST=BIN; 
REPEATED SUBJECT=HABCID /TYPE=EXCH COVB CORRW;
run;
PROC GENMOD DATA=FRAIL7 DESCENDING;
CLASS HABCID BRACHGROUP WAVE; 
MODEL FRAILGROUP=BRACHGROUP WAVE TOTKCAL/DIST=BIN; 
REPEATED SUBJECT=HABCID /TYPE=EXCH COVB CORRW;
run;
*SATURATED MODELS LOOKING FOR INTERACTIONS FIRST WITH CV1AGE GENDER RACE 
EDUC NEWMAR SMK1  
CURDRNK1 Y1PCHD1 Y1PCBVD Y1PPAD Y1PDIAB1 LOWEROA Y1PHBP1 Y1PDEPR1 
Y1PPULCD; 
PROC GENMOD DATA=FRAIL7 DESCENDING;
CLASS HABCID; 
MODEL FRAILGROUP=  WAVE MINGROUP|CV1AGE MINGROUP|GENDER MINGROUP|RACE 
MINGROUP|EDUC  
MINGROUP|NEWMAR MINGROUP|SMK1 MINGROUP|CURDRNK1 
MINGROUP|Y1PCHD1 MINGROUP|Y1PCBVD MINGROUP|Y1PPAD MINGROUP|Y1PDIAB1 
MINGROUP|LOWEROA 
MINGROUP|Y1PHBP1 MINGROUP|Y1PDEPR1 MINGROUP|Y1PPULCD; 
REPEATED SUBJECT=HABCID/TYPE=EXCH COVB CORRW;
RUN;
PROC GENMOD DATA=FRAIL7 DESCENDING;
CLASS HABCID; 
MODEL FRAILGROUP= WAVE INTGROUP|CV1AGE INTGROUP|GENDER INTGROUP|RACE 
INTGROUP|EDUC  
INTGROUP|NEWMAR INTGROUP|SMK1 INTGROUP|CURDRNK1 
INTGROUP|Y1PCHD1 INTGROUP|Y1PCBVD INTGROUP|Y1PPAD INTGROUP|Y1PDIAB1 
INTGROUP|LOWEROA  
INTGROUP|Y1PHBP1 INTGROUP|Y1PDEPR1 INTGROUP|Y1PPULCD; 
REPEATED SUBJECT=HABCID/TYPE=EXCH COVB CORRW;
RUN;
PROC GENMOD DATA=FRAIL7 DESCENDING;
CLASS HABCID; 
MODEL FRAILGROUP= WAVE BRACHGROUP|CV1AGE BRACHGROUP|GENDER BRACHGROUP|RACE 
BRACHGROUP|EDUC  
BRACHGROUP|NEWMAR BRACHGROUP|SMK1 BRACHGROUP|Y1PPAD BRACHGROUP|Y1PDIAB1 
BRACHGROUP|LOWEROA  
BRACHGROUP|Y1PHBP1 BRACHGROUP|Y1PDEPR1 BRACHGROUP|Y1PPULCD; 
REPEATED SUBJECT=HABCID/TYPE=EXCH COVB CORRW;
RUN;
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*FINAL ADJUSTED MODELS WITH REDUCED FIT TO ONLY INCLUDE SIGNIFICANT 
INTERACTIONS- 
WHICH WERE NONE WHEN REDUCING THE MODEL BACK DOWN- AND OTHER A PRIORI 
COVARIATES. ALSO 
ADDED COUNTDX INSTEAD OF INDIVIDUAL DX; 
PROC GENMOD DATA=FRAIL7 DESCENDING;
CLASS HABCID MINGROUP WAVE; 
MODEL FRAILGROUP= MINGROUP WAVE TOTKCAL CV1AGE GENDER RACE EDUC NEWMAR 
SMK1 CURDRNK1  
P3ABI COUNTDX; 
REPEATED SUBJECT=HABCID/TYPE=EXCH COVB CORRW;
RUN;
PROC GENMOD DATA=FRAIL7 DESCENDING;
CLASS HABCID INTGROUP WAVE; 
MODEL FRAILGROUP= INTGROUP SMK1 TOTKCAL CV1AGE GENDER RACE EDUC  
NEWMAR CURDRNK1 P3ABI COUNTDX; 
REPEATED SUBJECT=HABCID/TYPE=EXCH COVB CORRW;
RUN;
PROC GENMOD DATA=FRAIL7 DESCENDING;
CLASS HABCID BRACHGROUP WAVE; 
MODEL FRAILGROUP= BRACHGROUP SMK1 TOTKCAL GENDER CV1AGE RACE EDUC NEWMAR 
CURDRNK1  
P3ABI COUNTDX; 
REPEATED SUBJECT=HABCID/TYPE=EXCH COVB CORRW;
RUN;
*THESE ANALYSES ARE TESTING DIFFERENCES IN PA EFFECT BETWEEN SRATA. IN 
OTHER WORDS, 
DO THOSE WHO ARE FRAIL AT BASELINE CHANGE TO NOT FRAIL WITH HIGH PA 
LEVELS?; 
DATA FRAIL8; 
SET FINALFRAIL; 
IF FRAILY1 IN (1) THEN DELETE;
IF FRAILY1 IN(2,3) THEN FRAILY1=2;
IF FRAILY4 IN(2,3) THEN FRAILY4=2;
IF FRAILY6 IN(2,3) THEN FRAILY6=2;
WAVE=4;
FRAILGROUP=FRAILY4; 
OUTPUT;
WAVE=6;
FRAILGROUP=FRAILY6; 
OUTPUT;
KEEP HABCID WAVE MINGROUP INTGROUP BRACHGROUP FRAILY1 FRAILGROUP TOTKCAL 
CV1AGE GENDER 
RACE EDUC NEWMAR SMK1 CURDRNK1 Y1PCHD1 Y1PCHF Y1PCBVD Y1PPAD Y1PDIAB1 
LOWEROA COUNTDX Y1PHBP1 Y1PDEPR1 Y1PPULCD Y1PCANCR P3ABI; 
RUN;
*MODELS ESTIMATING ODDS OF CHANGING FRAILTY STATUS IN THOSE FRAIL AT 
BASELINE; 
PROC GENMOD DATA=FRAIL8; 
CLASS HABCID MINGROUP WAVE; 
MODEL FRAILGROUP= MINGROUP WAVE TOTKCAL CV1AGE GENDER RACE EDUC NEWMAR 
SMK1 CURDRNK1  
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P3ABI COUNTDX; 
REPEATED SUBJECT=HABCID/TYPE=EXCH COVB CORRW;
RUN;
PROC GENMOD DATA=FRAIL8; 
CLASS HABCID INTGROUP WAVE; 
MODEL FRAILGROUP= INTGROUP SMK1 TOTKCAL CV1AGE GENDER RACE EDUC  
NEWMAR CURDRNK1 P3ABI COUNTDX; 
REPEATED SUBJECT=HABCID/TYPE=EXCH COVB CORRW;
RUN;
PROC GENMOD DATA=FRAIL8; 
CLASS HABCID BRACHGROUP WAVE; 
MODEL FRAILGROUP= BRACHGROUP SMK1 TOTKCAL GENDER CV1AGE RACE EDUC NEWMAR 
CURDRNK1  
P3ABI COUNTDX; 
REPEATED SUBJECT=HABCID/TYPE=EXCH COVB CORRW;
RUN;
*AND MODELS ESTIMATING ODDS OF CHANGING FRAILTY STATUS IN THOSE NOT FRAIL 
AT BASELINE; 
DATA FRAIL9; 
SET FINALFRAIL; 
IF FRAILY1 IN(2,3) THEN DELETE;
IF FRAILY4 IN (2,3) THEN FRAILY4=2;
IF FRAILY6 IN(2,3) THEN FRAILY6=2;
RUN;
DATA FRAIL10;  
SET FRAIL9; 
WAVE=4;
FRAILGROUP=FRAILY4; 
OUTPUT;
WAVE=6;
FRAILGROUP=FRAILY6; 
OUTPUT;
KEEP HABCID WAVE MINGROUP INTGROUP BRACHGROUP FRAILY1 FRAILGROUP COUNTDX 
TOTKCAL CV1AGE GENDER 
RACE EDUC NEWMAR SMK1 CURDRNK1 Y1PCHD1 Y1PCHF Y1PCBVD Y1PPAD Y1PDIAB1 
LOWEROA Y1PHBP1 Y1PDEPR1 Y1PPULCD Y1PCANCR P3ABI; 
RUN;
PROC GENMOD DATA=FRAIL10 DESCENDING;
CLASS HABCID MINGROUP WAVE; 
MODEL FRAILGROUP= MINGROUP WAVE TOTKCAL CV1AGE GENDER RACE EDUC NEWMAR 
SMK1 CURDRNK1  
P3ABI COUNTDX; 
REPEATED SUBJECT=HABCID/TYPE=EXCH COVB CORRW;
RUN;
PROC GENMOD DATA=FRAIL10 DESCENDING;
CLASS HABCID INTGROUP WAVE; 
MODEL FRAILGROUP= INTGROUP TOTKCAL CV1AGE GENDER RACE EDUC  
NEWMAR SMK1 CURDRNK1 P3ABI COUNTDX; 
REPEATED SUBJECT=HABCID/TYPE=EXCH COVB CORRW;
RUN;
156
PROC GENMOD DATA=FRAIL10 DESCENDING;
CLASS HABCID BRACHGROUP WAVE; 
MODEL FRAILGROUP= BRACHGROUP TOTKCAL GENDER CV1AGE RACE EDUC NEWMAR SMK1 
CURDRNK1  
P3ABI COUNTDX; 
REPEATED SUBJECT=HABCID/TYPE=EXCH COVB CORRW;
RUN;
data odds (keep=group est1 est2 est logest low_ci up_ci var Z  q); 
input group $  est1 se1 est2 se2 ; 
 
var1=se1** 2;
var2=se2** 2;
wt=(1 /var1) + (1 /var2); 
logest= ((est1*(1 /var1)) + (est2*(1 /var2))) / wt ; 
var=1 /wt; 
z=logest/sqrt(var); 
est=exp(logest); 
up_ci=exp(logest +1.96 *sqrt(var)); 
low_ci=exp(logest -1.96 *sqrt(var)); 
 
* homogeneity; 
q=(((est1-logest)** 2 )/var1) + (((est2-logest)** 2)/var2); 
 
cards ; 
lotime .1896 .1364 -.0107 .0120 
modtime -.2065 .2257 -.0163 .0214 
sedint .1668 .1626 -.0091 .0194 
lightint .1662 .1437 -.0138 .0148 
modint -.1191 .1806 -.0096 .0152 
sedbrach .1256 .1880 .0348 .0178 
lifbrach .0968 .1578 -.0021 .0121 
 
;
proc print ; 
run ; 
 
*-------------------------------------------------------------------------
------------; 
*TESTING TO SEE WHAT CHARACTERISTICS DROP-OUTS HAD COMPARED TO THOSE THAT 
REMAINED IN THE STUDY; 
DATA DROP; 
SET FINALFRAIL; 
IF FRAILY6=.;
GROUP=2;
RUN;
DATA NOTDROP; 
SET FINALFRAIL; 
IF FRAILY6 NOT=.;
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GROUP=1;
RUN;
PROC SORT DATA=NOTDROP; 
BY HABCID; 
RUN;
PROC SORT DATA=DROP; 
BY HABCID; 
RUN;
DATA DROPALL; 
MERGE DROP NOTDROP; 
BY HABCID; 
RUN;
PROC FREQ DATA=DROPALL; 
TABLES CV1AGE*GROUP/CMH;
TABLES COUNTDX*GROUP/CMH;
TABLES GENDER*GROUP/CMH;
TABLES FRAILY1*GROUP/CMH;
TABLES MINGROUP*GROUP/CMH;
TABLES INTGROUP*GROUP/CMH;
TABLES BRACHGROUP*GROUP/CMH;
RUN;
*ANALYSIS OF THE STABILITY OF THE EXERCISE TIME GROUP OVER TIME; 
DATA PAWAVE1; 
SET FINALFRAIL; 
DROP MINGROUP; 
TOTMIN=Y1WKTIME+HIGHXMIN; 
IF TOTMIN>=200 THEN MINGROUP1=3;
IF 150<=TOTMIN<200 THEN MINGROUP1=2;
IF TOTMIN<150 THEN MINGROUP1=1;
IF (Y2BWTIME+Y2WKTIME)>=200 THEN MINGROUP2=3;
IF 150<=(Y2BWTIME+Y2WKTIME)<200 THEN MINGROUP2=2;
IF (Y2BWTIME+Y2WKTIME)<150 THEN MINGROUP2=1;
IF (Y3BWTIME+Y3WKTIME)>=200 THEN MINGROUP3=3;
IF 150<=(Y3BWTIME+Y3WKTIME)<200 THEN MINGROUP3=2;
IF (Y3BWTIME+Y3WKTIME)<150 THEN MINGROUP3=1;
IF (Y5BWTIME+Y5WKTIME)>=200 THEN MINGROUP5=3;
IF 150<=(Y5BWTIME+Y5WKTIME)<200 THEN MINGROUP5=2;
IF (Y5BWTIME+Y5WKTIME)<150 THEN MINGROUP5=1;
DATA PAWAVE2; 
SET PAWAVE1; 
IF MINGROUP1=. THEN DELETE;
IF MINGROUP2=. THEN DELETE;
IF MINGROUP3=. THEN DELETE;
IF MINGROUP5=. THEN DELETE;
RUN;
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DATA PAWAVE3;  
SET PAWAVE2; 
WAVE=1;
MINGROUP=MINGROUP1; 
WALKMIN=Y1WKTIME; 
OUTPUT;
WAVE=2;
MINGROUP=MINGROUP2; 
WALKMIN=Y2WKTIME; 
OUTPUT;
WAVE=3;
MINGROUP=MINGROUP3; 
WALKMIN=Y3WKTIME; 
OUTPUT;
WAVE=5;
MINGROUP=MINGROUP5; 
WALKMIN=Y5WKTIME; 
OUTPUT;
KEEP HABCID WAVE MINGROUP WALKMIN; 
RUN;
PROC VARCOMP DATA=PAWAVE3 METHOD=TYPE1; 
CLASS HABCID; 
MODEL MINGROUP=HABCID; 
RUN;
PROC GLM DATA=PAWAVE3; 
CLASS WAVE; 
MODEL WALKMIN=WAVE; 
MEANS WAVE/tukey;
RUN;
PROC VARCOMP DATA=PAWAVE3 METHOD=TYPE1; 
CLASS HABCID WAVE; 
MODEL MINGROUP=HABCID WAVE; 
RUN;
PROC VARCOMP DATA=PAWAVE3 METHOD=TYPE1; 
CLASS HABCID WAVE; 
MODEL MINGROUP=HABCID WAVE/FIXED=1;; 
RUN;
